Role of D1 receptor antagonism in contextual fear learning and memory by Heath, Florence
Heath, Florence (2015) Role of D1 receptor antagonism 
in contextual fear learning and memory. PhD thesis, 
University of Nottingham. 
Access from the University of Nottingham repository: 
http://eprints.nottingham.ac.uk/28516/1/PhD%20thesis%20Florence%20Heath.pdf
Copyright and reuse: 
The Nottingham ePrints service makes this work by researchers of the University of 
Nottingham available open access under the following conditions.
· Copyright and all moral rights to the version of the paper presented here belong to 
the individual author(s) and/or other copyright owners.
· To the extent reasonable and practicable the material made available in Nottingham 
ePrints has been checked for eligibility before being made available.
· Copies of full items can be used for personal research or study, educational, or not-
for-profit purposes without prior permission or charge provided that the authors, title 
and full bibliographic details are credited, a hyperlink and/or URL is given for the 
original metadata page and the content is not changed in any way.
· Quotations or similar reproductions must be sufficiently acknowledged.
Please see our full end user licence at: 
http://eprints.nottingham.ac.uk/end_user_agreement.pdf 
A note on versions: 
The version presented here may differ from the published version or from the version of 
record. If you wish to cite this item you are advised to consult the publisher’s version. Please 
see the repository url above for details on accessing the published version and note that 
access may require a subscription.
For more information, please contact eprints@nottingham.ac.uk
  
Role of D1 Receptor 
Antagonism in Contextual 
Fear Learning and Memory 
 
Florence Heath BSc 
 
Thesis submitted to the University of 
Nottingham for the degree of Doctor of Philosophy 
 
July 2015 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
Understanding the modulation of contextual fear learning and memory by the 
neurotransmitter dopamine is important as it could lead to a greater 
understanding of the mechanisms underlying anxiety disorders.  The effect of 
D1 receptor antagonism during the contextual fear learning and memory 
stages was investigated.  In the first set of experiments the D1 receptor 
antagonist SCH 23390 (0.1mg/kg; i.p.) was administered systemically before 
or immediately after contextual fear conditioning to determine whether D1 
receptors are involved in the acquisition and/or consolidation stages.  This 
experiment was followed up by investigating the effects of SCH 23390 infusion 
ŝŶƚŽ ƚŚĞĚŽƌƐĂůŚŝƉƉŽĐĂŵƉƵƐ  ? ?ʅŐ ƉĞƌ ƐŝĚĞ ?ŽƌĂŵǇŐĚĂůĂ  ? ? ? ?ʅŐƉĞƌ ƐŝĚĞ ?ŽŶ
contextual fear acquisition.  The second set of experiments investigated the 
involvement of systemic SCH 23390 in the reconsolidation, retrieval, 
destabilization and extinction of contextual fear.  SCH 23390 was 
administered before or immediately after either a short reactivation or longer 
extinction session.  In the destabilization experiment SCH 23390 was 
administered prior to reactivation and the NMDA receptor antagonist MK-801 
(0.1mg/kg; i.p) immediately after to determine if SCH 23390 could rescue the 
amnesic effects of NMDA receptor antagonism.  It was found that systemic 
and intra-hippocampal but not intra-amygdala SCH 23390 reduced freezing 
during memory retention testing, twenty four hours and seven days after 
conditioning.  There was no effect of SCH 23390 when immediately given after 
conditioning.  There was also no effect of SCH 23390 when given either before 
or after reactivation or extinction sessions.  The destabilization experiment 
was inconclusive as MK-801 was not found to impair memory when 
administered after reactivation.  In conclusion, D1 receptors were found to be 
involved in the acquisition of contextual fear, and this modulation was found 
to occur in the dorsal hippocampus but not the amygdala.  D1 type receptors 
were not found to be involved in the consolidation, retrieval, reconsolidation 
or extinction of contextual fear. 
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General Introduction 
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1.1 Overview 
Learning and memory are essential for survival.  Acquiring knowledge and 
being able to store and recall that knowledge to obtain rewards such as food, 
or to avoid dangers such as predators, could mean the difference between life 
and death.  Learning and memory is therefore a fundamental requirement.  In 
a constantly changing world it is also important that memories can be 
adapted and modified when new and more relevant information about a 
situation becomes available.  Fear learning and memory can be divided into a 
number of different stages including acquisition, consolidation and retrieval.  
Acquisition is when an association or event is originally learnt, consolidation is 
where this learning is encoded into a stable long term memory representation 
and retrieval occurs when this memory representation is recalled at a later 
date.  Additional memory stages include reconsolidation and extinction.  
Reconsolidation is required to return a retrieved, unstable memory back to a 
stable form.  Extinction is where a new memory about an association or event 
is formed that competes with the original memory.  Fear learning and 
memory is very beneficial, however, if it becomes maladaptive then it can 
lead to increased stress and development of anxiety disorders.  Therefore 
understanding the basic mechanisms underlying fear learning and memory 
could lead to insight into such disorders and potentially help in the 
development of treatments. 
 
Associative learning is where two stimuli are experienced together and 
therefore become associated, so that if one stimulus is encountered the other 
stimulus is expected.  The Russian physiologist Pavlov was the first person to 
investigate associative learning (Pavlov, 1927).  He discovered that if a bell 
was rung while a dog was chewing on meat then with time the ringing of the 
bell alone without the meat was enough to cause the dog to salivate.  This 
indicated that the dog had learnt to associate the ringing of the bell with the 
delivery of meat.  This method is known as classical or Pavlovian conditioning.  
The bell is the conditioned stimulus (CS), the meat is the unconditioned 
stimulus (US) and the salivation resulting from the ringing of the bell alone is 
3 
the conditioned response.  Pavlov also found that if the bell was then 
subsequently rung numerous times without being followed by the meat, the 
dogs learnt to no longer associate the two stimuli and stopped salivating to 
the bell.  This is extinction (Pavlov, 1927).  Classical conditioning can also be 
used to investigate fear learning and memory.  Auditory fear conditioning is a 
modification of the method used by Pavlov, where a tone is paired with the 
delivery of an electrical shock, leading to the expression of fear behaviours in 
response to the tone alone.  Another type of classical conditioning is 
contextual fear conditioning (CFC; outlined in section 1.2).  Contexts are a 
multisensory set of circumstances that surround an event.  For example, a 
spatial context includes the space and arrangement of objects within the 
space.  Temporal, interoceptive, cognitive and social contexts also make 
important contributions to an experience (Maren et al., 2013). Contextual fear 
ŵĞŵŽƌǇ ŝƐ ǁŚĞƌĞ Ă ƉĂƌƚŝĐƵůĂƌ ĐŽŶƚĞǆƚ ŝƐ ĂƐƐŽĐŝĂƚĞĚ ǁŝƚŚ  ‘ƵŶƉůĞĂƐĂŶƚ ? ĨĞĂr 
inducing stimuli.  During CFC a previously neutral context (the CS) is 
associated with a fear inducing stimulus (the US) so that the context alone 
induces a fear response.  In studies using rats the context is often a fear 
conditioning chamber and the fear stimulus an electrical footshock (Fanslow 
and Tighe, 1988). Fear conditioning is an excellent experimental method as it 
allows control over the different learning and memory stages and memory 
expression can be easily measured.  It has also been demonstrated in a wide 
array of species from sea snails to humans (Hawkins et al., 1983; Grillon et al., 
2006). 
Dopamine (DA; outlined in section 1.4) is a neurotransmitter that is widely 
distributed throughout the brain.  To exert its physiological responses 
dopamine binds to dopamine receptors that are located on neurons within 
specific brain regions.  There are two main families of dopamine receptors, 
the D1 receptor family and the D2 receptor family.  The activation of these 
receptors by dopamine leads to the initiation of intra-cellular signalling 
cascades resulting in altered gene and protein expression.  Previous research 
has shown that DA is important in fear learning and memory and the 
4 
development of drugs that modulate the effect of DA could potentially be 
used for pharmacological enhancement of psychological therapy used to treat 
anxiety.  The experiments undertaken in this thesis confirm and extend 
previous research by investigating the involvement of the D1 receptor 
signalling in the different contextual fear learning and memory stages. 
1.2 Anxiety Disorders and Contextual Fear Conditioning 
Brain regions thought to be important for contextual fear learning include the 
amygdala and hippocampus.  The neuroanatomy of these brain regions along 
with their intrinsic synaptic pathways and some of the numerous lesion and 
inactivation studies undertaken to ascertain their function during CFC have 
been outlined in sections 1.2.2 to 1.2.6.  The brain pathways thought to 
underlie CFC have been outlined in section 1.2.7 and human CFC in section 
1.2.8.  If human CFC becomes maladaptive then increased stress and the 
development of anxiety disorders such as post traumatic stress disorder 
(PTSD) can occur. These have been outlined below.   
It is potentially beneficial for future therapy advancement to understand the 
mechanisms and brain regions underlying CFC.  Extinction (outlined in section 
1.3) based treatments such as exposure therapy, are widely used to treat 
anxiety disorders.  Functional magnetic resonance imaging (fMRI), a non-
invasive method where increased blood flow is used as a measure of 
increased activity in different brain regions of interest,  was used in 
participants with PTSD to assess brain activity during extinction training and 
recall (Milad et al., 2009).  Participants first underwent fear conditioning to a 
background picture of a room in which a lamp was represented with different 
coloured lights (e.g. blue, red or yellow). Two of the lamp colours were paired 
with a shock to the hand and the other was presented without shock.  
Extinction training was then undertaken in which one of the coloured lamps 
which was previously associated with receiving a shock was represented in a 
different background picture and was this time presented without the shock.  
The next day extinction recall was tested by presenting the original 
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background pictures and lamp colours.  Skin conductance responses were 
used as a measure of fear.  It was found that PTSD patients had impaired 
extinction recall compared with controls (trauma exposed non-PTSD subjects).  
It was also found that PTSD patients had higher activation of the amygdala 
during extinction, whereas lower activation of the hippocampus was found 
during extinction recall (Milad et al., 2009).  One of the main problems with 
extinction based therapies is that the fear can often return.  This is also 
encountered in experimental extinction studies in the form of spontaneous 
recovery.  The reconsolidation process (outlined in section 1.3), in which the 
original memory trace can be modulated, is therefore also a potential 
treatment for anxiety disorders, either alone or in combination with 
extinction.   Spontaneous recovery of fear was found to be alleviated if 
extinction training was carried out within the reconsolidation time window 
(Schiller et al., 2010).  Extinction training conducted ten minutes, but not six 
hours, after reactivation was more effective at reducing fear as measured 
using skin conductance responses (Schiller et al., 2010).  This finding however 
was not replicated in another study (Kindt and Soeter, 2013), although it 
differed in the use of fear relevant conditioned stimuli (e.g. picture of a spider 
as opposed to geometric shapes) and behavioural measures (startle responses 
and expectancy ratings) which could explain the different results obtained 
(Kindt and Soeter, 2013). 
 
1.2.1 Anxiety Disorders  
There are a number of different types of anxiety disorders including simple 
phobias and PTSD (American Psychiatric Association, 2013).  These conditions 
involve uncontrollable, exaggerated and inappropriate fear responses that 
impede everyday living and functioning.  Simple phobias are where certain 
things (e.g. snakes or spiders) elicit a strong fear response.  Preparedness 
theory is the idea that fearful things are more likely to be learnt about and 
remembered because evolution prepared humans and animals for these types 
of stimuli, due to their potential danger.  PTSD is where exceptionally 
traumatic events have been experienced or witnessed.  Incidents of PTSD are 
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higher in war veterans and people who have suffered physical or sexual 
assault compared with the general population.  An estimated 3% of the UK 
population will suffer from PTSD at some point in their lives.  Traumatic 
learning underlies anxiety disorders such as phobias and PTSD and therefore 
some level of fear conditioning is involved.  CFC is thought to be particularly 
relevant in PTSD as the US is unpredictable and background cues that are 
present during the traumatic experience, when encountered later, are able to 
trigger the strong emotional responses.  For example, in a study examining 
contextual and cued conditioning in humans, it was found that CFC was 
stronger in an unpredictable context (Grillon et al., 2006).  In this study, the 
predictable virtual context was a particular room in which the switching on of 
a virtual lamp with a particular coloured light was paired with receiving hand 
shocks. In a second virtual room the delivering of shocks was unpredictable 
ĂŶĚ Ă ƚŚŝƌĚ  ‘ƐĂĨĞ ? ǀŝƌƚƵĂů ƌŽŽŵ ǁĂƐ ŶŽƚpaired with any shocks.  Fear was 
measured using potentiated startle of the eye-blink reflex to a burst of white 
noise, behavioural avoidance assessed by which virtual room participants 
subsequently chose to enter to receive a monetary reward and self reports of 
subjective feelings of anxiety toward each of the three rooms.   It was found 
that CFC was stronger in the unpredictable context whereas cued fear was 
stronger in the predictable one (Grillon et al., 2006). 
1.2.2 The Neuroanatomy of Contextual Fear 
The amygdala and hippocampus (see Fig 1.1) are brain regions that have been 
shown to have an important role in CFC.  The work in this thesis focuses on 
these structures, which have therefore been outlined in detail below along 
with studies investigating the input and output pathways to these brain 
regions, thought to be active during CFC. 
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Fig 1.1 Coronal section of the rat brain showing the sub-regions of the 
hippocampus (DG dentate gyrus, CA1 cornu ammonis 1, CA2 cornu ammonis 
2, CA3 cornu ammonis 3) and amygdala (laAMY lateral nucleus, blAMY 
basolateral nucleus and bmAMY basomedial nucleus, cAMY central nucelus) 
(modified form Paxinos and Watson, 2009) 
 
 
1.2.3 The Amygdaloid Complex 
The amygdaloid complex is located in the medial temporal lobe (see Fig 1.1).  
It comprises around thirteen nuclei including the lateral (laAMY), basolateral 
(blAMY), basomedial (bmAMY; also known as the accessory basal), central 
(cAMY), cortical and medial nuclei as well as the lateral and ventral 
intercalated paracapsular islands (IPC) and the amygdala part of the bed 
nucleus of stria terminalias.  The laAMY, blAMY and bmAMY can be grouped 
together as the basolateral complex (BLA).  The amygdala nuclei can be 
further subdivided for example the blAMY and bmAMY can each be divided 
into magnocelluar and parvicellular subdivisions and the cAMY includes the 
lateral and medial subregions (Sah et al., 2003; Lee et al., 2013). 
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Information in the amygdaloid complex flows medially from the BLA, the main 
input structure, to the medial cAMY, the main output structure (see Fig 1.2).  
Unimodal and polymodal sensory information enters the amygdala via the 
laAMY or bmAMY.  The laAMY projects to and receives reciprocal projections 
from the bmAMY and blAMY.  The blAMY and bmAMY both project to the 
medial division of the cAMY.  The medial cAMY receives inputs from many 
amygdala nuclei but only sends sparse reciprocal projections (Sah et al., 
2003).  Information is trafficked between the BLA and cAMY via the IPCs.  The 
BLA, cAMY and IPCs are composed of different neuronal types.  The BLA 
contains mainly pyramidal-like glutamergic projection neurons, whereas 
cAMY contains medium spiny GABAergic projection neurons.  The IPCs are 
composed of GABAergic interneurons (Sah et al., 2003).  Under normal, non-
fearful conditions the BLA glutamergic projection neurons are kept under 
basal suppression by the GABAergic inhibitory neurons located in the laAMY 
and lateral IPC.  Likewise, the medial cAMY GABAergic projection neurons are 
inhibited by GABAergic neurons located in the lateral cAMY and ventral IPC 
(Lee et al., 2013). 
 
1.2.4 The Amygdaloid Complex and Contextual Fear Memory 
Lesion studies of the amygdala demonstrate that it is important for contextual 
fear memory.  Electrolytic lesions of the amygdala created by passing anodal 
current prior to CFC impaired freezing behaviour (a commonly used measure 
of fear, see section 1.2.7) immediately and twenty four hours later (Kim et al., 
1993; Phillips and LeDoux, 1992).  Excitotoxic BLA lesions using N-methyl D-
aspartate (NMDA) prior to or after conditioning impaired freezing to 
background context indicating that the BLA lesions result in both anterograde 
and retrograde amnesia (Maren et al., 1996a).  Inactivating the BLA 
temporally, using muscimol (a GABAA receptor agonist) prior to CFC also 
impaired freezing twenty four hours later (Helmstetter and Bellgowan 1994; 
Muller et al., 1997; Maren and Holt, 2004).  However other studies found that 
rats with lesions of the BLA can learn contextual fear with extensive over-
training (Maren, 1999; Ponnusamy et al., 2007).  Over-training on the other 
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hand, did not prevent retrograde amnesia (Maren, 1999; Ponnusamy et al., 
2007).  This implies that the BLA is normally required for the acquisition of 
contextual fear; however, if the BLA is inactivated rats can learn but do so 
inefficiently.  This would indicate that other brain structures are able to 
compensate for the loss of the BLA.  The bed nucleus of the stria terminalis 
(BNST) has been shown to be able to do this as lesions of both the BLA and 
BNST prevented acquisition of contextual fear after extensive over-training, 
whereas BLA lesions alone did not (Poulos et al., 2010).  As mentioned above, 
another crucial structure for CFC is the hippocampus, which is discussed in 
more detail below. 
 
1.2.5 The Hippocampal Formation  
The hippocampal formation (see Fig 1.1) is located in the medial temporal 
lobe and includes the hippocampus proper, dentate gyrus (DG), subiculum, 
presubiculum, parasubiculum and entorhinal cortex (EC) (Golgi et al., 2001).  
The three sub regions of the hippocampus proper are named cornu ammonis 
(CA1, CA2 and CA3).  The hippocampal formation can be divided into dorsal, 
intermediate and ventral regions (Fanselow and Dong, 2010).  The dorsal 
hippocampus (dHC) is thought to be predominantly associated with cognitive 
and spatial processes whereas the ventral hippocampus (vHC) with its direct 
projections to the amygdala is thought to be important for emotions such as 
fear (Fanselow and Dong, 2010). 
 
Information flows through the hippocampal formation via a unidirectional 
intrinsic pathway (see Fig 1.2).  Polymodal sensory information from the 
cortex (e.g. the perirhinal and postrhinal cortices) and subcortical (e.g. the 
thalamus) regions enters the superficial layer of the EC (Anderson et al., 
2007).  The EC projects to the DG via the perforant pathway. The DG granule 
cells extend their mossy fibres to the CA3 region which, in turn, projects to 
the CA1 via the Schaffer collaterals.  The CA1 projects to both the subiculum 
and the deep layers of the EC.  The subiculum also projects to the EC along 
with the presubiculum and parasubiculum.  The presubiculum and 
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parasubiculum send projections to subcortical regions whereas the EC 
projects back to the cortex, closing the pathway loop (Anderson et al., 2007).  
The principal neuronal type of the hippocampus proper, subiculum, 
presubiculum, parasubiculum and EC are glutamatergic pyramidal neurons, 
whereas the principal cells in the DG are the granule cells.  All regions of the 
hippocampal formation contain many different types of inhibitory GABAergic 
interneurons (Anderson et al., 2007). 
 
1.2.6 The Hippocampal Formation and Contextual Fear Memory 
Numerous studies have been undertaken in which permanent or transient 
lesions of the hippocampus have been used to assess its involvement in 
contextual fear.  These studies produced mixed findings however on balance 
it would seem that the dHC and most likely the vHC are important in 
contextual fear under normal circumstances.  Initial studies found that lesions 
of the dorsal or ventral hippocampus caused anterograde amnesia of 
contextual fear (Kim et al., 1993; Young et al., 1994).  Electrolytic (using 
anodal current) and neurotoxic (using NMDA) dHC lesions prior to 
conditioning impaired freezing twenty four hours later (Kim et al., 1993; 
Young et al., 1994).  Temporary dHC or vHC inactivation using muscimol was 
also found to impair CFC (Zhang et al., 2014).  Likewise, inactivation of the vHC 
using tetrodotoxin (Na+ channel inhibitor) or muscimol blocked CFC (Bast et 
al., 2001; Zhang et al., 2014).  Other studies, however, found that while dHC 
neurotoxic lesions (using NMDA) made after CFC produced severe retrograde 
amnesia, lesions made prior to conditioning did not (Maren et al., 1997).  
Muscimol infusions into either the dHC or the vHC prior to CFC were also not 
found to impair acquisition (Matus-Amat et al., 2004; Maren and Holt, 2004).  
Lesioned rats did not learn as efficiently as control rats but this was overcome 
with increased conditioning trials, whereas lesions made after conditioning 
resulted in complete retrograde amnesia (Wiltgen et al., 2006).  It would 
therefore seem that the training protocol strongly influences whether or not 
hippocampal lesions prior to conditioning produce anterograde amnesia.  Less 
challenging CFC protocols (i.e. with greater number of shocks and context 
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exposure) would appear to be able to be acquired without the hippocampus 
(Fanselow, 2010).  The dynamic memory systems theory postulates that under 
normal circumstances the hippocampus is important in contextual fear 
acquisition, however if the hippocampus is unavailable, other competing 
memory systems can compensate for its loss (Fanselow, 2010).  The 
infralimbic cortex (IL) and prelimbic cortex (PL) subregions of the medial 
prefrontal cortex (mPFC) have been proposed to be a competing memory 
system for contextual fear as dHC and IL or PL NMDA neurotoxic lesions prior 
to CFC resulted in impaired learning whereas dHC lesions alone did not 
(Zelikowsky et al., 2013). 
 
1.2.7 Fear Conditioning Pathways 
During CFC, contextual information inputs to the amygdala from the 
hippocampus. Somatosensory pain information from the spinothalamic tract 
terminates in the posterior thalamus which in turn projects to the amygdala.  
The amygdala has therefore been proposed to be a potential site of CS-US 
convergence during CFC (Fendt and Fanselow, 1999; LeDoux, 2000). The 
amygdala connects to brainstem regions involved in eliciting physiological 
responses and behavioural expression of fear (e.g. freezing behaviour, release 
of glucocorticoids; Fendt and Fanselow, 1999; LeDoux, 2000). This is discussed 
in more detail below.  
 
Input pathways: 
The amygdaloid complex receives both modality specific and polymodal 
sensory inputs and is therefore proposed to be the site of the CS-US 
association (LeDoux, 2000).  Polymodal inputs project to the amygdala from 
the hippocampal formation and prefrontal cortex (Sah et al., 2003).  Using the 
anterograde tracer Phaseolus vulgaris-leucoagglutinin (which is taken up by 
the cell bodies and transported by the axons to the synapses), extensive 
reciprocal connections between the ventral hippocampal formation and 
amygdaloid compex have been identified (Canteras and Swanson, 1992; 
Pikkarainen et al., 1999).  Heavy reciprocal projections exist between the BLA 
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and the EC which also projects to the cAMY but does not receive reciprocal 
projections from this amygdala subregion (Pikkarainen et al., 1999).  The 
blAMY and bmAMY project to CA3, CA2 and CA1 but these are only 
reciprocated by the CA1.  The subiculum projects to the BLA and cAMY and 
receives projections back from the blAMY and bmAMY (Pikkarainen et al., 
1999).  Hippocampal nuclei such as the DG that do not have direct 
connections with the amygdala can receive information via intra-hippocampal 
circuitry (Pitkanen et al., 2000).  In another study a recombinant virus that 
expressed channel rhodopsin (a protein that can be activated by light) fused 
with the fluorescent markers mCherry or eYFP was injected into the vHC.  
Dense fluorescent labelling was observed in the blAMY (Hubner et al., 2014).  
Both principal neurons and interneurons in the blAMY were shown to receive 
excitatory glutamatergic monosynaptic projections from the vHC (Hubner et 
al., 2014).  It has also been shown that high frequency electrical stimulation of 
the ventral angular bundle which projects between the hippocampus and BLA 
produced long term potentiation (LTP) in the BLA of anesthetized rats (Maren 
and Fanselow, 1995).  Likewise high frequency electrical stimulation in the 
BLA was found to produce LTP in the DG of the hippocampus (Abe et al., 
2003).  There are also extensive connections between the amygdala and the 
mPFC which includes the PL and IL regions.  The PL sends dense projections to 
the blAMY and cAMY and is thought to be important for fear expression 
whereas the IL projects to a wider distribution of amygdala nuclei including 
the BLA, cAMY and IPCs and is proposed to suppress fear (Vertes, 2004; 
Hubner et al., 2014). 
 
Modality specific nociceptive information from the spinothalamic tract has 
been shown to input to the amygdala via the posterior thalamus.  
Spinothalamic tract neurons have been shown to terminate in the posterior 
thalamus. The anterograde tracer wheat germ agglutinin-conjugated 
horseradish peroxidise was injected into the spinal cord and found to 
terminate in the posterior thalamus which includes the medial geniculate and 
the posterior intralaminar nucleus (LeDoux et al., 1987).  Lesions of the 
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posterior thalamus were found to block the acquisition of auditory fear 
conditioning (LeDoux et al. 1986).  Projections from the posterior thalamus, 
including the medial geniculate body and the posterior intra laminar nucleus 
have been shown to terminate in a number of amygdala nuclei including the 
laAMY, blAMY, bmAMY and cAMY (LeDoux et al. 1985; LeDoux et al., 1990).  
During fear conditioning local inhibitory circuits within the amygdala are 
thought to control the flow of information between the BLA and cAMY 
enabling activation of output pathways and expression of fear (see Fig 1.2). 
Cortical projections (most likely from the mPFC) suppress feedforward 
inhibition of the GABAergic neurons located in the lateral IPC thereby 
disinhibiting the glutamatergic projection neurons of the BLA.  The bmAMY 
and blAMY project to the medial cAMY leading to activation of GABAergic 
output neurons projecting to the periaqueductal grey (PAG) (Lee et al., 2013) 
discussed in more detail below. 
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Fig 1.2 Contextual fear conditioning circuitry  
During CFC US information inputs to the BLA via the posterior thalamus and 
contextual CS information inputs to the BLA from the EC and subiculum.  The 
inhibition of the BLA by the lateral IPC is disinhibited by projections from the 
mPFC.  The BLA projects to the cAMY which in turn projects to the PAG 
leading to the expression of freezing behaviour.  
 
 
Output pathways: 
The medial CE is thought to be the main output region of the amygdaloid 
complex and therefore has an important role in fear expression (LeDoux, 
2000).  The main behavioural measures of fear expression include freezing 
behaviour (see below), release of corticosteroids, hypoalgesia (pain 
reduction), increased arterial pressure and heart rate and suppression of 
appetitive responding.  Lesions of the corticomedial region of the rat 
amygdala, which includes the cAMY, resulted in reduced freezing responses to 
a natural predator (the cat) and to placement in a context previously 
associated with footshocks (Blanchard and Blanchard, 1972).  Lesions of the 
cAMY and BLA prior to CFC impaired conditional hypoalgesia and freezing 
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twenty four hours later (Helmstetter, 1992) and arterial pressure and heart 
rate were increased in rats following electrical stimulation of the cAMY (Iwata 
et al., 1987).   
 
Freezing behaviour is defined as no movement apart from that caused by 
respiration.  It is an adaptive fear response of rats as it makes them less likely 
to be observed and therefore attacked by predators.  Experimentally, freezing 
behaviour can be easily measured and is the method used in the experiments 
carried out in this thesis.  The assessment of freezing behaviour assumes that 
if a rat is moving (i.e. not freezing) then it is not afraid.  However some rats 
will express their fear in a more active form (i.e. try to escape the chamber).  
Activation of cAMY type 1 cells, which display a prominent depolarizing after 
potential, results in suppression of cholinergic ventral forebrain neurons that 
are important for exploratory behaviour leading to passive expression of fear 
(e.g. freezing) whereas inhibition of these neurons leads to active fear 
responses (Gozzi et al., 2010).  Differences in the numbers of cAMY type 1 
cells could therefore potentially explain variation in freezing levels seen 
between rats given the same conditioning training (Gozzi et al., 2010). 
 
The cAMY projects to brainstem regions important for freezing behaviour for 
example the PAG.  The PAG has been shown to be required for freezing 
behaviour as lesions impaired freezing to footshock administration or the 
presence of a cat (Liebman et al., 1970; LeDoux et al., 1988; De Oca et al., 
1998) and stimulation of the dorsal PAG (dPAG) results in freezing and escape 
defensive behaviours in rats (Brandao et al., 1982).  The PAG is also important 
in suppression of pain; ventral and dorsal lesions impaired hypoalgesia (as 
assessed by tail flick; Helmstetter and Tershner, 1994).  PAG lesions do not 
however, affect arterial pressure (LeDoux et al., 1988; Helmstetter and 
Tershner, 1994), whereas lateral hypothalamus lesions do (LeDoux et al., 
1988).  The hippocampus and amygdala have been shown to be involved in 
PAG dependent freezing behaviour.  Lesions of the vHC but not dHC increased 
the threshold of dPAG stimulation that elicited freezing or escape responses 
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but did not impair freezing behaviour following dPAG stimulation (Ballesteros 
et al., 2014).  However, muscimol inactivation of the laAMY, BLA or cAMY had 
no effect on the freezing and escape thresholds but did impair post 
stimulation freezing (Martinez et al., 2006). 
 
1.2.8 Contextual Fear Conditioning in Humans 
A number of studies have been undertaken to investigate the involvement of 
the amygdala and hippocampus during CFC in humans.  These studies have 
yielded mixed results.  In one study, sustained contextual anxiety was found 
to increase cerebral blood flow in a number of regions including the 
hippocampus, PFC and PAG but not the amygdala.  In contrast, visual cues 
predicting shocks resulted in increased cerebral blood flow in brain regions 
including the PFC and amygdala but not the hippocampus (Hasler et al., 2007).   
The effect of CFC on hippocampal and amygdala volume was investigated in 
another study (Pohlack et al., 2012).  The conditioned contextual stimuli (CS+ 
and CS-) were two coloured backgrounds (orange and blue).  CS+ was paired 
with an electrical shock to the right thumb whereas CS- was unpaired.  It was 
found that participants with larger hippocampal volume were more efficient 
at acquiring contextual fear compared to those with smaller volumes and that 
the posterior hippocampus (equivalent to the dHC in rats) was most 
important for this.  Amygdala volume, however, was not found to affect CFC 
(Pohlack et al., 2012).  In another study using the same conditioning methods 
it was found that there was increased activity in the hippocampus and 
anterior cingulate cortex during early acquisition to the CS+ whereas the 
amygdala and inferior frontal cortext (part of the PFC) was found to be active 
during late acquisition.  Connectivity analysis showed correlated activity 
between the hippocampus and anterior cingulate cortex during acquisition 
(Lang et al., 2009).  Other studies used pictures of rooms as contextual stimuli.  
One study found that the hippocampus but not the amygdala was activated 
by CS+ presentation (Marschner et al., 2008).  However in another study the 
amygdala was found to be activated by the CS+ (LaBar et al., 1998).  Both the 
hippocampus and the amygdala showed increased activity in a study in which 
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virtual reality apparatus was used to create a more realistic context (Alvarez 
et al., 2008).  On balance the above studies indicate that the human 
hippocampus and amygdala, similar to that found for the rat, are involved in 
contextual fear memory processing.   
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1.3 Stages of Learning and Memory 
Learning and memory can be divided into a number of different stages; these 
include acquisition, consolidation, retrieval, reconsolidation, destabilization 
and extinction.  Learning or acquisition is the first stage in memory formation.  
In CFC this is where the animals learn to associate the fear conditioning 
chamber with the footshocks. Memory acquisition has been proposed to 
involve Hebbian mechanisms.  The induction of LTP fits with the Hebbian 
model of learning and is thought to underlie memory acquisition.  
Consolidation is where a short term memory (STM), which is unstable and 
vulnerable to manipulation, is converted to stable long term memory (LTM).  
This idea was first proposed in 1900 by Muller and Pilzecker who found, 
working with humans, that interference of new learning impaired original 
learning (McGaugh, 2000).  Further evidence supporting this theory came 
initially from rodent studies showing that electroconvulsive shock, if applied 
directly after memory acquisition, disrupted memory formation leading to 
retrograde amnesia. In contrast the central nervous system stimulant 
strychnine (which acts by blocking glycine receptors) led to memory 
enhancement (Duncan, 1949; McGaugh and Krivanek, 1970). 
 
Retrieval or recall is the activation of a previously consolidated memory trace.  
In fear conditioning, a CS-US association can be retrieved by presentation of 
the CS alone.  It has been shown using transgenic mice that some of the same 
amygdala neurons that were activated during auditory fear conditioning were 
also active during retrieval (Reijmers et al., 2007).  Expression refers to the 
behaviours that are associated with the memory when it is retrieved; for 
example, freezing is a classic fear behaviour that is expressed in mice and rats.  
Experimentally it can be difficult to distinguish between retrieval and 
expression.  Many experiments use expression (i.e. freezing behaviour) as a 
measure of retrieval and the terms are often used interchangeably. The term 
retrieval has been used in this thesis, although in most of the studies outlined 
it cannot be ruled out that expression, rather than retrieval, is being affected.  
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Retrieval and expression are independent processes and therefore caution 
should be taken when interpreting results (Barreiro et al., 2013). 
 
Reconsolidation is where a destabilized memory is returned to a stable form.  
It has been shown by numerous studies that if a consolidated memory is 
reactivated it can become labile and vulnerable to manipulation and therefore 
requires reconsolidation in order to be restabilized again.  For example, 
electroconvulsive shock applied after reactivation of a consolidated memory 
impairs that memory (Misanin et al., 1968), whereas strychnine application 
causes enhancement (Gordon, 1977).  This provided support for the proposal 
that memories either newly acquired or already consolidated should be 
classed as either being in an inactive state in which they are relatively stable 
or an active state in which they are vulnerable to manipulation (Lewis, 1979). 
The process of reconsolidation has been shown across a large number of 
memory paradigms and species, including humans (Walker et al., 2003).  
Reconsolidation has been shown to depend on many of the same but also 
some different macromolecules as consolidation.  For example, it was found 
using antisense oligodeoxynucleotides (which inhibit local protein synthesis) 
infused into the DH that the immediate early gene Zif268 and brain derived 
neurotrophic factor (BDNF) show doubly dissociable roles in reconsolidation 
and consolidation, respectively, of contextual fear memory (Lee et al., 2004). 
In rats infused with BDNF antisense oligodeoxynucleotides, consolidation of 
LTM was impaired, whereas Zif268 antisense oligodeoxynucleotides had no 
effect.  Zif268 antisense oligodeoxynucleotides infused rats, on the other 
hand, had impaired post reactive long term memory (PR-LTM; memory tested 
following a reactivation session) whereas BDNF antisense 
oligodeoxynucleotides infused rats did not (Lee et al., 2004).  Reconsolidation 
has been shown to be a separate process from extinction (Duvarci et al., 
2006).  In this study each rat was trained to have two different auditory fear 
memories by using two different CSs (a tone or white noise).  The next day 
one of the auditory memories was reactivated for a short time period to 
induce reconsolidation whereas the other auditory memory was reactivated 
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for a longer period to induce extinction.  Anisomycin was then infused into the 
BLA.  It was found that reconsolidation but not extinction was impaired 
indicating that the two processes are independent (Duvarci et al., 2006).  The 
process of reconsolidation has been extensively studied; however, in order for 
a memory to be restabilized it must first undergo a destabilization process.  
Recent studies have started to investigate this memory stage. 
 
Extinction is where repeated or prolonged presentation of an unreinforced CS 
results in a new memory being formed that competes with the previously 
learnt association to suppress conditioned behaviour (Pavlov, 1927).  For 
example, previously conditioned contextual stimuli presented for prolonged 
durations without footshocks are no longer feared, as measured by reductions 
in freezing behaviour.  Extinction is new learning and includes a number of 
stages, including acquisition, consolidation and retrieval (Quirk and Mueller, 
2008).  More recently it has been demonstrated that extinction memories can 
also undergo reconsolidation (Rossato et al., 2010).  Following extinction 
training, the original conditioned response can spontaneously recover with 
time.  Conditioned responses have also been found to be reinstated if the 
animal is exposed to the original unconditioned stimulus or renewed if the 
conditioned stimulus is presented in a different context to where extinction 
training occurred (Herry et al., 2010).  Because fear memories can undergo 
spontaneous recovery, renewal and reinstatement after extinction it has 
generally been accepted that extinction involves new learning that 
suppresses, rather than erases, the fear memory.    
 
Numerous neurobiological mechanisms have been demonstrated to be 
required during the different learning and memory stages.  These include LTP 
induction or reversal, protein synthesis or degradation, N-methyl D-aspartate 
(NMDA) and a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
ionotropic glutamate receptor activation and synthesis of macromolecules 
such as cyclic AMP-response element binding protein (CREB).  Studies 
investigating the involvement of these mechanisms during acquisition, 
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consolidation, retrieval, reconsolidation, destabilization and extinction have 
therefore been outlined below. 
 
1.3.1 The Neurobiology of Acquisition 
Research has demonstrated that LTP induction and NMDA receptor (NMDAR) 
and AMPA receptor (AMPAR) activation are involved in the process of 
memory acquisition.  These studies have been outlined below. 
 
1.3.1.1 Acquisition and Long Term Potentiation  
/Ŷ ŚŝƐ ŝŶĨůƵĞŶƚŝĂů ďŽŽŬ  ‘KƌŐĂŶŝǌĂƚŝŽŶ ŽĨ ĞŚĂǀŝŽƵƌ ? published in 1949, Hebb 
proposed that increased synaptic efficiency could be brought about by 
concurrent activation of pre- and post-synaptic neurons (Sejnowski, 1999).  A 
type of activity-dependent plasticity is LTP which is a lasting enhancement in 
synaptic efficiency in a post-synaptic neuron brought about by stimulation of 
both neurons and is a form of Hebbian plasticity.  LTP has been demonstrated 
in both the hippocampus (Bliss and Lomo, 1973) and amygdala (Rogan et al., 
1997) and has been produced in the DG by high frequency stimulation of the 
BLA (Abe et al., 2003).  It has been shown that LTP is induced in the 
hippocampus of rats by fear learning (Whitlock et al., 2006).  Theta (4-12 Hz) 
and gamma (30-100 Hz) oscillations precede electrically-induced LTP in the 
hippocampus of awake-behaving rats (Bikbaev and Manahan-Vaughan, 2008). 
 
1.3.1.2 Acquisition and NMDA Receptors  
LTP can be induced by activation of NMDARs (Malenka and Nicoll, 1999).  
NMDARs are ionotropic receptors that require binding of glutamate and 
sufficient depolarization leading to movement of Mg2+, opening up the pore 
and enabling the influx of cations, including Ca2+.  Because of this unique 
property of NMDARs they have been proposed to act as coincidence detectors 
ĂŶĚ Ĩŝƚ ǁĞůů ǁŝƚŚ ,Ğďď ?Ɛ ŵŽĚĞů ŽĨ ůĞĂƌŶŝng (Sejnowski, 1999). NMDARs are 
heterotetramers composed of GluN1 and GluN2 subunits.  Activation of 
NMDARs enables the influx of cations, including Ca2+, into the dendrite which 
is a critical trigger of LTP, leading to autophosphorylation of calcium-
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calmodulin-dependent protein kinase II (CaMKII); this process plays an 
important role in memory formation (Silva, 2003).  Studies using a variety of 
NMDAR antagonists have demonstrated that they are required during fear 
learning.  In one study, systemic administration of the non selective NMDAR 
antagonist (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-
imine maleate (MK-801) prior to conditioning impaired freezing to contextual, 
but not auditory stimuli twenty four hours later (Gould et al., 2002).  This 
effect was found to be mediated by the GluN2B subunit of the NMDAR as 
systemic administration of ifenprodil (GluN2B antagonist) impaired the 
acquisition of both auditory fear conditioning and CFC (Rodrigues et al., 2001).  
Intraventricular infusion of another NMDAR antagonist DL-2-amino-5-
phosphonovaleric acid (APV) has also been shown to impair the acquisition of 
CFC (Kim et al., 1991).  Studies in which the NMDAR antagonists were infused 
into the amygdala and hippocampus have shown that these brain regions are 
important in NMDAR mediated memory acquisition. Intra-amygdala infusion 
of APV blocked acquisition of second order fear conditioning (Gewirtz and 
Davis, 1997) and fear potentiated startle (FPS) (Miserendino et al., 1990).  
Second order fear conditioning involves two conditioned stimuli; for example, 
two distinct tones, one (CS1) of which is associated with a footshock so that it 
elicits a fear response.  CS1 is then associated with CS2 so that it then also 
elicits a fear response when presented alone.  FPS is where a salient stimulus, 
such as a footshock, is associated with a neutral stimulus, such as a light; the 
effect of then presenting the light alone with a startling noise is measured.  If 
an association between the shock and light has been learnt, then the light 
when presented with the noise will potentiate the startle reflex.  Intra-
amygdala APV has also been shown to block the acquisition of contextual fear 
(Maren et al., 1996b) and this was shown to involve the GluN2B subunit 
(Rodrigues et al., 2001).  Intra-hippocampal APV infusions were found to 
impair CFC (Young et al., 1994; Quinn et al., 2005).  Intra-hippocampal 
infusions of MK-801 also blocked contextual but not auditory cued fear (Bast 
et al., 2003).  In another study however, it was found that GluN2A-containing, 
rather than GluN2B containing, NMDARs are important for memory 
23 
 
acquisition (Dalton et al., 2012).  Systemic administration of NVP-AAM077 (a 
selective GluN2A antagonist), but not Ro25-6981 (a GluN2B antagonist), prior 
to conditioning was found to impair auditory fear acquisition (Dalton et al., 
2012).  It is also important to point out that not all LTP is dependent on 
NMDAR.  For example, LTP induction in the laAMY has been shown to be 
dependent on either voltage gated Ca2+ channels or NMDARs depending on 
the stimulation protocol used, with both likely contributing to memory 
formation in vivo (Bauer et al., 2002). Moreover, LTP in the BLA-DG pathway 
was found to be NMDAR independent (Abe et al., 2003).  
 
1.3.1.3 Acquisition and AMPA Receptors  
The AMPAR is a heteromer composed of various combinations of GluR1, 
GluR2, GluR3 and GluR4 subunits (Mayer, 2005).  During LTP induction 
AMPARs are phosphorylated by CaMKII.  This increases their channel 
conductance and boosts the numbers of GluR1 containing AMPARs trafficked 
to the dendrite spines (Malenka and Nicoll, 1999; Shi, 1999). Increased GluR1-
containing AMPARs were found in the dendritic spines of amygdala neurons 
following auditory fear conditioning (Rumpel et al., 2005; Nedelescu et al., 
2010).  Synaptic delivery of GluR1 containing AMPAR was also found to be 
required in the dHC for inhibitory avoidance acquisition (Mitsushima et al., 
2011).  Inhibitory avoidance involves the animal being initially placed in a safe, 
light compartment of the training apparatus.  When it first moves into the 
dark compartment a door shuts, preventing the animal from re-entering the 
safe area.  When the animal reaches the far end of the dark compartment it 
ƌĞĐĞŝǀĞƐĂĨŽŽƚƐŚŽĐŬ ? dŚĞĂŶŝŵĂů ?ƐŵĞŵŽƌǇ ŝƐ later tested by placing it back 
into the chamber and measuring its latency to enter the dark compartment.  
Mice in which the GluR1 subunit of the AMPAR had been knocked out showed 
an absence of LTP in the amygdala and impaired acquisition of contextual and 
auditory fear (Humeau et al., 2007).  Spatial working memory was also 
impaired in mice lacking the GluR1 subunit (Reisel et al., 2002). 
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1.3.2 The Neurobiology of Consolidation 
Studies have shown that memory consolidation requires protein synthesis and 
activation of different molecular pathways, leading to transcription of genes 
important for plasticity (e.g. changes to dendritic structure).  Synaptic tagging 
and capture is a theory for how early LTP (E-LTP) is converted to late LTP (L-
LTP), a process that could explain memory consolidation at the cellular level 
and has therefore been described in more detail below. 
 
1.3.2.1 Consolidation Requires Protein Synthesis 
Much of what is known about memory today was initiated by studies 
undertaken on a simple form of aversive learning in the marine snail Aplysia.  
Work carried out by Kandel and colleagues showed that the gill withdrawl 
reflex (a defensive reflex where stimulation of the siphon causes withdrawal 
of the gill) was enhanced when preceded by shocks to the tail (Hawkins et al., 
1983).  By reconstituting this reflex in cell culture they found that application 
of the neurotransmitter serotonin simulated the effect of tail shock with one 
application, producing short-term facilitation that lasted a few minutes, 
whereas five applications of serotonin induced long-term facilitation that 
lasted over twenty four hours.  Long-term, but not short-term, facilitation was 
found to require both protein and RNA synthesis as anisomycin and emetine 
(protein synthesis inhŝďŝƚŽƌƐ ? ?ĂŶĚĂĐƚŝŶŽŵǇĐŝŶĂŶĚɲ-amanitin (RNA synthesis 
inhibitors), blocked the actions of five applications of serotonin but not one 
(Montarolo et al., 1986).  This work was subsequently followed up with work 
in other animals including mice and rats.  It was found that mice administered 
anisomycin (a protein synthesis inhibitor) after auditory fear conditioning 
displayed reduced freezing to both context and cued stimuli twenty four 
hours later (Bourtchouladze et al., 1998).  In another study anisomycin 
infusion into the rat BLA immediately after auditory fear conditioning 
impaired LTM but not STM (Schafe and LeDoux, 2000).   Anisomycin infused 
after six hours however did not affect LTM (Schafe and LeDoux, 2000).  The 
mRNA synthesis inhibitor actinomycin-D was infused into the BLA prior to 
auditory fear conditioning.  Freezing to both tone and context stimuli were 
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impaired (Bailey et al., 1999).  Contextual fear and inhibitory avoidance 
memory were both impaired by anisomycin infusions into the hippocampus 
prior to training (Suzuki et al., 2004; Quevedo, 1999).  The object recognition 
ŵĞŵŽƌǇ ƉĂƌĂĚŝŐŵ ƚĂŬĞƐ ĂĚǀĂŶƚĂŐĞ ŽĨ Ă ƌĂƚ ?Ɛ ŶĂƚƵƌĂů ƚĞŶĚĞŶĐǇ ƚŽ ĞǆƉůŽƌĞ
novel objects.  During training the rats are presented with a number of objects 
that they will explore.  During testing a new object is presented along with the 
previously explored object.  The time spent exploring the new object 
compared to the previously encountered object is used as a measure of the 
ƌĂƚƐ ?ŵĞŵŽƌǇ ?Object recognition memory was also found to require protein 
synthesis in the hippocampus; anisomycin infused immediately or three hours 
after training impaired subsequent recall (Rossato et al., 2007).    It could be 
argued that the above studies result from a retrieval deficit (i.e. a memory 
was formed but is not able to be retrieved), rather than protein synthesis 
inhibitors blocking the consolidation process.  However, this was shown not to 
be the case.  Hardt et al. (2009) demonstrated that protein blockade in the 
hippocampus results from a storage deficit rather than a retrieval deficit.  
They took advantage of the fact that NMDAR are needed for the first but not a 
second learning trial of contextual fear.  The NMDAR inhibitor APV disrupted a 
second learning trial when anisomycin had been administered immediately 
after the first learning trial, indicating that anisomycin had impaired 
consolidation of the first context memory trial and not its subsequent 
retrieval (Hardt et al., 2009). 
1.3.2.2 Consolidation and Molecular Pathways 
As highlighted above, LTM formation is dependent on de novo protein 
synthesis.  Extensive work has been undertaken to understand the molecular 
pathways that lead to this synthesis of new proteins during memory 
consolidation.  The first molecular pathways and molecules to be linked to 
memory formation were again discovered for simple learning in Aplysia.  Long 
term facilitation sets in action the cyclic adenosine monophosphate/protein 
kinase A (cAMP-PKA) molecular pathway (see Fig 1.4).  The second messenger 
cAMP was found to be required for facilitation (Schacher et al., 1988; Scholz 
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and Byrne, 1988).  cAMP activates PKA which moves to the nucleus where it 
activates the transcription factor cAMP response element binding protein 
(CREB).  CREB binds to cAMP response element (CRE) in the DNA promoter 
region, leading to protein synthesis (Dash et al., 1990; Bartsch et al., 1998).  
CREB can also be activated by the phospholipase C (PLC) pathway (see Fig 
1.4).  In this pathway, PLC hydrolysis of phosphatidylinositol 4,5-bisphosphate 
(PIP2) to inositol trisphosphate 3 (IP3) and diacylglycerol (Dg) which act as 
second messengers (Berridge, 1984).  Dg activates protein kinase C (PKC) 
whereas IP3 is liberated and binds to its receptors located in the endoplasmic 
reticulum, leading to intracellular release of Ca2+ and CREB activation. 
These molecular pathways have also been found to be important in fear 
conditioning in mice and rats. Intraventricular infusion of inhibitors of PKA 
activity impaired contextual and auditory fear memory (Schafe et al., 1999). 
To explore the role of PKA in the hippocampus during auditory fear 
conditioning, transgenic mice, in which PKA is knocked down in the 
hippocampus, were developed.  It was found that L-LTP was reduced in the 
CA1 of these mice and contextual and cued fear LTM, but not STM, was 
impaired (Abel et al., 1997).  Infusions of H89, a PKA inhibitor, into the 
hippocampus immediately after fear conditioning impaired memory twenty 
four and fourty eight hours later, whereas infusions of bucladesine, a cell 
permeable analog of cAMP, improved memory (Nassireslami et al., 2013).  In 
another study, injecting 8-Bromoadenosine-3',5'- cyclic monophosphate (8Br-
CAMP; a degradation resistant activator of PKA) into the hippocampus 
immediately after IA training using a weak footshock increased LTM two, 
seven and fourteen days later (Rossato et al., 2009).  Injecting PK1 (an 
inhibitor of PKA) after training with a strong footshock on the other hand, 
decreased LTM at these time points.  Interestingly, if 8Br-CAMP or PK1 are 
given twelve hours rather than immediately after training then fear memory is 
only affected at the seven and fourteen day time points (Rossato et al., 2009). 
8Br-CAMP infusions into the hippocampus three or six hours after inhibitory 
avoidance training also improved memory, whereas KT5720 (a PKA inhibitor) 
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impaired it (Bernabeu et al., 1997).  The amygdala also uses the cAMP-PKA 
pathway as infusions of Rp-cAMPS (an inhibitor of PKA activity) into the laAMY 
following auditory fear conditioning disrupted freezing levels twenty four 
hours later (Schafe and LeDoux, 2000). The BLA but not the cAMY nucleus of 
the amygdala has also been shown to require PKA and PKC during contextual 
fear memory formation (Goosens et al., 2000).  CREB is activated by 
phosphorylation on Ser 133.  Increased levels of phosphorylated CREB 
(pCREB) compared with controls were found three to six hours after 
contextual fear learning in the hippocampus and amygdala of mice (Stanciu et 
al., 2001).  Levels of pCREB were elevated immediately, three and six hours 
after training in the hippocampus (Bernabeu et al., 1997).  In a recent study 
blocking NMDARs in the hippocampus prior to CFC led to decreased levels of 
pCREB in the amygdala (de Oliveira Coelho et al., 2013).  Contextual and 
auditory fear consolidation was impaired in transgenic mice in which CREB 
repression was reversibly induced in specific regions including the 
hippocampus and amygdala (Kida et al., 2002).  Transgenic mice in which 
CREB had been knocked out were found to have reduced L-LTP in the 
hippocampus and impaired long term contextual and cued auditory fear 
memory (Bourtchuladze et al., 1994).  Infusion of lentivirus vectors containing 
a mutant form of CREB into the dHC also resulted in impaired contextual fear 
in rats (Kathirvelu et al., 2013).  However, contextual fear is not always 
impaired by disruption of hippocampal CREB, indicating that CREB-
independent fear memory formation is possible, perhaps due to 
compensation by other transcription factors or proteins (Balschun et al., 2003; 
Pittenger et al., 2002). 
 
1.3.2.3 Consolidation and Structural Change 
Changes to synaptic structure have been found to occur during consolidation. 
For example, increased varicosities and arbors were found in sensory neurons 
in Aplysia following fear learning (Bailey and Chen, 1988) and changes to 
dendrite spines occur in the laAMY following fear conditioning (Ostroff et al., 
2010).  Local protein synthesis has been shown to take place resulting in 
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structural changes that are specific to activated, rather than non-activated, 
Aplysia synapses (Martin et al., 1997). This local protein translation has been 
visualized directly using fluorescent translational reporters (Wang et al., 
2009).  The synaptic tagging and capture hypothesis postulates that during the 
induction of E->dW ĂĐƚŝǀĞ ƐǇŶĂƉƐĞƐ ĂƌĞ  ‘ƚĂŐŐĞĚ ? ǁŚŝĐŚ ĂůůŽǁ ƚŚĞŵ ƚŽ ůĂƚĞƌ
receive plasticity related proteins (PRP), enabling E-LTP to be converted to L-
LTP (Frey and Morris, 1997; Martin et al., 1997).  Evidence for this was first 
demonstrated in rat hippocampal slices and in cultured Aplysia neurons.  
Using hippocampal slices, electrodes were positioned to stimulate three 
different synapses designated S1, S2 and S3; both S1 and S2 were from the 
same neuronal population, whereas S3 was from a separate neuronal 
population.  Firstly S1 was stimulated to induce L-LTP.  S2 and S3 were then 
stimulated but this time in the presence of the protein synthesis inhibitor 
anisomycin.  It was found that L-LTP occurred in S2 but not in S3.  This 
indicated that S2 had been tagged and that protein synthesis produced for L-
LTP at S1 could be captured for L-LTP induction of S2 from the same neuronal 
population, but not S3 from a different neuronal population.  Synaptic capture 
also occurs in Aplysia neurons.  Pulses of serotonin to one synapse can lead to 
long term facilitation at another synapse which has received only one pulse of 
serotonin and would normally only lead to short term facilitation (Martin et 
al., 1997).  Serotonin pulses applied to the soma, which do not normally lead 
to long term facilitation, can result in long term facilitation at a specific 
synapse if that synapse also receives one pulse of serotonin (Casadio et al., 
1999). 
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1.3.3 The Neurobiology of Retrieval  
Studies investigating the involvement of NMDA and AMPA receptors along 
with the molecular pathways thought to be important in memory retrieval 
have been outlined.  The retrieval deficit has also been discussed. 
1.3.3.1 Retrieval and the Involvement of NMDA and AMPA Receptors 
There have been mixed reports looking at the involvement of NMDA and 
AMPA receptors in memory retrieval.  Some studies have found that AMPARs 
are involved in the retrieval of fear in the BLA and that NMDARs are not.  
Infusion of the AMPAR inhibitor 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) 
into the BLA prior to auditory fear memory reactivation was found to block 
retrieval whereas infusions of the GluN2B antagonist ifenprodil and the 
NMDAR antagonist APV prior to reactivation did not (Ben Mamou et al., 
2006).  Intra-hippocampal infusion of CNQX impaired IA retrieval whereas APV 
infusion had no effect (Szapiro et al., 2000).  Milton et al. (2013) also found 
that AMPARs (using the AMPAR antagonist LY293558) in the BLA were 
important for the retrieval of auditory fear memory.  The AMPAR antagonist 
2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBQX) was 
also found to block the retrieval of auditory fear when infused into the BLA or 
cAMY.  The NMDAR antagonist APV on the other hand, did not block retrieval 
(Zimmerman and Maren, 2010).  Intra-dHC infusion of APV did not affect the 
retrieval of contextual fear (Quinn et al., 2005).  Retrieval of taste aversion 
memory, in which a novel food is associated with stomach malaise (induced 
by injection of LiCl), was also found to be dependent on AMPARs in the BLA 
(Rodriguez-Ortiz et al., 2012; Garcia-DeLaTorre et al., 2014). Episodic-like 
memory retrieval was also found to be dependent on AMPARs but not 
NMDARs in the hippocampus (Day et al., 2003; Bast et al., 2005). Likewise, 
object recognition memory retrieval depended on AMPARs but not NMDARs 
in the perirhinal cortex (Winters and Bussey, 2005).  However, in experiments 
using the context signal model in the Chasmagnathus crab, in which retrieval 
and expression can be dissociated, the opposite was found.  AMPARs were 
not found to be involved in expression whereas NMDARs were. This was 
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shown by the fact that systemic CNQX did not impair expression, whereas APV 
did (Barreiro et al., 2013).  The context signal model involves placing the crabs 
individually into the training context, for example a round container.  A visual 
danger stimulus is then moved above the animal in both directions, this is 
ƌĞƉĞĂƚĞĚĂŶƵŵďĞƌŽĨƚŝŵĞƐĚƵƌŝŶŐǁŚŝĐŚƚŚĞĐƌĂďƐ ?ďĞŚĂǀŝŽƵƌƐǁŝƚĐŚĞs from 
ĂŶŝŶŝƚŝĂůĞƐĐĂƉĞƌĞƐƉŽŶƐĞƚŽĨƌĞĞǌŝŶŐďĞŚĂǀŝŽƵƌ ?dŚĞƌĞĚƵĐƚŝŽŶŝŶƚŚĞĐƌĂďƐ ?
movement is used as a measure of fear (Barreiro et al., 2013).  Other studies 
have also found using APV that NMDA receptors in the BLA are important for 
the retrieval of contextual fear (Maren et al., 1996b), auditory fear (Lee et al., 
2001) and FPS (Fendt, 2001).  However APV impairs both GluN2A and GluN2B 
containing NMDARs.  Another study found that GluN2B expressing NMDAR 
were not important in the retrieval of auditory or context fear in the BLA 
(Rodrigues et al., 2001).  Therefore it would seem that, in the BLA at least, 
AMPARs are important for the retrieval of fear whereas NMDARs containing 
the GluN2B subunit are not.  In other studies systemic application of non-
specific NMDAR antagonists (e.g. MK-801 and APV) have been found to impair 
memory, indicating that NMDAR could be important for memory retrieval in 
brain structures other than the BLA. 
1.3.3.2 Retrieval and Molecular Pathways 
CREB and PKA have been implicated in the retrieval process.  Increases in 
activated pCREB were found in the amygdala following cued fear retrieval 
(Hall et al., 2001).  In another study neurons in the laAMY were found to be 
recruited into a memory trace if they had high CREB activity at the time of 
auditory fear conditioning (Han et al., 2007).  Fear retrieval was found to be 
impaired if these neurons were specifically ablated (Han et al., 2009) and 
activating these neurons was found to be sufficient to recall a fear memory 
without behavioural cues (Kim et al., 2014).    Increases in pCREB were not 
found in the hippocampus following cued fear (Hall et al., 2001) or inhibitory 
avoidance retrieval (Szapiro et al., 2000).  However it was found that infusions 
of the PKA inhibitor Rp-cAMP into the hippocampus impaired retrieval of 
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inhibitory avoidance whereas PKA activator SP-cAMP enhanced it (Szapiro et 
al., 2000). 
1.3.3.3 The Retrieval Deficit 
Many studies struggle to definitively show that agents that induce amnesia 
prior to or immediately after initial learning or reactivation sessions are 
affecting the actual memory trace, rather than just resulting in an inability to 
retrieve an otherwise intact memory; this is known as a retrieval deficit.  
Recent studies have started to investigate this and have found that memory 
retrieval can be dissociated from consolidation, reconsolidation and 
destabilization.  For example, it has been demonstrated that protein synthesis 
blockade of CFC using anisomycin in the dHC results in a storage deficit rather 
than a retrieval deficit (Hardt et al., 2009).  Infusions of the GABAA receptor 
agonist muscimol into the perirhinal cortex blocked retrieval of object 
recognition memory. However, reconsolidation of object recognition was 
impaired with anisomycin infusion even when retrieval was impaired with 
muscimol, indicating that retrieval and reconsolidation are independent 
processes (Balderas et al., 2013).  AMPARs were found to be important for the 
retrieval of auditory fear but not for its destabilization (Ben Mamou et al., 
2006; Milton et al., 2013). 
1.3.4 The Neurobiology of Reconsolidation 
New protein synthesis, NMDARs and activation of macromolecules such as 
CREB have been proposed to be important in the reconsolidation process, 
which is similar to findings for consolidation.  These have been outlined below 
along with studies looking at the potential functional role of reconsolidation. 
1.3.4.1 Reconsolidation Requires Protein Synthesis 
LeDoux and colleagues were the first to show that the process of 
reconsolidation requires de novo protein synthesis (Nader et al., 2000).  They 
found that reactivating a conditioned fear memory and then infusing 
anisomycin into the BLA resulted in amnesia.  After initial fear conditioning, 
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they reactivated the fear memory by presenting the CS alone (a tone) the 
following day and then injected anisomycin.  The freezing behaviour of the 
rats was tested twenty four hours later and found to be reduced compared 
with vehicle injected controls (Nader et al., 2000).  They then investigated 
whether the time at which the anisomycin was infused after reactivation was 
important and found that if it is given six hours after recall, as opposed to 
immediately after, no effect was observed indicating that like consolidation, 
reconsolidation requires time-dependent protein synthesis (Nader et al., 
2000). This work initiated a renewed interest in the process of 
reconsolidation and led to the publication of numerous other studies. 
Reconsolidation of contextual fear memory was blocked following systemic 
(Suzuki et al., 2004), intra-amygdala (Parsons et al., 2006), and intra-
hippocampal (Debiec et al., 2002; Lee et al., 2004) administration of 
anisomycin.  Reconsolidation of IA memory however, was found to be 
dependent on protein synthesis in the BLA (Milekic et al., 2007) but not the 
hippocampus (Taubenfeld et al., 2001).  Reconsolidation in Aplysia was also 
found to require protein synthesis as injection of emetine immediately 
following reactivation impaired the siphon withdrawal reflex (Lee et al., 2012).  
However, systemic anisomycin was not found to impair reconsolidation of 
Pavlovian conditioned approach (PCA) using a sucrose reward (Blaiss and 
Janak, 2007).  In PCA, presentation of 10% sucrose solution is paired with a 
neutral stimulus (CS+; i.e. a change of cage lighting).  Memory was tested by 
presentation of the CS+ or a CS- (i.e. a tone not associated with sucrose 
reward) and measuring entries into the sucrose delivery port (Blaiss and 
Janak, 2007).  
1.3.4.2 Reconsolidation and NMDA Receptors 
NMDAR have been reported to be important in memory reconsolidation.  A 
number of studies have shown that systemic, intra-amygdala and intra-
hippocampal administration of NMDAR antagonists prior to reactivation 
impaired reconsolidation.  In one study, appetitive goal-tracking was used to 
investigate the effect of different training levels on reconsolidation (Reichelt 
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and Lee, 2012).  In this paradigm two auditory stimuli (i.e. a click and a tone) 
were used to designate the CS+ and CS-, where the CS+ was always paired with 
delivery of three sucrose pellets into a magazine port located in the chamber, 
whereas the CS- was never reinforced.  Reactivation sessions consisted of 
three unrewarded presentations of  the CS+ and CS-.   PR-LTM was measured 
twenty four hours later by recording the number of entries into the magazine 
during the CS+ presentation.  Systemic administration of the NMDAR 
antagonist MK-801, prior to reactivation sessions, impaired PR-LTM if six, but 
not twelve or three, days of training were undertaken (Reichelt and Lee, 
2012). Systemic MK-801 prior to appetitive memory reactivation was also 
found to impair reconsolidation in another study (Lee and Everitt, 2008).  
Systemic MK-801 prior to cued auditory fear reactivation was found to disrupt 
PR-LTM, whereas systemic and intra-amygdala administration of the NMDAR 
partial agonist D-cycloserine enhanced it (Lee et al., 2006).  Systemic 
administration of MK-801 and intra-amygdala administration of another 
NMDAR antagonist, D-APV, impaired drug-seeking associative memory when 
given before reactivation (Milton et al., 2008).  Systemic administration of the 
NMDAR antagonist D-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid 
prior to reactivation impaired contextual fear memory reconsolidation in mice 
(Suzuki et al., 2004) and D-APV infused into the dHC prior to reactivation was 
found to impair contextual fear memory in rats (Lee and Hynds, 2013).   
 
There have been mixed findings when NMDAR antagonists were administered 
immediately after reactivation, rather than before.  Systemic MK-801 
immediately after reactivation impaired reconsolidation of contextual fear in 
mice (Charlier and Tirelli, 2011) and appetitive goal tracking in rats (Reichelt et 
al., 2013).  However, in another study systemic MK-801 immediately after 
appetitive memory reactivation did not impair reconsolidation (Lee and 
Everitt, 2008) and infusion of D-APV immediately after reactivation into the 
amygdala did not impair drug-seeking associative memory (Milton et al., 
2008).  MK-801 has been shown to exhibit drug-induced state dependency 
effects. Flint et al., (2013) found that MK-801 given immediately after 
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reactivation of passive avoidance impaired retention twenty four hours later 
when tested drug free.  However, when MK-801 was given after reactivation 
and then again twenty minutes prior to a twenty four hour retention test, 
memory was this time unaffected, indicating state dependency. Caution 
should therefore be taken when interpreting studies using this drug (Flint et 
al., 2013). 
1.3.4.3 Reconsolidation and Molecular Pathways 
There is evidence to suggest the involvement of both PKA and CREB in the 
reconsolidation process.  PKA activation in the BLA enhanced reconsolidation 
of auditory fear memory, whereas reconsolidation was impaired by PKA 
inhibition (Tronson et al., 2006).   Infusion of Rp-CAMP (PKA inhibitor) into the 
BLA of rats before reactivation reduced reconsolidation of conditioned taste 
aversion, leading to quicker onset of extinction (Koh and Bernstein, 2003).  
Intra-amygdala blockade of PKA immediately, but not six hours after, 
reactivation also impaired reconsolidation of cocaine associative memory 
(Sanchez et al., 2010).  PKA activity was found to be increased in the snail 
Lymnaea if memory was reactivated six hours, but not twenty four hours, 
after associative conditioning.  Moreover, PKA inhibition six hours but not 
twenty four hours after training impaired reconsolidation (Kemenes et al., 
2006).  Contextual and auditory fear reconsolidation was impaired in 
transgenic mice in which CREB repression could be reversibly induced in 
specific regions, including the hippocampus and amygdala (Kida et al., 2002).  
Contextual fear memory reconsolidation was found to be impaired in 
transgenic mice in which CREB function was disrupted.  pCREB was increased 
in the hippocampus and amygdala but not the mPFC following reactivation 
(Mamiya et al., 2009). 
1.3.4.4 Role for Reconsolidation 
Although reconsolidation has been shown to occur in many instances, not all 
memories undergo the process. Such situations are referred to as boundary 
conditions and include the strength and age of the memory (Lee, 2009).  For 
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example, it has been shown that weaker memories are more likely to undergo 
reconsolidation than strong memories (Suzuki et al., 2004; Rodriguez-Otiz et 
al., 2008). It has also been shown for some memory paradigms (e.g. inhibitory 
avoidance) that older memories are less likely to undergo reconsolidation 
than weaker ones (Milekic and Alberini et al., 2002).  Boundary conditions 
could be argued to support a proposed role for reconsolidation in memory 
updating, thereby enabling the relevance of a memory to be maintained (Lee, 
2009).  Lee and colleagues provided further evidence supporting this idea.  By 
taking advantage of the doubly dissociable molecular mechanisms underlying 
consolidation (BDNF) and reconsolidation (Zif268), they found that fear 
memory strengthening that occurred as a result of a second learning trial was 
dependent on reconsolidation rather than consolidation mechanisms.  
Knockdown with Zif268 antisense oligodeoxynucleotides blocked the increase 
in memory strength, whereas BDNF antisense oligodeoxynucleotide infusion 
did not (Lee, 2008).  It has also been shown that reconsolidation is required to 
update a neutral contextual memory to a contextual fear memory in the dHC 
(Lee, 2010).  This experiment made use of the context pre-exposure 
facilitation effect.  In this paradigm rats are placed into a novel chamber in 
order to gain familiarity to it.  The next day the rats are returned to the 
chamber (which reactivates the contextual memory) and immediately given a 
footshock.  An association between the reactivated contextual memory and 
the footshock is learnt so that in a subsequent re-exposure test the rat 
exhibits increased freezing behaviour (Biedenkapp and Rudy, 2004).  By 
infusing either BDNF or Zif268 antisense oligodeoxynucleotides it was shown 
that reconsolidation (Zif268) but not consolidation (BDNF) mechanisms are 
required for updating hippocampal memory (Lee, 2010). 
 
1.3.5 The Neurobiology of Destabilization 
Studies have found that destabilization is dependent on protein degradation 
and glutamate receptor signalling.  It has been proposed that prediction error 
could determine whether or not memories will be destabilized and therefore 
undergo reconsolidation. This is discussed in more detail below 
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1.3.5.1 Destabilization Requires Protein Degradation 
Destabilization has been shown to require ubiquitin proteasome-dependent 
protein degradation.  The ubiquitin proteasome system involves the tagging of 
proteins by ubiquitin and their degradation by proteasomes, which are a 
complex of enzymes able to break peptide bonds.  Injection of 
ĐůĂƐƚŽůĂĐƚĂĐǇƐƚŝŶ ɴ-lactone (an ubiquitin proteasome inhibitor) into Aplysia 
following memory reactivation prevented PR-LTM impairment produced by 
the protein synthesis inhibitor emetine (Lee et al., 2012).  This was found to 
take place at the same sensory-motor neuron synapse in which the original 
learning occurred (Lee et al., 2012).  Ubiquitin/proteasome-dependent 
protein degradation was found to be important for contextual fear memory 
destabilization in the CA1 region of mice (Lee et al., 2008).  Protein 
degradation was also found to occur during cocaine conditioned place 
preference (CPP) destabilization in the nucleus accumbens core but not shell 
(Ren et al., 2013).  During CPP the rats learn to associate a certain context 
with a drug reward, such as amphetamine, morphine or cocaine.  They show 
this by spending more time in the drug, compared to the vehicle, associated 
area when tested later without drug present. 
1.3.5.2 Destabilization and the Involvement of NMDA and AMPA Receptors 
The GluN2B subunit of the NMDAR has been shown to be important in 
memory destabilization.  In one study, the GluN2B antagonist ifenprodil was 
infused into the BLA prior to auditory fear reactivation and was found not to 
impair reconsolidation, whereas anisomycin infusion immediately after did.  
However, when ifenprodil was administered before reactivation and 
anisomycin immediately after, PR-LTM was unaffected.  This indicated that 
blocking the GluN2B subunit before reactivation prevented destabilization as 
the memory trace was not vulnerable to manipulation by anisomycin (Ben 
Mamou et al., 2006).  Another study also found that the GluN2B subunit was 
important for auditory fear memory destabilization in the BLA (Milton et al., 
2013).  A double dissociation between GluN2B and GluN2A was established, 
with GluN2B shown to be required for destabilization and the
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for memory reconsolidation (Milton et al., 2013).  AMPAR have been found to 
participate in memory destabilization, with the transient exchange from Ca2+ 
impermeable AMPAR (GluA2 containing) to Ca2+ permeable AMPAR (no 
GluA2) having been shown to underlie destabilization of auditory fear 
memory in the laAMY (Hong et al., 2013). 
 
1.3.5.3 Destabilization and Prediction Error 
Prediction error occurs when there is discrepancy between expected and 
actual events.  Prediction error can be either positive or negative.  If a rat has 
previously undergone CFC and is returned to the conditioning chamber it 
would expect to receive a footshock in that context; if it does not, then 
arguably a negative prediction error could have occurred.  In regard to studies 
investigating reward, prediction error is positive if a reward is surprising or 
unexpected, whereas a negative prediction error occurs where a predicted 
reward is absent (Schultz, 2000).  Prediction errors can also be influenced by 
probability (e.g. what is the likelihood of gaining a reward) and by temporal 
elements (e.g. does the reward occur when expected or is it delayed) (Schultz, 
2000).  The presence of a prediction error would indicate that the memory 
needs to be updated, as the previously learnt association is no longer 
relevant.  Prediction error could potentially be important for modifying an 
existing memory trace, which occurs through the process of reconsolidation.  
In order for a memory to undergo reconsolidation the original trace needs to 
be destabilized.  It is possible that the occurrence of a prediction error 
determines whether or not a memory will be destabilized (Sevenster et al., 
2013).  Prediction error was found to be a requirement for fear memory 
reconsolidation in human subjects and was proposed to be a potential index 
for memory destabilization.  Reconsolidation of FPS was impaired by 
administration of propranolol, a beta-adrenergic antagonist that disrupts 
reconsolidation in several different paradigms, after reactivation but only in 
subjects where either positive or negative prediction error occurred.  In this 
experiment a positive prediction error was created by using partially 
reinforced training sessions (e.g. participants only received shocks some of 
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the time during the CS presentation and were then reinforced with a shock 
during the reactivation session).  The negative prediction error was created by 
always pairing the shock and CS together during training but not during the 
reactivation session (Sevenster et al., 2013).  In another study temporal 
prediction errors were also found to be important in determining whether or 
not a memory would be destabilized (Diaz-Mataix et al., 2013).  The timing 
between the CS and onset of the US was increased or decreased in duration 
compared with the timing used during training, therefore creating a temporal 
prediction error.  It was found that reconsolidation took place under 
conditions where temporal prediction error occurred, even for strong 
memories which can be subject to boundary conditions (see above), and that 
this could be blocked by infusions of anisomycin into the laAMY of rats (Diaz-
Mataix et al., 2013). 
 
1.3.6 The Neurobiology of Extinction 
Extinction, like consolidation, has been shown to require NMDAR activation, 
protein synthesis, and macromolecules such as CREB.  However more recent 
work has shown that weakening of the original memory also takes place in the 
form of reversed LTP or depotentiation (Pape and Pare, 2010).  These studies 
have been outlined below. 
 
1.3.6.1 Extinction and NMDA Receptors 
Acquisition of extinction, like acquisition of other types of memory, has been 
shown to require NMDARs.  Systemic administration of the NMDAR 
antagonists D-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid or MK-
801 impaired the extinction of contextual and auditory fear respectively 
(Suzuki et al., 2004; Baker and Azorlosa, 1996).  Systemic or intra-BLA 
administration of the NMDAR agonist D-cycloserine was found to enhance 
auditory fear extinction (Lee et al., 2006).  APV infused into BLA prior to non 
reinforced tone presentations blocked extinction of auditory fear, but not 
when infused into the cAMY (Zimmerman and Maren, 2010).  FPS extinction 
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also seems to be dependent on NMDARs in the BLA.  APV infusions were 
found to impair extinction (Falls et al., 1992) whereas D-cycloserine was found 
to enhance it (Walker et al., 2002).  Intra-BLA or dHC infusion of APV impaired 
extinction of inhibitory avoidance (Myskiw et al., 2010).  Systemic 
administration of the GluN2A antagonist NVP-AAM077 did not impair 
extinction of auditory fear, whereas the GluN2B antagonist Ro25-6981 did 
(Dalton et al., 2012).  It would seem that the laAMY and that GluN2B-
containing NMDARs (as opposed to GluN2A-containing NMDARs), are 
important for the acquisition of auditory fear extinction.  Ifenprodil (a GluN2B 
specific antagonist) infused into laAMY, but not the mPFC, prior to the 
extinction session impaired subsequent retention of auditory fear extinction 
(Sotres-Bayon et al., 2007).  Intra-laAMY infusions of ifenprodil immediately 
after extinction training did not impair extinction whereas intra-mPFC 
infusions did (Sotres-Bayon et al., 2009).  This indicates that GluN2B-
containing NMDARs within the laAMY are important for the acquisition but 
not the consolidation of auditory fear extinction, whereas in the mPFC 
GluN2B-containing NMDARs are important for consolidation of extinction but 
not its acquisition (Sotres-Bayon et al., 2009).  NMDARs were also found to be 
needed in the dHC for the extinction of IA (Szapiro et al., 2003). 
 
1.3.6.2 Extinction Requires Protein Synthesis 
Extinction consolidation, similar to other types of consolidation, has been 
shown to depend on protein synthesis in a number of brain regions depending 
on the type of memory paradigm used.  Application of the protein synthesis 
inhibitor cycloheximide one hour prior to a one hour extinction session 
reduced context fear consolidation in the Chasmagnathus crab (Pedreira and 
Maldonado, 2003).  Consolidation of auditory fear extinction was also found 
to require protein synthesis.  Infusions of anisomycin prior to extinction 
training into the lateral ventricle or the prefrontal cortex (PFC), but not the 
insular cortex of rats, blocked extinction retention the following day (Santini 
et al., 2004).  It would appear that the extinction of conditioned taste aversion 
however, does require protein synthesis in the insular cortex, as rats infused 
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with anisomycin prior to extinction sessions were found to have reduced 
extinction memory (Berman and Dudai 2001).  Protein synthesis also seems to 
be required in the BLA and hippocampus for fear memory extinction.  
Anisomycin infused into the BLA of rats prior to light alone presentations 
decreased FPS extinction (Lin et al., 2003b). Rats infused with anisomycin into 
the hippocampus immediately after the first of three retention tests showed 
impaired IA extinction compared with saline injected controls (Vianna et al., 
2001).  In another study intra-hippocampal protein synthesis inhibition was 
found to accelerate extinction (Fischer et al., 2004).  However, it could be 
argued that the drug infusions administered after the first three minute 
extinction session used in this study would have resulted in reconsolidation 
mechanisms being targeted rather than extinction. 
 
1.3.6.3 Extinction and Molecular Pathways  
CREB and PKA have been implicated in fear memory extinction.  Inhibitory 
avoidance extinction was impaired by intra-dHC infusions of Rp-cAMP (PKA 
inhibitor) before or after extinction training (Szapiro et al., 2003).  Intra-BLA or 
dHC infusion of Rp-cAMP also impaired acquisition of inhibitory avoidance 
extinction.  Increases in phosphorylated PKA were found in the dHC, but not 
the BLA, following extinction training (Myskiw et al., 2010).  Increases in 
pCREB were found in the mPFC and amygdala, but not the hippocampus, 
following contextual fear extinction training and reduction of CREB mediated 
transcription using CREB repressor mice impaired extinction (Mamiya et al., 
2009).  
 
1.3.6.4 Extinction and Synaptic Depotentiation 
Although it is generally accepted that extinction involves the formation of a 
new memory that competes with the original one, there is some evidence to 
suggest that extinction also results in some weakening of the original memory 
trace.  Depotentiation, a reversal in LTP, has been linked to memory extinction 
along with kinase dephosphorylation, impaired AMPAR endocytosis and 
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changes in dendrite structure.  Studies investigating these have been outlined 
below. 
Low frequency stimulation was found to result in depotentiation at the EC-
laAMY synapse in rat brain slices.  Application of cyclosporine A (inhibitor of 
calcineurin) was found to impair depotentiation, most likely by inactivating 
protein kinases important for synaptic plasticity.  In vivo quenching 
stimulation (low frequency laAMY stimulation) reduced FPS extinction in rats 
and systemic cyclosporine A administration prior to quenching stimulation 
impaired this (Lin et al., 2003a).  Calcineurin was increased in rat amygdala 
following FPS extinction and inhibitors of calcineurin, including cyclosporine A 
and FK-506, impaired extinction (Lin et al., 2003b).  Systemic administration of 
Tat-GluR23Y (a peptide that blocks the endocytosis of AMPAR) prior to 
unreinforced CS presentations was found to impair the acquisition of auditory 
fear extinction (Dalton et al., 2008). Systemic or intra-amygdala 
administration of 4-[2-(phenylsulfonylamino) ethylthio]-2,6-difluoro-
phenoxyacetamide (a potentiator of AMPARs) enhanced extinction but not 
reconsolidation of contextual fear in mice (Yamada et al., 2009).  Potentiation 
at the thalamic synaptic input to the laAMY was found to be reversed in brain 
slices taken from auditory fear extinction-trained rats.  Infusions of the Tat-
GluR23y peptide into the laAMY prior to a tone alone session impaired 
extinction (Kim et al., 2007).  Changes in dendritic spines were found to be 
altered in the frontal association cortex of mice following auditory fear 
training or extinction using transcranial two-photon microscopy; spines 
located on the same dendritic branch were either increased or decreased 
following either extinction or fear conditioning, respectively (Lai et al., 2012).  
Extinction along with the other learning and memory stages has been linked 
with DA transmission.  DA and its involvement in these processes, has 
therefore been outlined in the following sections. 
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1.4 Dopamine Transmission 
Previous research investigating DA transmission in memory acquisition, 
consolidation, retrieval, reactivation, destabilization and extinction has 
produced mixed results.  Some of this research has been outlined, along with 
studies investigating DA biosynthesis, metabolism and signalling.  The 
research in this thesis focuses on the involvement of D1 receptors (D1R) in the 
amygdala and hippocampus, studies showing the distribution of D1Rs and DA 
innervations of these brain regions have therefore also been outlined. 
1.4.1 Dopamine Biosynthesis and Metabolism 
DA was first identified as a neurotransmitter, rather than just a precursor for 
noradrenaline (NA), by Arvid Carlsson and colleagues (Carlsson et al., 1962).  
DA is a monoamine and member of the catecholamine family.  It is 
synthesised by the enzymes tyrosine hydroxylase (TH) and DOPA 
decarboxylase from tyrosine.  Tyrosine hydroxylase converts tyrosine to L-
DOPA, which, in turn is converted by DOPA decarboxylase into DA.  Once 
synthesized, DA is packaged into vesicles and released under conditions of 
depolarization.  DA is transported from the extracellular space in the synapse 
to the pre-synaptic terminal by the dopamine transporter (DAT), thereby 
controlling the levels of available DA in the brain.  The DAT is a plasma 
membrane protein with twelve transmembrane spanning helices, helice one 
and six form the active site. The DAT is a member of the solute carrier six 
transporter family of neurotransmitter transporters. The DAT couples inward 
DA transport with the movement of Na+ and Cl- down their electrochemical 
gradient (Vaughan and Foster, 2013; Pramod et al., 2013; Schmitt and Reith, 
2010).  Once back in the neuron DA is either repackaged into vesicles for 
reuse or metabolised into dihydroxphenylacetic acid (DOPAC) and 
homovanillic acid (HVA) by monoamine oxidase B (MAO) or catechol-O-
methyl transferase (COMT), respectively. 
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1.4.2 Dopamine Innervations of the Amygdala and Hippocampus 
Fig 1.3 Horizontal section of rat brain showing DA innervations of the 
amygdala complex and hippocampal formation (modified from Paxinos and 
Watson, 2009)  
Dahlstroem and Fuxe (1964) were the first to determine the main 
catecholamine projections, DA and NA, in the brain and named them A1-A12.  
They used the Falck-Hillarp technique, which utilizes formaldehyde vapour to 
convert DA and NA to isoquinoline molecules which can then be visualized as 
a yellow-green fluorescence.  Dopaminergic neurons located within the 
midbrain were found in the retrorubral area, the substantia nigra (SN) and 
ventral tegmental area (VTA) and were designated A8, A9 and A10, 
respectively.  Early studies found that the neurons originating in the SN and 
retrorubral area formed the nigrostriatal pathway projecting to striatal 
regions such as the putamen and caudate nucleus, whereas neurons 
originating within the VTA formed the mesolimbic and mesocortical pathways 
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projecting to structures including the nucleus accumbens, amygdala, 
hippocampus and PFC.  However, the advance of more refined staining 
techniques such as immunohistochemistry, which can stain enzymes 
important in the synthesis of dopamine such as TH, has shown this to be an 
oversimplification (Bjorklund and Dunnett, 2007).  The SN not only 
contributes projections to the nigrostriatal pathway but also to the 
mesolimbic and mesocortical pathways and the VTA projects to the striatum 
as well as limbic and cortical structures (Fallon and Moore, 1978; Swanson, 
1982).  Studies using TH immunohistochemistry have revealed that the lateral 
division of the cAMY, the BLA and the IPCs receive substantial dopaminergic 
innervations from the SN-VTA complex (Asan, 1997; Brinley-Reed and 
McDonald, 1999; Fuxe et al., 2003; Pinard et al., 2008).  The IPCs and lateral 
division of the cAMY contain inhibitory interneurons which are important for 
the trafficking of information from the BLA to the medial cAMY and receive 
the highest DA innervations.  DA is therefore ideally placed to modulate this 
information flow (de la Mora et al., 2010).  Retrograde tracing using the 
fluorescent tracer fluoro-gold and anterograde tracing combined with 
immunocytochemistry staining for TH showed a modest dopaminergic 
projection from the SN-VTA complex to the hippocampal formation, with the 
CA1 and subiculum nuclei receiving the highest innervations (Gasbarri et al., 
1994).  Initial studies investigating DA projections in humans used Falck-
Hillarp fluorescence histochemistry and TH immunohistochemical staining of 
post-mortem brains and confirmed the A1-A12 distribution of catecholamines 
(including DA) previously outlined in animals (Olson et al., 1973; Pearson et 
al., 1979; Pearson et al., 1983).  However more recent studies have indicated 
that the mesolimbic pathway originates from both the SN and VTA and that 
an anatomical distinction between these regions is less apparent in humans 
compared with rats (Düzel et al., 2009). Multi-tensor diffusion tensor imaging 
was used to compare neural connectivity between the SN or VTA and 
different brain regions in humans.  Higher connectivity was found between 
the SN than the VTA for all brain regions assessed, including the amygdala 
(Kwon and Jang, 2014). 
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1.4.3 Dopamine Receptors 
DA receptors are comprised of seven transmembrane regions which are linked 
by protein loops and come together to form the ligand binding site.  They also 
have an intracellular carboxyl tail and are coupled to a GTP-binding protein 
(G-protein).  The initial classification of two families of DA receptors was 
based on findings from biochemical and pharmacological studies. It was found 
that while activation of some DA receptors led to adenylate cyclase 
dependent increases in the synthesis of cAMP, others did not.  It was also 
shown that selective drugs had high affinities for some DA receptors but not 
others (Kebabian et al., 1972; Kebabian and Calne, 1979).  Two classes of 
dopamine receptors were therefore named the D1Rs and the D2 receptors 
(D2Rs).   Activation of D1Rs leads to increased cAMP levels whereas D2R 
activation inhibits cAMP synthesis.  D1Rs are antagonised by benzazepine 
ligands such as R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-
tetrahydro-1H-3-benzazepine hydrochloride (SCH 23390), whereas D2Rs are 
antagonised by benzamides such as sulpiride (Kebabian and Calne, 1979). 
With the advance of molecular techniques in the late 1980s, gene cloning and 
the elucidation of the protein structures of the dopamine receptors was 
undertaken.  Five different DA receptors were identified and designated D1-D5.  
In this thesis the term D1R is used to describe the D1 receptor family which 
includes the D1 and D5 receptors and the term D2R is used to describe the D2 
receptor family which includes the D2, D3 and D4 receptors.  D1Rs were found 
to have no introns (the parts of the gene removed by splicing) in their genes. 
In contrast, the D2Rs do have introns (Zhou et al., 1990; Sunahara et al., 1991; 
Tiberi et al., 1991).  The protein structures also differ between the two 
families.  For example, the third intracellular loop and the carboxyl tail were 
found to be longer in the D1R family, compared with the D2R family (Strange, 
2000).  The classification of DA receptors into D1 and D2-like families, 
however, is over-simplistic.  Recent work has shown that subunits from D1Rs 
can come together with subunits from the same or different receptor families 
to form heteromers.  For example, the D1R has been shown to form 
heteromers with the NMDAR.  The GluN1 subunit of NMDA receptors can 
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form direct interactions with the D1R via protein-protein bonds (Nai et al., 
2010). These new combinations of receptor subunits can lead to alterations in 
activation of signalling pathways, can affect ligand binding leading to changes 
in the potency of agonists, and new binding sites can be created (Missale et 
al., 2010).  D1 and D2 receptors are widely distributed in the brain. They are 
located in the caudate, putamen, nucleus accumbens olfactory tubercle, SN, 
VTA, PFC, amygdala complex and hippocampal formation, with the density of 
D1Rs tending to be greater in most brain regions compared to D2Rs (Neve and 
Neve, 1997). 
 
1.4.4 Distribution of D1 Receptors in Amygdala and Hippocampus 
The localization of D1Rs within the amygdala and hippocampus are outlined in 
more detail below.  Quantitative autoradiographic methods using radioligands 
such as 3H-SCH 23390 and 3H-SKF-83566 (D1R antagonists) have been used to 
determine the levels of D1Rs in the rat brain.  High densities of D1R were 
found in the amygdaloid complex, with the ventral BL nucleus and the IPCs 
having the highest level. D1Rs were also located in the hippocampal complex, 
including the EC, parasubiculum, hippocampus proper and DG (Boyson et al., 
1986; Dawson et al., 1986; Köhler et al., 1991; Scibilia et al., 1992).  These 
studies were later confirmed by immunohistochemical localization of D1R in 
rat brain using a polyclonal antibody directed to the D1R (Huang et al., 1992; 
Perez de la mora et al., 2006).  In situ hybridization histochemistry (using a 
labelled complementary RNA probe for D1R mRNA) also showed D1R mRNA 
expression was present in the amygdala and hippocampus (Weiner et al., 
1991).  Electron microscopy has revealed that the D1 and D5 subtypes are both 
present in the same BLA neurons, with the D1 subtype predominantly found 
on the dendritic spines and the D5 subtype at dendritic terminals (Muly et al., 
2009).  The rat D1R gene is 92% identical to the human D1R gene (Zhou et al., 
1990) and D1Rs are located in the human brain, including in the amygdala and 
hippocampus (Mengod et al., 1991).  Reverse transcription polymerase chain 
reaction was used to ascertain the levels of D1R mRNA in the different 
subregions of the human amygdala; in contrast to findings in the rat, the 
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cAMY was found to have the highest level of D1R expression (Xiang et al., 
2008). 
 
1.4.5 D1 Receptor Signalling 
DA receptors are coupled to G-proteins ǁŚŝĐŚ ĂƌĞ ĐŽŵƉŽƐĞĚ ŽĨ ɲ ? ɴ ĂŶĚ ɶ
ƐƵďƵŶŝƚƐ ? ?ZƐĐĂŶďĞůŝŶŬĞĚǁŝƚŚĚŝĨĨĞƌĞŶƚɲƐƵďƵŶŝƚƐŝŶĐůƵĚŝŶŐ'ɲs ?'ɲolf or 
'ɲq whereas D2Rs ĂƌĞ ůŝŶŬĞĚ ƚŽ 'ɲi or 'ɲo.  G-ƉƌŽƚĞŝŶƐ ĐŽŶƚĂŝŶŝŶŐ ƚŚĞ 'ɲs, 
'ɲolf Žƌ'ɲq subunit have been shown to initiate the cAMP pathway (see Fig 
1.4).  The enzyme adenylate cyclase is activated by D1R stimulation and 
converts ATP to cAMP, which, in turn, activates PKA, leading to gene 
expression via transcription factors such as CREB and phosphorylation of DA 
and cAMP regulated phosphoprotein, 32kDA (DARPP-32).  DARPP-32 is then 
able to inhibit protein phosphatase 1.  PKA activation can lead to modulation 
of ion channels, including K+, Ca2+ and Na+ channels (Neve et al., 2004; Undieh, 
2010).  D2R activation on the other hand results in reduced levels of adenylate 
cyclase, leading to decreased PKA and DARPP-32 activation (Neve et al., 
 ? ? ? ? ? ? 'ƉƌŽƚĞŝŶƐ ĐŽŶƚĂŝŶŝŶŐ'ɲq can also lead to the activation of the PLC 
pathway which also results in activation of CREB. 
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Fig 1.4 D1R signalling 
DA is synthesised from tyrosine before being released into the synapse and 
binding to D1Rs.  D1Rs coupled to Gɲs result in activation of the enzyme 
adenylate cyclase and increased levels of cAMP.  PKA is activated which in 
turn activates CREB.  D1Rs coupled to Gɲq stimulated PLC leading to increased 
Dg and IP3.  Dg activates PKC whereas IP3 leads to release of Ca
2+ from the 
endoplasmic reticulum and activation of CREB.  DA is returned to the neuron 
by the DAT where it is metabolised by COMT or MAO into DOPAC and HVA.  
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There is evidence to suggest that D1R activation in the amygdala and 
hippocampus is linked to the PLC pathway and D5 ĐŽƵƉůŝŶŐ ƚŽ 'ɲq.  In the 
hippocampus and amygdala D1Rs ǁĞƌĞ ĨŽƵŶĚ ƚŽ ĐŽƵƉůĞ ƚŽ 'ɲq but not 'ɲs 
(Jin et al., 2001).  D1R activation was found to increase IP3 formation in the 
amygdala and hippocampus (Undie and Friedman 1990).  D1 knockout mice 
had reduced cAMP production but inositol phosphate accumulation following 
D1R stimulation was unaffected.  Binding of 3H-^, ? ? ? ? ?ƚŽ'ɲq subunit was 
ĂůƐŽ ƵŶĂĨĨĞĐƚĞĚ ? ǁŚĞƌĞĂƐ 'ɲs was reduced (Friedman et al., 1997).  
Conversely, D5 knockout mice were found to have deficient PLC signalling 
(Sahu et al., 2009).  It was also found that increased intracellular Ca2+ was 
released in cultured hippocampal neurons following D1R activation (Lezcano 
and Bergson, 2002) and that amygdaloid D1R activation did not increase 
cAMP (Leonard et al., 2003).  SKF 83959 is a selective D1R agonist that does 
not work by stimulating adenylyl cyclase but instead increases PLC mediated 
hydrolysis of phosphoinositide (Panchalingam and Undie, 2001).  Application 
of SKF 83959 to cultured hippocampal neurons resulted in a PLC-dependent 
increase in Ca2+ release from internal stores and also increased influx via Ca2+ 
channels (Ming et al., 2006). D1R signalling ǀŝĂ 'ɲq coupling to the PLC 
pathway has also been demonstrated in the PFC of humans (Pacheco and 
Jope, 1997). 
 
1.4.6 Dopaminergic Modulation of Memory Acquisition 
DA has been shown to be an important modulator of memory acquisition.  
There is strong evidence from electrophysiological studies to suggest that 
D1Rs are involved in the induction of LTP in vitro and in vivo.  Application of 
the D1R agonists, 6-chloro-PB and dihydrexidine, prior to high frequency 
stimulation increased E-LTP in the CA1 of hippocampal slices whereas SCH 
23390 impaired this effect (Otmakhova and Lisman, 1996).  L-LTP in the CA1 
was also found to be blocked by application of SCH 23390 during but not 
after, high frequency stimulation (Frey et al., 1991; Huang and Kandel, 1995).  
In another study, a high frequency stimulation protocol that does not elicit 
LTP under control conditions was found to result in LTP induction in the 
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presence of the D1R agonist SKF 38393 in both regular-spiking and burst-
spiking subiculum neurons, an effect which was blocked by SCH 23390 
application.  This LTP induction was also found to be dependent on NMDARs, 
PKA and post-synaptic Ca2+ increases (Roggenhofer et al., 2010; Roggenhofer 
et al., 2013).  Slices taken from the brains of D1R knockout mice showed a 
reduction in hippocampal LTP (Matthies et al., 1997).  D1-NMDA receptor 
heterodimerization could be important for this as LTP was found to be 
impaired in cultured hippocampal cells in which D1-GluN1 coupling was 
disrupted with the interfering peptide D1-t2 (Nai et al., 2010).  In a study using 
awake-behaving rats, in vivo recording of LTP at the Schaffer collateral CA1 
synapse was undertaken. It was found that intra-ventricular administration of 
chloro-PB (D1R agonist) assisted the induction of LTP, whereas SCH 23390 
blocked this.  Short term potentiation (STP) was converted to LTP by exposure 
of the rats to an empty hole-board apparatus and this was also blocked by 
SCH 23390 administration (Lemon and Manahan-Vaughan, 2006).  Similarly, it 
was found that LTP could be induced by a weak high frequency stimulation 
protocol if the rats were allowed to explore a novel environment and this was 
also blocked by intra-ventricular SCH 23390 administration prior to testing (Li 
et al., 2003).  Reduced LTP was found in the CA3-CA1 Schaffer collaterals 
following high frequency stimulation in D1R knockout (D1R KO) mice and in 
control mice injected with small interfering RNA into the hippocampus to 
knock down D1R expression (Ortiz et al., 2010).  LTP has also been found to 
occur in the amygdala (Rogan et al., 1997).  L-LTP can be induced in the laAMY 
following both low and high frequency stimulation of fibres from the cortex 
(by stimulating the external capsule) in brain slice preparations (Huang and 
Kandel, 2007).  Application of the D1R antagonist SCH23390 before low 
frequency stimulation resulted in blockade of L-LTP (Huang and Kandel, 2007). 
However, in another study LTP induction in the laAMY was found to be 
modulated by the D2R but not the D1R (Bissiere et al., 2003).   
 
Numerous behavioural studies have investigated the role of DA in different 
types of memory acquisition including contextual and auditory fear 
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conditioning, object recognition, spatial, episodic-like memory and appetitive 
learning (Inoue et al., 2000; Pezze et al., 2002; Clausen et al., 2011; K ?ĂƌƌŽůů
et al., 2006; Bethus et al., 2010; Hiroi and White, 1991).  Increased levels of 
DOPAC were observed in the amygdala following footshock administration 
(Herman et al., 1982). In another study DA levels in the hippocampus and 
DOPAC levels in the amygdala were found to be increased after CFC and 
following placement in the fear conditioning chamber without footshocks 
twenty four hours later (Inoue et al., 1994).  Object recognition was found to 
be impaired by D1R antagonism (Clausen et al., 2011).  Rats injected with SCH 
23390 prior to training spent less time exploring a novel object when tested 
five minutes later compared with saline injected controls (Clausen et al., 
2011).  D1Rs have also been shown to be important in the delayed matching-
to-place (DMP) water maze test.  In this test rats are tested on their ability to 
locate a hidden platform after one learning trial.  Swimming path lengths are 
used as an indication of memory, with shorter path lengths indicating better 
memory retention.  Intra-dHC SCH 23390 fifteen minutes before a new 
location trial, was found to impair memory in the DMP water maze thirty 
minutes (Pezze and Bast, 2012) and six hours later  ?K ?ĂƌƌŽůů Ğƚ Ăů ? ?  ? ? ? ? ? ? 
Episodic-like memory acquisition also requires DA.  In one memory paradigm 
rats were trained to associate a particular flavoured food pellet (e.g. banana) 
with a particular location in an event arena.  The rats then underwent probe 
tests in which they were either cued with a flavour or were not cued before 
being placed in the event arena. The time they spent digging at the correct 
location was used as an indication of memory performance; their episodic-like 
ŵĞŵŽƌǇ ĨŽƌ  ‘ǁŚĂƚ ? ĂŶĚ  ‘ǁŚĞƌĞ ?ǁĂƐ ƚŚĞƌĞĨŽƌĞďĞŝŶg tested.  Rats that were 
infused with SCH 23390 into the dHC prior to learning a new paired 
association had impaired memory twenty four hours, but not thirty minutes, 
later (Bethus et al., 2010). It was found that D1R KO mice had impaired spatial 
learning in the Barnes maze and Morris water maze (Ortiz et al., 2010; EL-
Ghundi et al., 1999).  In the Barnes maze the mouse is placed on the white 
circular surface with holes around the periphery, one of which leads to a drop 
box into which the mouse can escape the exposure of the table top.  The 
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ŵŽƵƐĞ ?ƐƐƉĂƚŝĂůŵĞŵŽƌǇŝƐĂƐƐĞƐƐĞĚŽŶŝƚƐĂďŝůŝƚǇƚŽƌĞŵĞŵďĞƌƚŚĞůŽĐĂƚŝŽŶŽĨ
the one hole which leads to the drop box.  It was also found that these mice 
had impaired inhibitory avoidance, contextual and auditory fear conditioning 
(Oritz et al., 2010) and D1R striatum specific KO mice were found to have 
impaired CFC (Ikegami et al., 2014).  However, in another study, D1R KO mice 
were found to have normal CFC and inhibitory avoidance acquisition (EL-
Ghundi et al., 2001).  The DA receptor agonist, apomorphine, was found to 
enhance two-way avoidance learning (Reis et al., 2004).  In this test 
presentation of a light stimulus is associated with the onset of a footshock.  
The rats can avoid being footshocked by quickly moving to a safe 
compartment when the light stimulus is turned on.  It was found that 
apomorphine injected rats learnt faster than the saline-injected controls (Reis 
et al., 2004).  Intra-nucleus accumbens and intra-striatum infusion of SCH 
23390 prior to two-way active avoidance training impaired subsequent 
retention (Wietzikoski et al., 2012).  D1Rs have also been implicated in the 
acquisition of CPP D1R mutant mice were found to have impaired acquisition 
of cocaine CPP (Chen and Xu, 2010).  Systemic administration of SCH 23390 
has been shown to block the acquisition of CPP to cocaine (Cervo and 
Samanin, 1995) and amphetamine (Hiroi and White, 1991).  Other studies 
have investigated the involvement of D1Rs in contextual and auditory fear 
acquisition.  Infusion of the D1R agonist SKF 82958 into the BLA was found to 
enhance CFC (Biedenkapp and Rudy, 2009).  DA antagonists given systemically 
or centrally have been shown to impair FPS (Greba and Kokkinidis, 2000), 
auditory fear conditioning (Pezze et al., 2002; Guarraci et al., 1999) and CFC 
(Inoue et al., 1996; Inoue et al., 2000; Calzavara et al., 2009; Bai et al., 2009).  
These studies are outlined in greater detail in chapters three and four.  It 
should be noted that due to the substantial DA innervations of the basal 
ganglia, a brain region important in the production of movement, most DA 
drugs especially when administered systemically can have non-specific effects 
on locomotion that could interfere with behavioural performance.  For 
example systemic SCH 23390 has been shown to impair total distance moved 
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in the open field (Gessa et al., 1985; Salmi and Ahlenius, 2000; Clausen et al., 
2011). 
 
1.4.7 Dopaminergic Modulation of Consolidation 
There are numerous studies indicating a link between DA and memory 
consolidation.  The protein synthesis-inhibiting drug anisomycin infused into 
the BLA immediately after auditory fear conditioning impaired memory 
(Schafe and LeDoux, 2000).  It has been argued that anisomycin induced 
amnesia could be a result of aberrant neurotransmitter release, rather than 
(or as well as) blockade of de novo protein synthesis, as large increases in DA 
have been shown in both the amygdala and hippocampus following 
anisomycin infusion (Canal et al., 2007; Qi and Gold, 2009). 
 
Studies using D1R antagonists and agonists have demonstrated the 
involvement of D1Rs in consolidation in many different memory paradigms.  
The effects of amphetamine, which causes the release of DA and NA from the 
pre-synaptic terminal, on the consolidation of morphine CPP was assessed 
(Blaiss and Janak, 2006).  It was found that injecting amphetamine 
immediately after training resulted in the enhancement of morphine CPP, 
indicating DA and/or NA involvement in its consolidation (Blaiss and Janak, 
2006).  CPP using cocaine was also found to result in increased D1R protein 
and mRNA expression in the hippocampus (Tanaka et al., 2011).  In another 
study the effect of infusing SCH 23390 and SKF 38393 (D1 agonist) into the 
PFC on the consolidation of object recognition memory was investigated 
(Maroun and Akirav, 2009).  Two groups of rats were used; one group had 
been habituated to the testing area and so had low arousal, while the other 
group were non-habituated rats that had high arousal levels and thus 
increased circulating corticosteroids and higher extracellular levels of DA.  
They found that the rats that had intermediate levels of D1R activation (i.e. 
H/SKF38393 and NH/SCH23390 rats) had optimum memory performance 
(Maroun and Akirav, 2009).  It was also found that systemic administration of 
SKF 38393 immediately after object recognition training enhanced memory, 
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whereas enhancement by the non-selective DA agonist apomorphine 
administered immediately after training was blocked when preceded by SCH 
23390 treatment, implying D1R involvement  (De Lima et al., 2011).  Other 
studies have shown the involvement of D1R in inhibitory avoidance 
consolidation.  It was found that dopamine deficient (DD) and D1R KO mice 
have impaired short-term (10 min) and long-term (24 hr) inhibitory avoidance 
memory (Fadok et al., 2009).  Restoration of DA levels in DD mice by 
administration of L-DOPA enabled memory formation if administered 
immediately after training, indicating the involvement of DA in memory 
consolidation.  DA restoration selectively in the BLA rescued STM, but not 
LTM, whereas VTA DA restoration rescued both STM and LTM (Fadok et al., 
2009).   
 
Methylphenidate (prevents reuptake of DA and NA) administration into the 
BLA immediately but not six hours after inhibitory avoidance training 
enhanced memory forty eight hours later (Zheng et al., 2008).  It was also 
found that D1R antagonist infused into the amygdala or hippocampus after 
inhibitory avoidance training impaired memory when administered at certain 
time points (LaLumiere et al., 2004; Bernabeu et al., 1997; Bevilaqua et al., 
1997; Rossato et al., 2009).  DA infusions into the BLA within three hours of 
training enhanced retention when tested forty eight hours later whereas SCH 
23390 administration resulted in impairment (LaLumiere et al., 2004).  SCH 
23390 was infused into the hippocampus immediately, nine or twelve hours 
after inhibitory avoidance training.  It was found that SCH 23390 injected into 
the hippocampus twelve hours after training impaired memory seven and 
fourteen, but not two, days later whereas SCH 23390 injected immediately or 
nine hours after training had no effect (Rossato et al., 2009).  Infusion of the 
D1R agonist SKF 38393 twelve hours after training, on the other hand, was 
found to increase memory seven and fourteen, but not two, days later 
(Rossato et al., 2009).  SCH 23390 infused into the hippocampus but not the 
amygdala three or six hours, but not immediately after inhibitory avoidance, 
impaired memory whereas SKF 38393 facilitated memory formation 
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(Bernabeu et al., 1997; Bevilaqua et al., 1997).  SCH 23390 administered into 
the CA1 immediately after inhibitory avoidance training did not affect LTM (24 
hr) but enhanced STM (1.5 hr).  Administration into the EC on the other hand, 
impaired LTM but not STM.  SKF 38393 into the CA1 and EC impaired STM but 
not LTM (Izquierdo et al., 1998).  Studies investigating contextual and cued 
fear memory consolidation however, have reported mixed results.  
Amphetamine infusion into the dHC immediately after auditory fear 
conditioning was found to increase freezing (i.e. improved memory) to 
background context but not to tone presentation (White and Salinas, 2003).  
SCH 23390 infused into the CA1 immediately after CFC, attenuated the 
enhancement in CFC brought about by systemic corticosterone, indicating 
that D1R are involved in modulating the actions of glucocorticoids in the 
hippocampus (Liao et al., 2013).  Administration of SCH 23390 immediately 
after CFC had no effect (Inoue et al., 2000; Bai et al., 2009).  These studies are 
outlined in chapter three in more detail. 
 
D1Rs have also been proposed to be important in the synthesis of PRPs as 
outlined by the synaptic tagging and capture hypothesis (see above).  It has 
been proposed that D1Rs are involved in the synthesis of PRPs (Wang et al., 
 ? ? ? ? ?^ĂũŝŬƵŵĂƌĂŶĚ&ƌĞǇ ?  ? ? ? ? ? ? WƌŽƚĞŝŶŬŝŶĂƐĞDɺ ?ĂŶ ŝƐŽĨŽƌŵ of PKC, has 
been proposed to be a PRP that is induced by DA activity (Navakkode et al., 
2010).  In another study, L-LTP was induced in one synapse S1 in hippocampal 
slices.  SCH 23390 was then applied followed by stimulation of a second 
synapse S2.  L-LTP occurred normally in both S1 and S2, indicating that D1R 
activated proteins whose synthesis was initiated by S1 stimulation can be 
used for L-LTP at S2 (Sajjkumar and Frey, 2004).  It has also been shown that L-
LTP inducing stimulation of one pathway in the presence of SCH 23390 (which 
would normally impair it) was rescued by stimulation of a different pathway 
prior to SCH 23390 application (Wang et al., 2010).  In the behaving animal it 
was found that novel exploration, which has been shown to result in 
increased DA release, prior to episodic-like memory formation in the presence 
of SCH 23390 can rescue that memory (Wang et al., 2010). 
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1.4.8 Dopaminergic Modulation of Retrieval 
Studies investigating the involvement of DA in the retrieval of memory have 
produced mixed results.  In one study rabbits underwent auditory fear 
conditioning where presentation of a tone (CS+) was associated with a shock 
to the pinna.  Recordings from DA neurons in the VTA of rabbits showed that 
the majority of these neurons increased in activity following CS+ presentation 
whereas other neurons decreased their activity (Guarraci and Kapp, 1999).  
Intra-mPFC infusion of cis-flupenthixol (D1/D2R antagonist) was found to 
impair the retrieval of auditory fear (Pezze et al., 2003).  In another study 
electrical stimulation of the VTA was found to increase FPS amplitudes 
(Borowski and Kokkinidis, 1996). However, intra-VTA administration of SCH 
23390 or SKF 38393 prior to FPS testing was not found to affect retrieval (De 
Oliveira et al., 2009).  Likewise systemic or intra-amygdala infusion of SCH 
23390 had no effect (Greba and Kokkinidis, 2000).  Infusions of SCH 23390 or 
SKF 38393 into the hippocampal formation had no effect on retrieval of 
inhibitory avoidance (Izquierdo et al., 1998).  However, in another study, CA1 
and EC infusions of SCH 23390 impaired retention of inhibitory avoidance 
whereas SKF 38393 enhanced it but intra-amygdala infusions had no effect 
(Barros et al., 2001).  D1Rs appear to be required for the retrieval of object 
recognition memory in some circumstances (Hotte et al., 2005).  The D1R 
agonist SKF 81297 was administered systemically prior to testing of object 
recognition either fifteen minutes or four hours after training.  It was found 
that at the fifteen minute delay SKF 81297 at high or low doses left the rats 
unable to recognise the familiar object and therefore exploration of both 
novel and familiar objects was similar compared with controls, who explored 
the novel object more.  At the four hour delay however, rats given the high 
dose of SKF 81297 showed enhanced object recognition retrieval compared 
with the rats administered a low dose or saline (Hotte et al., 2005).  Western 
blot analysis showed that phosphorylated DARPP-32 levels in the PFC were 
increased in SKF 81297 treated rats following the four hour but not the fifteen 
minute delay (Hotte et al., 2006).  Other research has shown the involvement 
of the D1Rs in the retrieval of fear using a second order conditioning paradigm 
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(Nader and LeDoux, 1999).  SCH 23390 was infused directly into the BLA prior 
to the CS1 being paired with the CS2 and this resulted in impairment of 
second order fear conditioning, indicating that D1Rs are needed for retrieval 
(Nader and LeDoux, 1999).  D1R activation in the mPFC was found to be 
important in the retrieval of olfactory fear-conditioning (Lauzon et al., 2009).  
Systemic administration of SCH 23390 was not found to impair the retrieval of 
contextual fear (Inoue et al., 2000).  However other research has shown that 
SCH 23390 infused into the shell sub-region of the nucleus accumbens and 
anterior cingulate cortex increased rather than decreased freezing during 
contextual fear retrieval (Albrechet-Souza et al., 2013) and the DA agonist 
amphetamine was found to impair the retrieval of auditory fear (Pezze et al., 
2003).  
 
1.4.9 Dopaminergic Modulation of Reconsolidation 
There have not been many previous studies looking at the involvement of DA 
in the reconsolidation of fear memories.  However object recognition, passive 
avoidance memory in chicks and PCA have been investigated with mixed 
findings.  The effects of infusing SCH 23390 (D1R antagonist) and SKF 38393 
(D1R agonist) into the PFC on the consolidation and reconsolidation of 
recognition memory was tested using habituated (low arousal) and non-
habituated (high arousal) rats with low and high corticosteroid, and therefore 
DA levels, respectively (see above).  It was found that the habituated group 
had impaired reconsolidation when infused with SKF 38393 but SCH 23390 
infusion had no effect, whereas reconsolidation was impaired by both drugs in 
the non-habituated group (Maroun and Akirav, 2009).   The effect of SCH 
23390 on reconsolidation in day old chicks using the single-trial passive 
avoidance task was studied.  This involved training the chicks with balls 
covered in the aversive tasting methyl anthranilate.  The chicks were then 
injected with SCH 23390 five minutes before reactivation.  Their memory was 
tested by assessing their subsequent pecking rate on a dry ball.  It was found 
that memory was impaired, implying that D1Rs are critically involved in the 
reconsolidation of passive avoidance in chicks (Sherry et al., 2005).  
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Amphetamine however, was not found to have an effect on reconsolidation of 
PCA using a sucrose reward (Blaiss and Janak, 2007). In another study 
however, it was found that injecting amphetamine immediately after 
reactivation resulted in enhancement of morphine CPP, indicating DA and/or 
NA involvement (Blaiss and Janak, 2006). 
 
1.3.10 Dopaminergic Modulation of Destabilization 
Research undertaken using reward paradigms, has shown the involvement of 
dopamine neurons in the VTA in learning mediated by prediction error.  
Prediction error has been proposed to be required for memory destabilization 
(see above), indicating that DA could be important in the destabilization 
process.  DA neurons in the midbrain, including the SN and VTA, of monkeys 
have been shown to respond in a bidirectional way to positive and negative 
reward prediction error.  Positive prediction error leads to these neurons 
increasing their activity whereas negative prediction errors result in neuronal 
depression (Schultz, 2013).  A linear relationship between the probability of a 
prediction error occurring was also found in these neurons (Fiorillo et al., 
2003).  Other research using fMRI has shown that human brain regions which 
have strong DA projections such as the putamen (part of the striatum) and 
nucleus accumbens are activated by reward prediction errors.  In one study a 
delayed incentive task was used where a cue represented the probability of 
obtaining a monetary reward if the subjects completed a simple task 
correctly.  It was found that nucleus accumbens activity was high during the 
maximum level of positive prediction error (e.g. when the participants won 
despite only being cued with a 25% probability of winning) and was lowest 
during the minimum level of negative prediction error (e.g. when the 
participants lost despite being cued with a 75% probability of winning) (Abler 
et al., 2006).  In another study human participants were trained to associate a 
light presentation with delivery of juice six seconds later.  To test temporal 
prediction ĞƌƌŽƌƐ  ‘ĐĂƚĐŚ ĞǀĞŶƚƐ ?were introduced in which the juice reward 
was delayed to ten seconds after the light presentation.  Therefore a positive 
prediction error was created at the ten second time point (as participants 
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received an unexpected reward) and a negative prediction error was created 
at the six second time point (as the participants expected to gain a reward but 
did not).  It was found that activity in the left and, to a lesser extent, right 
putamen was increased during the positive prediction error and decreased 
during the negative prediction error (McClure et al., 2003).  Bilateral ventral 
striatum activation was correlated with both positive and negative reward 
prediction errors.  L-DOPA (DA metabolic precursor) was found to enhance 
the blood oxygen level dependent signal compared with haloperidol (D2R 
antagonist), for the positive but not the negative prediction error (Pessiglione 
et al., 2006).  Other research has used the Pavlovian over-expectation method 
in rats (Takahashi et al., 2009).  In this task the rats first learnt to associate 
two auditory cues and one visual cue with delivery of three sucrose pellets 
into a food cup.  The rats then underwent compound conditioning in which 
the visual cue and one of the auditory cues were paired together, resulting in 
delivery of three sucrose pellets for both cues rather than for each cue 
individually that the rats had been used to receiving.  A negative prediction 
error was therefore created.  After this the rats were tested for the amount of 
time they placed their noses in the food cap following presentation of all the 
cues individually.  It was found that the rats spent less time waiting for the 
cues that had been compounded, indicating that they had learnt that these 
cues were no longer rewarded as well as the others.  Inactivation of DA 
neurons in the VTA prior to compound conditioning resulted in these rats not 
altering their response to the less well rewarded cues during testing, 
indicating that the VTA is important for learning following negative prediction 
error (Takahashi et al., 2009).  In another study using an appetitive goal-
tracking paradigm it was found that a mix of muscimol and baclofen (GABAB 
receptor agonist) infused into the VTA prior to reactivation prevented the 
normally amnesic effect of systemic MK-801 when administered after 
reactivation (Reichelt et al., 2013).  This indicated the involvement of VTA 
neuronal activity in destabilization following negative prediction error.  The 
VTA however, was not thought to be the site of this destabilization as intra-
VTA APV or Mk-801 prior to reactivation did not mimic the effects of systemic 
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MK-801 administration and impair memory reconsolidation, implying that 
other brain regions are involved in the process (Reichelt et al., 2013). 
 
1.3.11 Dopaminergic Modulation of Extinction 
Researchers have started to investigate the role of DA in associative memory 
extinction.  These studies have utilized dopamine agonists and antagonists 
and genetic knockout mice and have yielded mixed results.  In one study 
methylphenidate was administered systemically prior to or immediately after 
contextual fear extinction training.  It was found to improve subsequent 
retention (Abraham et al., 2012).  Systemic administration of the DA agonist ?Ɛ 
amphetamine or cocaine or the D1R agonist SKF 38393 prior to FPS extinction 
training blocked extinction, leading to fear enhancement (Borowski and 
Kokkinidis, 1998).  D1R KO mice were found to have impaired extinction of 
passive avoidance and contextual fear (EL-Ghundi et al., 2001).  Auditory fear 
extinction was impaired by intra-PFC, but not intra-BLA, infusion of SCH 23390 
(Hikind and Maroun, 2008).  Intra-CA1 infusion of SCH 23390 impaired and 
SKF 38393 enhanced the extinction of both inhibitory avoidance and 
contextual fear (Fiorenza et al., 2012).  Intra-BLA and intra-mPFC infusions of 
SCH 23390 and SKF 238393 on the other hand, had no effect on contextual 
fear extinction.  Intra-BLA and intra-mPFC SCH 23390 impaired the extinction 
of inhibitory avoidance but SKF 38393 had no effect (Fiorenza et al., 2012).  
Extinction of CPP using cocaine was also found to depend on D1Rs (Fricks-
Gleason et al., 2012).  Systemic SCH 23390 was administered immediately 
following subsequent unreinforced extinction sessions.  It was found that SCH 
23390 increased the time for extinction to occur (i.e. no preference for the 
drug associated compartment), indicating the involvement of D1Rs in the 
extinction of appetitive memory (Fricks-Gleason et al., 2012).  However, other 
studies have failed to find an involvement of DA or D1Rs in fear memory 
extinction.  Systemic administration of amphetamine at high or low doses was 
not found to enhance extinction of auditory fear memory (Mueller et al., 
2009; Carmack et al., 2010) and D1R KO mice were not found to have 
impaired extinction of contextual or auditory fear (Ortiz et al., 2010).  In the 
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reward literature negative prediction error following reward omission has 
been proposed to result in extinction learning (Schultz, 2000).  This has been 
shown in a study where rats that had previously been trained to associate a 
tone with delivery of sucrose, underwent extinction training which involved 
sucrose omission.  A negative prediction error was therefore created.  It was 
found that if DA neurons within the VTA were optogenetically activated 
during this prediction error (e.g. when these neurons would normally 
decrease their firing rates) then extinction learning was reduced (Steinberg et 
al., 2013).  
 
1.3.12 Dopaminergic Modulation of Anxiety Disorders 
The involvement of DA in anxiety disorders is starting to be investigated.  It 
was found that the SLC6A3 3 ?ǀĂƌŝĂďůĞŶƵŵďĞƌƚĂŶĚĞŵƌĞƉĞĂƚpolymorphism 
of the DAT gene, which is linked to increased DA levels, was higher in PTSD 
compared with trauma-exposed non-PTSD controls (Segman et al., 2002).  
Plasma DA levels were also found to be increased in PTSD (Hamner and 
Diamond, 1993). In another study, homozygotes for the Val allele (Val/Val) of 
the val158met polymorphism of the COMT enzyme, which is associated with 
greater COMT activity, showed greater reacquisition (fear conditioning 
conducted after extinction has occurred) when extinction training was 
conducted six hours, but not ten minutes, after reactivation (Agren et al., 
2012). 
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1.5 Aims and Objectives 
The aims for the work carried out in this thesis were to investigate the role of 
D1Rs in the different learning and memory stages of contextual fear.  The D1R 
selective antagonist SCH 23390 was therefore used.  In the first set of 
experiments outlined in chapters three and four, the effects of systemic 
(chapter three) and central (chapter four) administration of SCH 23390 on 
acquisition and consolidation was investigated.  It has already been 
demonstrated that systemic SCH 23390 impairs acquisition but not the 
consolidation of contextual fear (Inoue et al., 2000).  The experiments 
undertaken in chapter three replicated this work.  Previous research has 
shown that intra-dHC SCH 23390 impairs the acquisition of other types of 
memory, such as spatial (K ?ĂƌƌŽůůĞƚĂů ? ? ? ? ? ?) and episodic-like (Bethus et al., 
2010), however working memory in the radial maze was not impaired 
(Wilkerson and Levin, 1999).  Intra-BLA infusion of the D1R agonist SKF 82958 
was found to enhance the acquisition of contextual fear (Biendenkapp and 
Rudy, 2009), whereas it was found that intra- BLA SCH 23390 impaired the 
acquisition of FPS in one study (Greba and Kokkinidis, 2000) but not another 
(De Oliveira et al., 2011).  It has not previously been shown if central 
administration of SCH 23390 into the BLA or dHC impairs the acquisition of 
contextual fear.  The experiments undertaken in chapter four therefore 
extend previous research by administering SCH 23390 into either the dHC or 
BLA prior to CFC. 
 
In the second set of experiments, outlined in chapters five and six, the effects 
of systemic SCH 23390 on contextual fear retrieval, reconsolidation, extinction 
and destabilization are investigated.  Previous systemic research has shown 
that SCH 23390 did not impair contextual fear retrieval (Inoue et al., 2000). 
The reconsolidation of passive avoidance was impaired by systemic SCH 
23390 administration (Sherry et al., 2005).  Systemic administration of the 
non-selective DA agonist methylphenidate before and after contextual fear 
was found to improved auditory fear extinction (Abraham et al., 2012) 
whereas amphetamine did not (Mueller et al., 2009; Carmack et al., 2010) and 
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systemic SCH 23390 impaired the extinction of CPP (Fricks-Gleason et al., 
2012).  The experiments in chapters five therefore repeat previous research 
by testing the effect of systemic SCH 23390 prior to the retrieval of contextual 
fear. They also extend previous research by testing the effect of systemic SCH 
23390 administration prior to and immediately after reconsolidation and 
extinction sessions.  In chapter six, the effect of SCH 23390 on the 
destabilization of contextual fear was investigated as this has not been tested 
before.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
64 
 
 
 
Chapter Two 
General Methods and Validation Studies 
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2.1 General methods 
The general methods used for the experiments discussed in this thesis have 
been outlined below.  Validation studies were carried out to determine the 
CFC parameters to be used.  The first validation study determined the most 
suitable number of footshocks to use.  The second and third validation studies 
investigated the effect of systemic NMDAR antagonism on CFC and its 
reconsolidation. 
 
2.1.1 Animals 
Male Lister hooded rats (Harlan, UK), weighing 250-400g were housed in 
groups of four on arrival to the animal unit and kept on a twelve hour 
light/dark cycle (lights on at 6:30am) with ad libitum food (standard chow) 
and water.  They were habituated to handling (three days for two minutes 
each) before experiments were undertaken.  The rats that were implanted 
with guide cannulae (see chapter 4) were housed separately after surgery and 
allowed at least five days to recover prior to behavioural testing.  All methods 
used were conducted in accordance with the Animals (Scientific Procedures) 
Act 1986.  A total of three hundred and twenty animals were used for the 
experiments carried out in this thesis. 
 
2.1.2 Drugs 
For systemic administration studies, SCH 23390 (Tocris, UK) and MK-801 
(Sigma-Aldrich, UK) were made up fresh on the morning of use to the required 
concentration (0.1mg/kg) by dissolving in sterile saline (0.9%; 1 ml/kg).  These 
doses of SCH 23390 and MK-801 have previously been shown to impair fear 
conditioning or fear memory reconsolidation (Inoue et al., 2000; Lee et al., 
2006).  SCH 23390 or MK-801 was injected either thirty minutes before or 
immediately after conditioning, reactivation or extinction sessions (see 
below). Controls received saline injections.  All systemic drug administration 
experiments in this thesis used i.p. injections.  Details on central drug 
infusions are presented in chapter four. 
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2.1.3 Behavioural Procedures  
Contextual fear conditioning:  
Fear conditioning took place in two chambers from Med Associates (base: 30 
x 24 cm, height: 30 cm) connected to an electric shock generator which 
delivered constant current shocks via the metal grid floor.  A speaker and light 
were mounted on the side of the chamber.  The light came on at the 
beginning of the conditioning and memory testing sessions and stayed on 
throughout, this added to the contextual background.  White noise (60 dB) 
was also played throughout to lessen the impact of outsight noise.  The 
chambers were decorated with either stripes or spots and cleaned with 40% 
ethanol solution to provide a distinctive contextual background for the rats. 
 
During conditioning the rats were individually placed into either one of the 
two chambers.  In the first validation study, the rats waited two minutes 
before receiving either four or six unsignalled footshocks (one minute inter-
trial interval (ITI)) and were removed two minutes after the last shock (see 
below).  In all subsequent experiments the rats received four footshocks 
during conditioning.  For the systemic drug injection experiments, the 
footshocks were half a mA and lasted for half a second. The duration of the 
footshocks was increased to one second for the central drug infusion 
experiments because rats with implants are less sensitive to footshock 
administration.   For the acquisition and consolidation experiments, the rats 
were returned to the same chamber twenty four hours and seven days after 
conditioning for a two minute LTM retention test, during which their 
behaviour was digitally recorded.  Videos were later analysed for freezing 
behaviour.  Freezing behaviour (defined as no movement apart from that 
required for respiration) was scored manually by observation at three-second 
intervals and calculated as a percentage of the two minute test sessions.  The 
animals were randomly assigned to groups and the scoring was carried out 
blind to condition by two observers. 
 
67 
 
For the reconsolidation and destabilization experiments, the rats were 
conditioned as above. However, they received a two minute reactivation 
session twenty four hours later, where they were returned to the same 
chamber before undergoing two minute PR-LTM retention tests twenty four 
hours and seven days after the reactivation session.  Behaviour was digitally 
recorded during each session and freezing behaviour was assessed during the 
last two minutes of the conditioning session, the reactivation session and the 
twenty four hours and seven day PR-LTM retention sessions. 
 
For the extinction experiments the rats were conditioned as above, however, 
they then underwent an extinction session twenty four hours later, where 
they were returned to the same chamber as conditioning for twenty minutes 
without receiving any footshocks.  They then underwent retention testing 
twenty four hours and seven days after the extinction session.  Behaviour was 
digitally recorded during each session and freezing behaviour was assessed 
during the last two minutes of the conditioning session, the first and last two 
minutes of the extinction session, and the twenty four hour and seven day 
retention sessions.  
 
Open Field:  
Some of the same rats that were fear conditioned were later tested in the 
open field (black perspex, base: 100 x 100 cm, enclosing wall: 50 cm high) to 
examine the effects of SCH 23390 on locomotor activity and innate fear.  All 
rats were introduced into the apparatus at the same peripheral location and 
the testing was conducted in a dimly lit room for ten minutes.  Behaviour was 
recorded with a video camera positioned directly above the arena for later 
analysis (see below). The rats that were given SCH 23390 or vehicle 
systemically were placed individually into the open field arena either thirty 
minutes or twenty four hours later.  The rats that were infused with SCH 
23390 or vehicle into the dHC or BLA were placed individually into the arena 
ten minutes after microinfusion (see below). Open field data were analysed 
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using Ethovision software and the following variables were quantified: total 
distance moved, rearing, and time spent in the centre. 
 
Shock Sensitivity: 
Some of the same rats that were fear conditioned were later assessed for 
their shock sensitivity threshold.  The rats were injected with SCH 23390 or 
saline thirty minutes before being placed into a novel chamber and, after ten 
minutes of habituation, were administered ten footshocks (one minute ITI) 
increasing in intensity from 0.05-0.5 mA.  Behaviour was recorded and the 
threshold for the first flinch (raising hind paws briefly off the bars) and first 
audible vocalization following footsock administration was assessed in each 
rat (Quick et al., 2000). 
 
2.2 Validation Studies 
The first validation study was carried out to assess the optimal number of 
footshocks to administer during conditioning in order to obtain moderate (i.e. 
40-50%) freezing levels during subsequent memory retention tests;  this was 
to avoid potential floor or ceiling effects.  In the second validation study the 
NMDAR antagonist MK-801 was administered systemically (i.p.) prior to 
conditioning in order to assess the injection procedure and to replicate 
previous findings showing impaired conditioning with this treatment. In the 
third validation study MK-801 was administered systemically prior to 
reactivation to assess the effects of NMDAR antagonism on reconsolidation. 
 
2.2.1 Four vs Six Footshocks on Contextual Fear Conditioning 
 
Methods 
The contextual fear apparatus and procedure have been outlined in detail in 
section 2.1. Half the rats (n=10) received six footshocks, whereas the other 
half (n=10) received four footshocks during conditioning.  Two-way mixed 
analysis of variance (ANOVA) was used to analyse the freezing levels, with 
footshock (four or six) as the between-subject factor and memory testing 
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session (e.g. conditioning (COND), reactivation (REACT), 24 hr and 7 d) as the 
within-subject factor.  All data are presented as the mean + standard error of 
the mean (SEM). 
 
Results 
Both six and four footshocks led to freezing behaviour after the last shock 
during the conditioning session, during reactivation (also equivalent to LTM 
testing 24hrs after conditioning), and during PR-LTM testing twenty four hours 
and seven days after reactivation (see Fig 2.1).  A two-way mixed ANOVA 
revealed no main effect of footshock (F(1,18)=0.393, P>0.05) and no footshock x 
time interaction (F(3,54)=0.292, P>0.05).  Both six and four footshocks resulted 
in freezing behaviour of ~80% in the last two minutes of the conditioning 
session and for the reactivation session 46% and 54% respectively.  Six 
footshocks resulted in freezing levels of around 30% during the twenty four 
hour and seven day PR-LTM retention sessions, whereas four footshocks 
resulted in freezing levels of 38% and 36%  during the twenty four hour and 
seven day PR-LTM retention sessions respectively. 
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Discussion 
An optimum freezing level of 40-50% during reactivation (i.e. LTM testing) was 
achieved by administering four footshocks during the conditioning session, 
freezing did not differ significantly between rats conditioned using four or six 
shocks.  To minimise unnecessary suffering experienced by the rats and 
Fig 2.1 The effect of six vs four 
footshocks (FS).  There were 
no differences in freezing 
between six and four FS 
during contextual fear 
reactivation (REACT), PR-LTM 
24 hr after reactivation (PR-
LTM1) and PR-LTM 7 d after 
reactivation (PR-LTM7) 
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because strong conditioning has previously been shown to be more resistant 
to undergoing reconsolidation (Suzuki et al., 2004), the experiments in this 
thesis were therefore all conducted using a four footshock CFC protocol. 
 
2.2.2 Systemic NMDA Receptor Antagonism during Contextual Fear 
Conditioning 
 
Introduction 
The second validation study was undertaken to assess the systemic injection 
procedure and to determine if conditioning using the four footshock protocol 
could be effectively impaired by NMDAR antagonism.  Previous research has 
shown that NMDA receptor antagonists impair many different types of 
memory acquisition.  For example, systemic injection of MK-801 was found to 
impair the acquisition of tasks in the Morris water maze, T-maze, passive 
avoidance and object recognition (van de Staays et al., 2011) and CFC (Gould 
et al., 2002). MK-801 or vehicle was injected thirty minutes prior to CFC.   
 
Methods 
The methods for this experiment are outlined in detail in section 2.1.  Briefly, 
MK-801 (n=8) or vehicle (n=7) was injected i.p. thirty minutes prior to CFC.  
Two minute LTM retention sessions were conducted twenty four hours and 
seven days later, during which freezing behaviour was assessed.  Two-way 
mixed ANOVA was used to analyse the freezing levels, with drug (MK-801 or 
vehicle) as the between-subject factor and memory testing session (e.g. 
COND, 24 hr and 7 d) as the within-subject factor.  All data are presented as 
the mean + SEM. 
 
Results 
It was found that, compared to vehicle, systemic MK-801 given prior to CFC 
impaired freezing during the last two minutes of the conditioning session and 
during subsequent memory retention sessions twenty four hours and seven 
days later (See Fig 2.2).  Analysis of freezing behaviour using a two-way 
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ANOVA revealed a significant main effect of drug (F1,13=5.974, P<0.05) but no 
drug x time interaction (F2,26=1.369, P>0.05).  
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Discussion 
It was found that systemic NMDA receptor antagonism impaired the 
acquisition of contextual fear.  MK-801 given prior to conditioning led to 
reduced freezing at the end of the conditioning session and during the LTM 
retention sessions twenty four hours and seven days later.  This is in 
agreement with a previous study showing that systemic and intra-
hippocampal MK-801 prior to conditioning impaired contextual but not 
auditory fear (Gould et al., 2002; Bast et al., 2003).  Other studies using the 
NMDA receptor antagonist APV were also found to impair CFC with intra-
ventricular (Kim et al., 1991) intra-amygdala (Maren et al., 1996b) and intra-
hippocampal (Young et al., 1994) infusion.  This study demonstrates that the 
injection procedure was carried out correctly and that the conditioning 
procedure using four footshocks gives an optimum level of freezing behaviour 
that is able to be reduced by NMDAR antagonism. 
 
 
 
 
 
Fig 2.2 The effect of NMDA 
receptor antagonism on 
contextual fear conditioning.  
MK-801 prior to conditioning 
decreased freezing in the last 
two minutes of the conditioning 
session (COND) and during the 
retention sessions (*P<0.05) 
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2.2.3 Systemic NMDA Receptor Antagonism during Contextual Fear 
Reactivation 
 
Introduction 
The third validation study was undertaken to determine if the conditioning 
paradigm allows for pharmacological disruption of reconsolidation.  Previous 
research has shown that NMDAR antagonists impair reconsolidation.  For 
example, systemic injection of MK-801 was found to impair auditory fear 
reconsolidation (Lee et al., 2006).  MK-801 or vehicle was injected thirty 
minutes prior to contextual fear memory reactivation.  To the best of our 
knowledge this has not been tested before, for contextual fear. 
 
Methods 
The methods for this experiment are outlined in detail in section 2.1.  Briefly, 
MK-801 (n=9) or vehicle (n=9) was injected i.p. thirty minutes prior to 
contextual fear reactivation.  Two minute PR-LTM retention sessions were 
conducted twenty four hours (PR-LTM1) and seven days (PR-LTM7) later, 
during which freezing behaviour was assessed.  Two-way mixed ANOVA was 
used to analyse the freezing levels, with drug (MK-801 or vehicle) as the 
between-subject factor and memory testing session (e.g. COND, REACT, PR-
LTM1 and PR-LTM7) as the within-subject factor.  All data are presented as 
the mean + SEM. 
 
Results 
It was found that, compared to vehicle, systemic MK-801 given prior to 
contextual fear reactivation impaired freezing behaviour (see Fig 2.3).  
Analysis of freezing behaviour using a two-way ANOVA revealed a main effect 
of drug (F(1,15)=5.747, P<0.05) and a drug x time interaction (F(3,45)=3.364, 
P<0.05).  Post hoc analysis using independent t-tests indicated that freezing 
behaviour was significantly decreased during the reactivation session and PR-
LTM1 twenty four hours later (P<0.05).  As only three groups were used and a 
significant F value was obtained the max type one error rate is held at the 
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chosen level of 5% and therefore the post hoc analysis does not need to be 
corrected for repeated measures (Cardinal and Aitken, 2006). 
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Discussion 
Systemic administration of MK-801 prior to reactivation was found to impair 
contextual fear reconsolidation.  Freezing behaviour was reduced in the drug 
group during post reactivation testing sessions twenty four hours later.  This 
has, to the best of our knowledge, not previously been demonstrated and 
indicates the involvement of NMDARs in the reconsolidation of contextual 
fear.  This finding is in agreement with research undertaken using other 
memory paradigms.  Systemic MK-801 prior to reactivation impaired 
reconsolidation of auditory fear (Lee et al., 2006), appetitive memory (Lee and 
Everitt, 2008) and drug seeking associative memory (Milton et al., 2008).  In 
another study systemic MK-801 prior to reactivation of an appetitive goal 
tracking task was found to impair PR-LTM if six, but not twelve or three days 
of training were given (Reichelt and Lee, 2012). This result indicates that the 
CFC procedure used in our experiment was not too strong and therefore able 
to undergo reconsolidation and also that a reactivation session of two 
minutes was adequate for reconsolidation to occur. 
 
 
 
Fig 2.3 The effect of NMDA 
receptor antagonism on 
contextual fear 
reconsolidation. MK-801 prior 
to reactivation impaired 
freezing levels during 
reactivation (REACT) and PR-
LTM 24 hr (PR-LTM1) but not 7 
d (PR-LTM7) later (*P<0.05) 
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Chapter Two Summary 
The effect of administering four vs six footshocks was tested in order to 
determine what CFC protocol to use for the experiments undertaken in this 
thesis.  Both four and six footshocks led to optimal freezing levels of around 
50% during the reactivation session, therefore in order to minimise rat 
suffering, a four footshock protocol was used for all subsequent experiments 
outlined in this thesis.  The effect of systemic NMDAR antagonism on 
contextual fear was also investigated.  It was found that MK-801 administered 
prior to CFC impaired its acquisition in agreement with previous research.  It 
was also found that MK-801 administration prior to contextual fear 
reactivation impaired reconsolidation.  To the best of our knowledge this has 
not previously been demonstrated.  These results validate the i.p. injection 
procedure, the MK-801 dose and the contextual fear behavioural parameters 
used in the experiments contained within this thesis. 
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Chapter Three 
Systemic D1 Receptor Antagonism during 
Contextual Fear Acquisition and 
Consolidation 
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3.1 Introduction 
Activation of D1Rs has been shown to lead to the initiation of a number of 
molecular pathways that are thought to be involved in initial fear memory 
formation.  D1R stimulation results in the activation of adenylate cyclase 
which leads to increased levels of cAMP which, in turn, activates PKA.  It was 
found that intraventricular infusion of PKA inhibitors impaired contextual fear 
memory consolidation (Schafe et al., 1999).  Both the cAMP/PKA and PLC 
pathways culminate in the activation of the transcription factor CREB, which 
can initiate synthesis of new proteins and lead to modulation of ion channels.  
It has been shown that CREB KO mice also have impaired CFC (Bourtchouladze 
et al., 1994).  Other evidence for the involvement of DA in fear memory 
acquisition has also been obtained using transgenic mice.  D1R KO mice have 
been shown to have reduced contextual and cued fear conditioning (Ortiz et 
al., 2010), and DA deficient and D1R KO mice were found to have impaired 
inhibitory avoidance memory (Fadok et al., 2009). 
 
Previous research using DA, and D1R antagonists and agonists, has also been 
undertaken.  In one study withdrawal from chronic amphetamine prior to 
conditioning was found to enhance memory formation; freezing behaviour in 
amphetamine pre-treated rats was increased during conditioning and 
subsequent tone alone memory testing sessions (Pezze et al., 2002).  Another 
DA agonist, apomorphine, was found to enhance two-way avoidance learning 
as apomorphine injected rats learnt faster than saline injected controls (Reis 
et al., 2004).  Other studies have made use of the selective D1R antagonist 
SCH 23390.  Systemic SCH 23390 prior to fear training has been found to 
impair FPS (Greba and Kokkinidis, 2000) and two-way avoidance learning (Reis 
et al., 2004).  It has been previously demonstrated that systemic 
administration of SCH 23390 given before CFC impairs freezing behaviour 
twenty four hours later (Inoue et al., 2000; Calzavara et al., 2009), whereas 
SCH 23390 administered immediately after CFC does not impair freezing 
behaviour twenty four hours later (Inoue et al., 2000; Bai et al., 2009). 
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Chapter Three Aims 
The experiments in this chapter re-examine previous research looking at the 
effects of systemic SCH 23390 administrations either before or immediately 
after CFC in rats.  To eliminate the possibility that the effect of SCH 23390 on 
fear learning was a result of non-specific effects on locomotion or pain 
sensitivity, the rats were also tested in the open field thirty minutes and 
twenty four hours after drug administration and had their shock sensitivity 
threshold assessed. 
3.2 Methods 
The methods used in this chapter have been outlined in chapter two.  Briefly, 
in the CFC experiments, SCH 23390 or saline was injected either thirty minutes 
before (SCH 23390 n=10, saline n=10) or immediately after (SCH 23390 n=10, 
saline n=10) CFC (four 0.5mA, half second footshocks; one minute ITI).  The 
rats underwent a two minute retention test twenty four hours and seven days 
after conditioning.  Freezing behaviour at the end of conditioning and during 
LTM testing was subsequently scored.  In the open field experiments, SCH 
23390 or saline was injected either thirty minutes (SCH 23390 n=11, saline 
n=9) or twenty four hours (SCH 23390 n=9, saline n=9) prior to placement in 
the open field arena for ten minutes.  The total distance moved and time 
spent in the inner-zone of the arena for each rat was obtained using Ethovison 
software.  Rearing behaviour was assessed manually by the experimenter at 
the time of testing.  In the shock sensitivity threshold experiment, rats were 
injected with SCH 23390 (n=10) or saline (n=10) thirty minutes prior to 
placement in novel chambers, where they received ten footshocks increasing 
in intensity from 0.05- ? ? ? ŵ ?  ĞŚĂǀŝŽƵƌ ǁĂƐ ƌĞĐŽƌĚĞĚ ĂŶĚ ƚŚĞ ƌĂƚƐ ?
thresholds to flinch and to vocalize were both assessed.  
 
Two-way mixed ANOVAs were used to analyse the freezing levels, with drug 
(SCH 23390 or vehicle) as the between-subject factor and memory testing 
session (24 hr and 7 d) as the within-subject factor in the CFC experiments.  In 
the pain sensitivity experiment drug was the between-subject factor (SCH 
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23390 or vehicle) and shock intensity was the within-subject factor (flinch and 
vocalize).  Open field data were analysed using Ethovision software.  Unpaired 
t-tests were used to compare the total distance moved, the rearing frequency 
(defined as lifting of front paws into the air or onto the wall of the arena) and 
percentage of time spent in the centre of the open field between the drug and 
saline treated groups.  All data are presented as the mean + SEM.  
 
3.3 Results 
3.3.1 Effect of Systemic D1 Receptor Antagonism on Contextual Fear 
Administration of SCH 23390 thirty minutes before CFC impaired freezing 
behaviour twenty four hours later (see Fig 3.1).  Analysis of freezing behaviour 
when drug was given before conditioning using a two-way ANOVA revealed a 
significant main effect of drug (F(1,18)=5.578, P<0.05) and drug x time 
interaction (F(1,18)=14.039, P<0.01).  Post hoc analysis using an independent t-
test indicated that freezing behaviour was significantly decreased during LTM 
testing twenty four hours later (P<0.01).  As SCH 23390 was found to effect 
behaviour in the open field when administered thirty minutes prior to testing 
(see below), the data for freezing behaviour during the last two minutes of 
the conditioning session were not included in the analysis as non-specific 
effects of the drug could not be ruled out. 
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Administration of SCH 23390 immediately after CFC had no effect on freezing 
behaviour during memory retention sessions twenty four hours and seven 
 
Fig 3.1 The effect of D1R 
antagonism during contextual 
fear conditioning.  SCH 23390 
prior to conditioning decreased 
freezing during memory 
retention 24 hr later      
(** P<0.01).   
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days later (see Fig 3.2). Analysis revealed no significant main effects of drug 
(F(1,18)=0.224, P>0.05) and no drug x time interaction (F(2,36)=0.808, P>0.05). 
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3.3.2 Effect of Systemic D1 Receptor Antagonism on Behaviour in the Open 
Field 
To eliminate the possibility that the effects of SCH 23390 on CFC were due to 
non-specific effects of the drug on locomotion or innate fear, behaviour in the 
open field was assessed (see Fig 3.3 and 3.4).  SCH 23390 administered 
systemically thirty minutes prior to open field testing reduced total distance 
moved (t(12)=4.04, P<0.01), rearing frequency (t(18) =2.76, P<0.05) and time 
spent in the inner-zone (t(16) =2.16, P<0.05). 
 
Fig 3.2 The effect of D1R 
antagonism after contextual 
fear conditioning.  SCH 23390 
immediately after conditioning 
did not alter freezing during 
memory retention sessions. 
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However, administration of SCH 23390 twenty four hours prior to open field 
testing did not affect total distance moved (t(16)=0.266, P>0.05), rearing 
frequency (t(16)=0.478, P>0.05) or time spent in the inner-zone (t(16)=0.484, 
P>0.05). 
 
Fig 3.3 The effect of D1R antagonism 
on behaviour in the open field.  SCH 
23390  30 min prior to testing 
significantly reduced the A) total 
distance moved, B) rearing 
frequency and C) time spent in the 
inner-zone (** P<0.01, * P<0.05). 
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3.3.3 Effect of Systemic D1 Receptor Antagonism on Pain Sensitivity 
To eliminate the possibility that the effects of SCH 23390 on contextual fear 
were due to side effects of SCH 23390 on the pain experienced by the rats, 
their shock sensitivity threshold was assessed (see Fig 3.5).  A two-way 
ANOVA revealed no significant main effect of drug on shock sensitivity 
threshold (F(1,18)=0.010, P>0.05). 
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Fig 3.4 The effect of D1R antagonism 
on behaviour in the open field.  SCH 
23390 24hrs before testing did not 
affect the A) total distance moved, 
B) rearing frequency or C) time spent 
in the inner-zone. 
Fig 3.5 The effect of D1R 
antagonism on pain sensitivity.  
SCH 23390 did not alter the rats' 
threshold to flinch or vocalize in 
response to footshock. 
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3.4 Discussion 
Systemic D1R antagonism during CFC was found to impair acquisition.  This 
indicates that DA acting at the D1 receptor is required during the initial 
formation of contextual fear memories.  In contrast SCH 23390 administered 
immediately after contextual fear memory had no effect on subsequent 
memory retention.  Administration of SCH 23390 thirty minutes prior to open 
field testing reduced total distance moved, rearing frequency and the time 
spent in the inner-zone, whereas administration twenty four hours prior to 
open field testing had no effect on these behaviours.  The shock sensitivity 
thresholds were similar between the drug and saline treated rats, indicating 
that SCH 23390 does not affect the pain experience of the footshock and thus 
ƚŚĞ ƌĂƚƐ ? ĂďŝůŝƚǇ ƚŽ ĂƐƐŽĐŝĂƚĞ ŝƚ ǁŝƚŚ ƚŚĞ ĨĞĂƌ ĐŽŶĚŝƚŝŽŶŝŶŐ ĐŚĂŵďĞƌ ĚƵĞ ƚŽ
impaired nociception. This confirms previous findings indicating that D1R 
antagonism has no effect on shock sensitivity (Inoue et al., 2000). 
 
3.4.1 Systemic D1 Receptor Antagonism during Acquisition  
The finding that systemic administration of SCH 23390 impairs the acquisition 
of contextual fear when administered prior to CFC is in agreement with 
previous research (Inoue et al., 2000, Calzavara et al., 2009).  Inoue and 
colleagues (2000) found that systemic SCH 23390 thirty minutes prior to CFC 
reduced freezing twenty four hours later (Inoue et al., 2000; Inoue et al., 
2005).  This reduction in freezing was found to be increased by administration 
of the D2R antagonist haloperidol at the same time, indicating D2R, as well as 
D1R involvement (Inoue et al., 2005).  Systemic SCH 23390 fifteen minutes 
prior to conditioning was also found to reduce freezing twenty four hours 
later in both spontaneously hypertensive rats and normotensive Wistar rats. 
The D2R antagonist metoclopramide, on the other hand, did not affect 
freezing in either group (Calzavara et al., 2009).  SCH 23390 also weakly 
antagonises 5-HT2 receptors (Hyttel, 1983); however, it has been shown that 
the 5-HT2 antagonist ICI169369 did not impair contextual fear acquisition, 
indicating that the effects of SCH 23390 on contextual fear acquisition result 
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from the antagonism of D1Rs and not 5-HT2 receptors (Inoue et al., 1996).  It 
can be difficult to determine if a drug given before conditioning is having an 
effect specifically on acquisition, short term or long term consolidation 
processes (Bast et al., 2001).  However, because in our study freezing 
behaviour was impaired in the last two minutes of the conditioning session, 
and SCH 23390 given immediately after conditioning did not affect freezing 
levels, it is most likely that the acquisition, as opposed to short or long term 
consolidation processes, were affected by D1R antagonism.  The shock 
sensitivity thresholds were similar between the drug and saline treated rats, 
indicating that the effects of SCH 23390 on the acquisition of contextual fear 
are a result of impaired memory acquisition rather than due to differences in 
the pain experienced by the rats. 
 
There are mixed results on the effect of SCH 23390 given prior to training in 
other fear memory paradigms. For example, administration before 
conditioning to a light stimulus paired with foot shocks reduced freezing to 
the light stimulus alone but did not affect the FPS response (De Oliveira et al., 
2006), whereas other research showed that SCH 23390 prior to fear 
conditioning did impair FPS (Greba and Kokkinidis, 2000).  Systemic SCH 23390 
prior to training was found to impair short term object recognition memory 
formation (Clausen et al., 2011).  The conflicts with previous research are 
possibly due to the memory paradigms used.  For example object recognition 
tasks may involve more complex ĐŽŐŶŝƚŝǀĞĨƵŶĐƚŝŽŶƐĂƐƚŚĞǇŵĞĂƐƵƌĞƚŚĞƌĂƚƐ ?
choices (e.g. explore or do not explore an object).  One the other hand, in CFC 
and retention testing the rats are placed into a conditioning chamber for a set 
period during which they cannot escape (i.e. they have no choice).  Therefore 
these memory paradigms likely involve different neural pathways and/or 
neurochemical mechanisms that rely differently on local D1R activation.   
The synaptic tagging and capture hypothesis postulates that during the 
induction of E->dW ĂĐƚŝǀĞ ƐǇŶĂƉƐĞƐ ĂƌĞ  ‘ƚĂŐŐĞĚ ? ǁŚŝĐŚ ĂůůŽǁ ƚŚĞŵ ƚŽ ůĂƚĞƌ
receive PRPs, enabling E-LTP to be converted to L-LTP (Frey and Morris, 1997).  
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It has been proposed that D1Rs are involved in the synthesis of PRPs (Wang et 
al., 2010; Sajikumar and Frey, 2004).  It could be that SCH 23390 given prior to 
CFC impairs the initiation of PRP synthesis and so E-LTP is not being converted 
to late L-LTP.  Therefore the rats do not remember the association between 
the fear conditioning chamber and the footshock twenty four hours later. 
3.4.2 Systemic D1 Receptor Antagonism during Consolidation 
The finding that systemic administration of SCH 23390 after CFC did not 
impair freezing behaviour twenty four hours or seven days later is in 
agreement with previous research (Inoue et al., 2000; Bai et al., 2009).  It 
would therefore seem that D1R signalling is not involved in contextual fear 
consolidation.  In one study, SCH 23390 injection thirty minutes after CFC was 
not found to impair freezing behaviour twenty four hours later (Inoue et al., 
2000).  In another SCH 23390 administered three times after CFC did not 
impair memory twenty four hours or eight days later (Bai et al., 2009).  It has 
also been shown that while SCH 23390 application during high frequency 
stimulation in CA1 slice preparations resulted in reduced LTP, SCH 23390 
application immediately after high frequency stimulation had no effect (Frey 
et al., 1991).  One possible explanation for the lack of effect of D1R 
antagonism immediately after CFC could be that D1R activation had already 
initiated PRP synthesis by the time SCH 23390 was administered.  That is, the 
mechanisms had already been set in motion and impairing D1R activity after 
CFC is too late to interfere with this.   
 
3.4.3 Systemic D1 Receptor Antagonism and Behaviour in the Open Field  
The finding that systemic SCH 23390 administered thirty minutes prior to 
open field testing significantly reduced total distance moved and rearing 
frequency is in agreement with previous research (Gessa et al., 1985; Salmi 
and Ahlenius, 2000; Clausen et al., 2011).  SCH 23390 has also been shown to 
reduce locomotion induced by D2R agonists such as the non-selective D2R 
agonist apomorphine or the selective D2R agonist Ru 24213 (Molloy et al., 
1986).  It has been proposed that high doses of SCH 23390 reduce locomotion 
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and rearing behaviour but that low doses can increase locomotion (Bruhwyler 
et al., 1991).  SCH 23390 administered thirty minutes prior to testing for ten 
minutes in the open field decreased peripheral and central ambulation at high 
doses (0.1 and 0.3mg/kg) but increased them at low doses (0.01 and 0.03 
mg/kg) (Bruhwyler et al., 1991).  However another study found that a dose of 
0.1mg/kg did not reduce locomotion (De Oliveira et al., 2006).  SCH 23390 
administered twenty four hours before open field testing did not affect total 
distance moved, rearing frequency or time spent in the inner-zone of the 
arena.  This finding indicates that SCH 23390 is no longer affecting the rats 
twenty four hours later when they undergo contextual fear memory testing, 
in agreement with the short half-life (thirty minutes) of this drug (Andersen 
and Gronvald, 1986).  The reduction in freezing behaviour observed during 
the twenty four hour and seven day memory retention sessions was therefore 
unlikely to be a consequence of non-specific effects of SCH 23390 on 
locomotion.  Given that SCH 23390 reduced the total distance moved in the 
open field it is difficult to draw conclusions on the time spent in the inner-
zone on, for example, drug induced increases in anxiety as the reduction could 
be a result of reduced locomotion overall. 
 
3.4.4 Chapter Three Summary 
The effect of systemic D1R antagonism on contextual fear was investigated.  It 
was found that SCH 23390 administered prior to CFC impaired acquisition as 
memory retention was significantly impaired twenty four hours later.  On the 
other hand SCH 23390 administered immediately after conditioning had no 
effect.  These results are in agreement with previous research.  This 
impairment of CFC acquisition by D1R antagonism is unlikely to be a result of 
non-specific effects of the drug on locomotion as administration of SCH 23390 
twenty four hours prior to open field testing did not affect total distance 
moved.  It is also unlikely to be a result of non-specific effects of the drug on 
nociception as both SCH 23390 and saline injected rats flinched and vocalized 
at the same level of footshock administration.  The experiments outlined in 
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chapter four extend these findings by exploring where in the brain this effect 
of D1R antagonism on contextual fear could be taking place. 
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Chapter Four 
D1 Receptor Antagonism in the 
Hippocampus and Amygdala during 
Contextual Fear Acquisition 
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4.1 Introduction 
The experiments outlined in chapter three showed that systemic 
administration of SCH 23390 prior to conditioning impairs the acquisition of 
contextual fear.  The logical next stage was therefore to try to determine 
which brain regions were mediating this effect.  The dHC and BLA nucleus of 
the amygdala were chosen as previous research has linked these brain regions 
with DA modulation of fear learning.  Evidence for involvement of the dHC 
and BLA in fear memory acquisition has been demonstrated using lesion 
methods.  Pre-training lesions of both the dHC (Kim et al., 1993; Young et al., 
1994) and BLA (Kim et al., 1993; Phillips and LeDoux, 1992) have been found 
to impair freezing to contextual stimuli.  These studies indicate that these 
regions are important in contextual fear acquisition under normal 
circumstances (Fanselow, 2010).  The hippocampus and amygdala receive 
dopaminergic projections from the SN-VTA forming part of the mesolimbic DA 
pathway.  Injections of [3H] leucine (an anterograde tracer) and horseradish 
peroxidase (a retrograde tracer) into VTA showed projections to the amygdala 
including to the BLA (Simon et al., 1979).  Retrograde tracing using fluorescent 
tracers such as fluoro-gold and immunocytochemistry staining for TH showed 
that dopaminergic neurons from the VTA project to the hippocampal 
formation (Gasbarri et al., 1994).  D1R are expressed in both the hippocampus 
and amygdala (Boyson et al., 1986; Weiner et al., 1991; Huang et al., 1992). 
 
Previous research has shown a link between memory acquisition and DA 
modulation in the amygdala and hippocampus.  DA levels in the hippocampus 
and DOPAC levels in the amygdala were found to be elevated following 
footshock administration (Inoue et al., 1994).  LTP is a proposed cellular model 
of memory formation and has been demonstrated in both the hippocampus 
(Bliss and Lomo, 1973) and amygdala (Rogan et al., 1997).   D1R antagonism 
has been shown to impair both E-LTP (Otmakhova and Lisman, 1996) and L-
LTP (Huang and Kandel, 1995) in the hippocampus.  Studies using D1R 
agonists and antagonists have investigated the involvement of DA in 
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numerous memory paradigms, including spatial (K ?ĂƌƌŽůůĞƚĂů ? ?  ? ? ? ?; Pezze 
and Bast, 2012) and episodic-like memory (Bethus et al., 2010).  The 
involvement of amygdala and hippocampal DA modulation of inhibitory 
avoidance has also been investigated.  DA deficient mice were found to have 
impaired inhibitory avoidance memory and this could be rescued by 
restoration of DA levels by L-DOPA administration in the amygdala (Fadok et 
al., 2009).  There have also been studies undertaken looking at the 
involvement of D1Rs in the acquisition and consolidation of Pavlovian fear 
memory.  Intra-BLA infusion of SCH 23390 prior to training was found to 
impair FPS acquisition (Greba and Kokkinidis, 2000).  SCH 23390 and SKF 
82958 (D1 agonist) infused prior to auditory training into the cAMY prior to 
auditory training resulted in freezing impairment and enhancement 
respectively, to both background context and tone presentations twenty four 
hours later (Guarraci et al., 1999).  Infusion of SKF 82958 into the BLA was 
found to enhance CFC (Biedenkapp and Rudy, 2009). 
Chapter Four Aims 
The aim of the experiments in this chapter was to determine if the 
impairment in the acquisition of contextual fear resulting from systemic D1R 
antagonism could be taking place in either the dHC or BLA.  Although the dHC 
and BLA are necessary under normal circumstances for contextual fear 
acquisition, the role of DA in this process remains unclear.  Therefore the 
effects of intra-dHC and intra-BLA SCH 23390 administration prior to CFC were 
examined. To eliminate the possibility that the effect of SCH 23390 on fear 
learning could result from non-specific effects on locomotion, the rats were 
also tested in the open field following intra-dHC and intra-BLA SCH 23390 
infusions. 
 
4.2 Methods 
4.2.1 Surgery 
Sixty two rats were habituated to the animal unit for one week before being 
implanted with bilateral guide cannulae (26 gauge) and stylets (33 gauge) 
90 
 
aimed at the dHC or BLA.  Anaesthesia was induced with 4-4.5% isoflurane in 
air and maintained on 1-3%.  They were placed in a stereotaxic frame and 
implanted with bilateral cannulae aimed at the following coordinates: dHC: 
4.5 mm posterior and 3 mm lateral from bregma, 3 mm ventral to the brain 
surface; BLA: 2.8 mm posterior and 4.7 mm lateral from bregma, 6.4 mm 
ventral to the brain surface.  The cannulae were secured to the skull with four 
stainless steel screws and dental cement.  For analgesia, the rats were 
injected with bupenorphine (0.05mg/kg) at the start of surgery, between six 
to eight hours later and the following morning; they were also injected with 
meloxicam (2mg/kg) at the end of surgery and received it orally for four days 
post surgery.  They were allowed to recover for at least five days before 
undergoing behavioural testing, during which time they were habituated for 
the drug microinfusions by gentle restraint followed by removal and 
reinsertion of their cannulae stylets. 
 
4.2.2 Drugs 
^,  ? ? ? ? ?ǁĂƐŵĂĚĞƵƉƚŽĂĐŽŶĐĞŶƚƌĂƚŝŽŶŽĨ  ?ʅŐ ?ʅ> ŝŶƐƚĞƌŝůĞƐĂůŝŶĞ ? dŚŝƐ
concentration of SCH 23390 has been used previously to examine the role of 
ŚŝƉƉŽĐĂŵƉĂů  ?Z ƐŝŐŶĂůůŝŶŐ ŝŶ ƐƉĂƚŝĂů ŵĞŵŽƌǇ ƉƌŽĐĞƐƐŝŶŐ  ?K ?ĂƌƌŽůl et al., 
2006).  In the dHC, SCH 23390  ? ?ʅŐŝŶ  ?ʅ>ƉĞƌƐŝĚĞ ?ǁĂƐŝŶĨƵƐĞĚŽǀĞƌĂƚǁŽ
ŵŝŶƵƚĞƉĞƌŝŽĚ ?/Ŷ> ?^, ? ? ? ? ? ? ? ? ?ʅŐŝŶ ? ? ?ʅ>ƉĞƌƐŝĚĞ ?ǁĂƐŝŶĨƵƐĞĚ over a 
one minute period.  The injectors, which extended 0.5mm (dHC) or 1mm 
(BLA) from the cannulae, were left in place for a further one minute to allow 
for drug diffusion before being removed.  The rats were returned to their 
home cages for ten minutes before undergoing behavioural testing. 
 
4.2.3 Histology 
After behavioural testing was finished, the animals were deeply anesthetised 
and then underwent cardiac perfusion with 0.9% saline followed by 4% 
paraformaldehyde.  The brains were kept in 4% paraformaldehyde before 
ďĞŝŶŐ ƐĞĐƚŝŽŶĞĚ Ăƚ  ? ? ?ʅŵ Žƌ  ? ?A?ŵ ĂŶĚ ƐƚĂŝŶĞĚ ĨŽƌ ƚŚĞ ƉƌĞƐĞŶĐĞ ŽĨ
acetylcholinesterase (Koelle and Friedenwald, 1949).  
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4.2.4 Behavioural Procedures 
The behavioural procedures used in this chapter have been outlined in 
chapter two.  Briefly, in the contextual fear experiments SCH 23390 or saline 
was infused into the dHC or BLA ten minutes prior to CFC (four 0.5mA, one 
second footshocks).  The rats underwent two minute retention tests twenty 
four hours and seven days later.  These were video recorded aŶĚ ƚŚĞ ƌĂƚƐ ?
freezing behaviour was subsequently scored.  In the open field experiments, 
SCH 23390 or saline was infused into the dHC or BLA ten minutes prior to 
placement in the open field arena for ten minutes.  The total distance moved 
and time spent in the inner-zone of the arena for each rat was obtained using 
Ethovison software.  Rearing behaviour was assessed manually by the 
experimenter at the time of testing.  
 
4.2.5 Data Analysis  
Two-way mixed ANOVA was used to analyse the freezing levels, with drug 
(SCH 23390 or vehicle) as the between-subject factor and memory retention 
session (24 hr and 7 d) as the within-subject factor.  Open field data were 
analysed using unpaired t-tests to compare the total distance moved, the 
rearing frequency and percentage of time spent in the centre of the open field 
between the drug and saline treated groups.  All data are presented as the 
mean + SEM. 
 
4.3 Results 
4.3.1 Cannulae Placements in the dHC and BLA  
Out of the sixty two rats used in these experiments nineteen were excluded 
due to illness after surgery (n=1), missed placements (n=10), or poor histology 
(due to using inappropriate equipment) leading to inability to see the 
cannulae tips (n=8).  Schematic representations of the cannula placements in 
the dHC and BLA are presented in Fig 4.1. 
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4.3.2 Effect of Intra-dHC D1 Receptor Antagonism on Contextual Fear 
Acquisition 
The effects of intra-dHC SCH 23390 or saline infusion ten minutes before 
conditioning are presented in Fig 4.2.  Analysis of the intra-dHC experiment 
(SCH 23390 n=12, saline n=11) using a two-way mixed ANOVA revealed a main 
effect of drug (F(1,21)=5.153, P<0.05) but no drug x time interaction 
(F(1,21)=0.863, P>0.05).  As SCH 23390 was found to effect behaviour in the 
open field when administered into the dHC thirty minutes prior to testing (see 
Fig 4.1 Placement diagrams showing 
location of cannulae tips in (A) the 
DH and (B) the BLA 
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below), the data for freezing behaviour during the last two minutes of the 
conditioning session was not included in the analysis as non-specific effects of 
the drug could not be ruled out. 
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4.3.3 Effect of Intra-BLA D1 Receptor Antagonism on Contextual Fear 
Acquisition 
Analysis of intra-BLA infusion of SCH 23390 (n=9) ten minutes before 
conditioning compared with saline (n=11) revealed no significant main effect 
of drug (F(1,17)=0.964, P>0.05) and no drug x time interaction (F(1,17)=0.050, 
P>0.05) (Fig 4.3).  As SCH 23390 was found to effect behaviour in the open 
field when administered into the BLA thirty minutes prior to testing (see 
below), the data for freezing behaviour during the last two minutes of the 
conditioning session was not included in the analysis as non-specific effects of 
the drug could not be ruled out.  Baseline freezing behaviour was decreased in 
the animals with BLA cannulae.  This could be due to partial BLA damage 
resulting from the implants. 
 
Fig 4.2 The effect of intra-DH 
D1R antagonism on contextual 
fear.  SCH23390 prior to 
conditioning impaired memory 
during retention sessions        
(* P<0.05). 
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4.3.4 Effect of Intra-dHC D1 Receptor Antagonism on Behaviour in the Open 
Field 
The effect of intra-dHC or intra-BLA SCH 23390 infusions on behaviour in the 
open field was tested (see Fig 4.4 and 4.5).  For intra-dHC infusions, unpaired 
t-tests revealed that SCH 23390 (n=13) compared with saline (n=10) 
significantly decreased the total distance moved (t(21)=3.254, P<0.01), rearing 
frequency (t(21)=4.595, P<0.01) and time spent in the inner-zone (t(16)=5.371, 
P<0.01). 
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Fig 4.3 The effect of intra-
BLA D1R antagonism on 
contextual fear.  SCH23390 
prior to conditioning did not 
affect freezing during 
memory retention sessions. 
Fig 4.4 The effect of intra-DH D1R 
antagonism on behaviour in the 
open field. A) Total distance, B) 
Rearing frequency and C) Time 
spent in the inner-zone were all 
decreased by SCH 23390 
(**P<0.01) 
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4.3.5 Effect of Intra-BLA D1 Receptor Antagonism on Behaviour in the Open 
Field 
For the intra-BLA open field experiment total distance moved was found to be 
reduced in SCH 23390 group (n=8) compared with the saline group (n=10).  
Unpaired t-tests revealed a significant effect on total distance moved 
(t(16)=4.410, P<0.01) but not rearing frequency (t(16)=1.735, P>0.05) or time 
spent in the inner-zone (t(16)=0.163, P>0.05).  
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4.4 Discussion 
D1R antagonism in the dHC impaired contextual fear memory acquisition. 
Administration of SCH 23390 into the dHC prior to CFC resulted in reduced 
freezing behaviour during LTM retention testing twenty four hours and seven 
days later.  Conversely, D1R antagonism in the BLA was not found to impair 
contextual fear memory acquisition.  Intra-BLA SCH 23390 administered prior 
to CFC did not reduce freezing during LTM testing.  Both intra-dHC and intra-
Fig 4.5 The effect of intra-BLA D1R 
antagonsim on behaviour in the 
open field. A) Total distance moved 
was decreased by SCH 23390 
(**P<0.01). B) Rearing frequency 
and  C) Time spent in the inner-zone 
were not affected by SCH 23390. 
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BLA infusions of SCH 23390 reduce total distance moved in the open field ten 
minutes after administration. 
 
4.4.1 D1 Receptor Antagonism in the Hippocampus during Contextual Fear 
Acquisition 
Intra-dHC SCH 23390 infusion prior to CFC was found to impair contextual fear 
acquisition.  To the best of our knowledge this has not been investigated 
before.  It has been proposed that D1Rs are involved in the synthesis of PRPs 
(Wang et al., 2010; Sajikumar and Frey, 2004).  It could be that intra-dHC SCH 
23390 prior to CFC impairs the initiation of PRP synthesis and so E-LTP is not 
being converted to late L-LTP, leading to impaired LTM.  An alternative 
explanation could be that attention is required during acquisition for the 
initial association between CS and US or for contextual encoding itself to 
occur and D1R antagonism could be impairing this.  It has been shown that 
attention increases stability of hippocampal place fields and that SCH 23390 
interferes with this (Kentros et al., 2004).  The finding that intra-dHC SCH 
23390 impairs CFC acquisition is in agreement with previous research 
investigating spatial and episodic-like memory.  Intra-dHC SCH 23390 fifteen 
minutes before a new location trial in the DMP watermaze was found to 
impair memory six houƌƐůĂƚĞƌ ?K ?ĂƌƌŽůůĞƚĂů ? ? ? ? ? ? ? ?/ŶĂŵŽĚŝĨŝĐĂƚŝŽŶŽĨƚŚĞ 
DMP water maze which included an additional more sensitive measure 
(search preference), SCH 23390 infusions before training were also found to 
impair memory thirty minutes later (Pezze and Bast, 2012).  Episodic-like 
memory was also impaired by Intra-dHC SCH 23390 prior to training during 
retention tests twenty four hours but not thirty minutes later (Bethus et al., 
2010).  However, previous research investigating the effects of SCH 23390 in 
the hippocampus on other memory paradigms including object recognition 
and the radial arm maze, found that D1R antagonism did not impair initial 
memory formation, in disagreement with our findings.  SCH 23390 infusions 
into the hippocampus before or after training did not impair object 
recognition memory (Balderas et al., 2013; Rossato et al., 2013).  Intra-dHC 
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infusions of SCH 23390 prior to working memory in the radial-arm maze was 
not affected by SCH 23390 infusions into the vHC (Wilkerson and Levin, 1999). 
 
4.4.2 D1 Receptor Antagonism in the Amygdala during Contextual Fear 
Acquisition 
Intra-BLA infusion of SCH 23390 was not found to affect the acquisition of 
contextual fear memory.  This is not in agreement with another study which 
found that SCH 23390 impaired the acquisition and retention of auditory and 
background contextual fear when infused into the amygdala (Guarraci et al., 
1999).  However, drug infusions were made into the cAMY of female Long 
Evans rats in that study, as opposed to the BLA of male Lister hooded rats in 
the present study; these variations could explain the different results 
obtained.  Also, in the Guarraci et al. (1999) study contextual freezing 
behaviour was measured in response to the background context during the 
interval between tone presentations.  Therefore it is difficult to say whether 
the rats were freezing due to cued associations induced by the tone or strictly 
to the contextual associations of the chamber.  There are mixed findings on 
the effects of amygdala D1R antagonism in other memory paradigms.  In one 
study, FPS acquisition was not impaired by intra-amygdala SCH 23390 
administered prior to training (De Oliveira et al., 2011) whereas another study 
found that intra-amygdala SCH 23390 prior to FPS training did impair 
subsequent memory retention (Greba and Kokkinidis, 2000).  The lack of 
effect of intra-BLA SCH 23390 prior to CFC could potentially be due to 
compensation by other brain regions.  The dynamic memory theory 
postulates that the hippocampus and amygdala under normal circumstances 
are necessary for contextual fear acquisition; however, when damaged other 
competing brain regions can compensate (Fanselow, 2010).  The bed nucleus 
of the stria terminalis has been shown to be able compensate for loss of the 
BLA (Poulos et al., 2010).  Lesions of both the BLA and the bed nuclei of stria 
terminalis prevented acquisition of contextual fear after extensive over 
training whereas BLA lesions alone did not (Poulos et al., 2010).  In another 
study, infusions of SKF 38393 (D1R agonist) concurrently into both the 
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amygdala and mPFC were required to overcome the object recognition 
memory impairment produced by VTA inactivation (Rossato et al., 2013). 
 
4.4.3 D1 Receptor Antagonism in the Hippocampus and Amygdala on 
Behaviour in the Open Field 
Intra-dHC or intra-BLA SCH 23390 infusions ten minutes prior to open field 
testing resulted in a reduction in total distance moved.  Intra-dHC SCH 23390 
also led to reduced rearing frequency and time spent in the inner zone of the 
open field, whereas intra-BLA SCH 23390 did not affect these behaviours.   
These results are in conflict with previous research.  Liao et al. (2013) found 
no effect of intra-CA1 SCH 23390 on locomotion in the open field, but a lower 
dose (30 ng) was used in their study as opposed to the 5µg per side used in 
our experiment (Liao et al., 2013).  SCH 23390 was also not found to reduce 
locomotion and rearing behaviour when infused into the vHC (Gimenez-Llort 
et al., 2002) but again a lower dose of SCH 23390 was used and drug infusions 
were made into the ventral as opposed to the dHC.  Other studies have also 
shown no effects of SCH 23390 on locomotion in the open field when infused 
into BLA or the IPCs before testing (de Oliveira et al., 2011; De la Mora et al., 
2005).  Again, lower doses of SCH 23390 were used in these studies which 
could explain why the results differ from ours.  The time spent in the inner-
zone of the open field is hard to interpret given that both intra-dHC and intra-
BLA SCH 23390 infusions were found to reduce total distance moved; 
therefore the reduction seen with intra-dHC SCH 23390 is most likely a result 
of decreased locomotion rather than drug induced increases in anxiety. 
 
4.4.4 Chapter Four Summary 
The effect of D1R antagonism in the dHC and BLA on contextual fear 
acquisition was investigated.  It was found that SCH 23390 infusions into the 
dHC but not the BLA impaired freezing behaviour during LTM retention 
sessions.  D1R activation during contextual fear acquisition in the dHC could 
be required for the initial synthesis of PRP (Wang et al., 2010; Sajikumar and 
Frey, 2004).  It is likely that D1Rs in the dHC are important for the encoding of 
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spatial representations of the fear context.  It is also possible that the dHC has 
a role in the association of the context with the US.  The experiments outlined 
in this chapter have not previously been undertaken for contextual fear 
memory and therefore extend the existing literature.   
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Chapter Five 
Systemic D1 Receptor Antagonism during 
Contextual Fear Retrieval, 
Reconsolidation and Extinction 
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5.1 Introduction 
The cAMP/PKA and PLC molecular pathways which are regulated by D1Rs 
both lead to the activation of the transcription factor CREB.  CREB activation 
initiates the synthesis of new proteins that can be used for plasticity related 
changes such as synthesis of structural proteins or ion channel modulation.  
Previous research has shown CREB to be involved in the processes of retrieval, 
reconsolidation and extinction.  In one study increases in CREB occurred in the 
hippocampus and amygdala following contextual and auditory fear 
reactivation (Kida et al., 2002; Mamiya et al., 2009).  However, another study 
found increased pCREB in the amygdala but not the hippocampus following 
cued fear retrieval (Hall et al., 2001).  Activation of neurons which had high 
CREB activity at the time of conditioning was found to be sufficient to retrieve 
an auditory fear memory without behavioural cues (Kim et al., 2014) and 
ablation of these specific neurons impaired retrieval (Han et al., 2009).  
Transgenic mice in which CREB was repressed in the hippocampus and 
amygdala were found to have impaired contextual and auditory fear 
reconsolidation (Kida et al., 2002).  CREB repressed mice were found to have 
impaired contextual fear extinction (Mamiya et al., 2009) and pCREB was 
increased in the mPFC and amygdala but not hippocampus following 
extinction training (Mamiya et al., 2009).   
 
There are mixed findings for the role of D1Rs in memory retrieval.  In one such 
study systemic SKF 81297 (D1R agonist) enhanced the retrieval of object 
recognition at a delay of four hours whereas at a delay of fifteen minutes the 
opposite was found, with the drug impairing retrieval (Hotte et al., 2005).  
SCH 23390 infused into the nucleus accumbens shell lead to enhanced 
retrieval of contextual fear (Albrechet-Souza et al., 2013).  SCH 23390 
infusions into either the VTA or the amygdala on the other hand, had no 
effect on the retrieval of FPS (De Oliveira et al., 2009; Greba and Kokkinidis, 
2000).  Intra-hippocampal SCH 23390 was not found to impair the retrieval of 
inhibitory avoidance in one study (Izquierdo et al., 1998), whereas another 
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study found that it did, but that intra-amygdala SCH 23390 did not (Barros et 
al., 2001).  Other research showed the involvement of D1Rs in the retrieval of 
fear using second order auditory fear conditioning (Nader and LeDoux, 1999).  
It has previously been shown that systemic D1R antagonism is not required 
for the retrieval of contextual fear (Inoue et al., 2000). 
 
The role of systemic D1Rs in the reconsolidation or extinction of contextual 
fear has not, to the best of our knowledge, been investigated before.  
However, studies testing other memory paradigms using D1R agonists and 
antagonists have produced mixed results, some of which have been outlined 
below.  Systemic amphetamine administration immediately following a 
reactivation session was not found to affect reconsolidation of PCA (Blais and 
Janak, 2007) but did enhance the reconsolidation of CPP (Blais and Janak, 
2006).  Systemic SCH 23390 was found to impair the reconsolidation of 
passive avoidance in chicks (Sherry et al., 2005) and SCH 23390 infused into 
the mPFC of non-habituated, but not habituated, rats resulted in impaired 
object recognition reconsolidation (Maroun and Akirav, 2009).  In one study 
investigating the involvement of D1Rs in extinction using transgenic mice, D1R 
KO mice did not have impaired contextual or auditory fear extinction (Ortiz et 
al., 2010), whereas another found that extinction of contextual fear and 
passive avoidance was impaired (EL-Ghundi et al., 2001).  Systemic 
administration of MPD before or after contextual fear was found to improve 
extinction (Abraham et al., 2012).  Other studies found no effect of systemic 
amphetamine on auditory fear extinction (Mueller et al., 2009; Carmack et al., 
2010).  Auditory fear extinction was found to be impaired by intra-PFC but not 
intra-BLA infusion of SCH 23390 (Hikind and Maroun, 2008).  But another 
study found that intra-PFC and BLA infusions of SCH 23390 did not affect the 
extinction of contextual fear or inhibitory avoidance, whereas intra-
hippocampal infusions did (Fiorenza et al., 2012).  Systemic SCH 23390 was 
found to impair the extinction of CPP (Fricks-Gleason et al., 2012) and D1R 
agonists, including SKF 38393, blocked FPS extinction (Borowski and 
Kokkinidis, 1998) 
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Chapter Five Aims 
The experiments in this chapter extend previous research by investigating the 
effects of systemic D1R antagonism on the reconsolidation and extinction of 
contextual fear in rats.  The aim was to test the effect of administration of SCH 
23390 prior to or immediately after either a short memory reactivation 
session or a longer extinction session. 
 
5.2 Methods 
The methods used in this chapter have been outlined in chapter two.  Briefly, 
in the reconsolidation experiments SCH 23390 or saline was injected thirty 
minutes before (SCH 23390 n=10; saline n=10) or immediately after (SCH 
23390: n=9; saline n=8) a reactivation session in which the rats were returned 
to the conditioning chamber for two minutes in the absence of footshocks.  
The rats had their memory tested twenty four hours and seven days later by 
again returning them to the chamber for two minutes.  As SCH 23390 or saline 
was injected before reactivation in some rats, this enabled memory retrieval 
to also be tested.  For the extinction experiments SCH 23390 or saline was 
injected thirty minutes before (SCH 23390: n=9; saline: n=9) or immediately 
after (SCH 23390: n=10; saline: n=9) a twenty minute extinction session in 
which the rats were returned to the conditioning chamber in the absence of 
footshocks.   
 
For the reconsolidation experiment, a two-way mixed ANOVA was used to 
analyse the freezing levels, with drug (SCH 23390 or vehicle) as the between-
subject factor and memory testing session (REACT, PR-LTM1 and PR-LTM7) as 
the within-subject factor.  For the extinction experiment in which SCH 23390 
or saline was administered prior to the extinction session, drug effects on 
extinction and its retention were examined separately. Two separate two-way 
ANOVAs were used, with drug (SCH 23390 or vehicle) as the between-subject 
factor and testing session (early or late extinction) as the within-subject factor 
in the first analysis, and extinction retention (24 hr and 7 d) as the within-
subject factor in the second analysis.  For the extinction experiment in which 
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SCH 23390 or saline was administered immediately after the extinction 
session, a two-way ANOVA was used with the within-subject factor being 
extinction retention (24 hr and 7 d). All data are presented as the mean + 
SEM. 
 
5.3 Results 
5.3.1 Effect of Systemic D1R Antagonism on Contextual Fear Retrieval and 
Reconsolidation 
Administration of SCH 23390 thirty minutes prior to contextual fear 
reactivation did not impair freezing behaviour during reactivation or PR-LTM 
testing twenty four hours or seven days later (see Fig5.1).  Analysis using a 
two-way ANOVA revealed no main effect of drug (F(1,18)=0.888, P>0.05) and no 
drug x time interaction (F(3,54)=1.780, P>0.05).  Likewise, SCH 23390 
administered immediately after reactivation had no effect on freezing twenty 
four hours or seven days later, as there was no main effect of drug 
(F(1,15)=0.545, P>0.05) and no interaction between drug and time (F(3,45)=1.536, 
P>0.05). 
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Fig 5.1 The effect of D1R antagonism on contextual fear reconsolidation.  SCH 23390 
A) prior to or B) immediately after reactivation (REACT) did not impair freezing 24hrs 
(PR-LTM1) or 7days (PR-LTM7) later. Conditioning (COND); arrow denotes time of 
drug administration. 
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5.3.2 Effect of Systemic D1R Antagonism on Contextual Fear Extinction 
There was also no difference between freezing behaviour in the drug and 
saline groups during early and late extinction with no main effect of drug 
(F(1,16)=0.817, P>0.05) and no drug x time interaction (F(1,16)=0.241, P>0.05).  
Administration of SCH 23390 thirty minutes prior to contextual fear extinction 
did not impair freezing behaviour twenty four hours or seven days later (see 
Fig5.2).  Analysis using a two-way ANOVA revealed no main effect of drug 
(F(1,16)=0.139, P>0.05) and no drug x time interaction (F(1,16)=0.570, P>0.05).  
Likewise SCH 23390 administered immediately after the extinction session 
had no effect on freezing twenty four hours or seven days later, as there was 
no main effect of drug (F(1,17)=1.079, P>0.05) and no drug x time interaction 
(F(1,17)=0.049, P>0.05).  
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5.4 Discussion  
Systemic D1R antagonism was not found to effect contextual fear memory 
retrieval, reconsolidation, or extinction.  This indicates that DA acting at the 
D1R is not required during these memory stages. 
 
5.4.1 Systemic D1 Receptor Antagonism during Retrieval 
Systemic administration of SCH 23390 was not found to affect the retrieval of 
contextual fear.  This is in agreement with previous research for contextual 
Fig 5.2 The effect of D1R antagonism on contextual fear extinction.  A) SCH 23390 
prior to or B) immediately after extinction (EXT) had no effect on memory retention 
24hrs and 7days later. Conditioning (COND), early extinction (E-EXT), late extinction 
(L-EXT), arrow denotes time of drug administration. 
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fear (Inoue et al., 2000).  This is also in agreement with previous research 
looking at FPS.  SCH 23390 infused into either the VTA (De Oliveira et al., 
2009) or the amygdala (Greba and Kokkinidis, 2000) was not found to effect 
FPS retrieval.  Intra-hippocampal SCH 23390 was not found to affect the 
retrieval of inhibitory avoidance, in agreement with the present results 
(Izquierdo et al., 1998).  However in another study intra-hippocampal SCH 
23390 impaired retrieval of inhibitory avoidance, whereas intra-amygdala SCH 
23390 did not (Barros et al., 2001).  Other research is also not in agreement, 
SCH 23390 infused into the nucleus accumbens shell enhanced the retrieval of 
contextual fear (Albrechet-Souza et al., 2013) and intra-BLA SCH 23390 
impaired the retrieval of cued fear (Nader and LeDoux, 1999). 
 
5.4.2 Systemic D1 Receptor Antagonism during Reconsolidation 
Systemic SCH 23390 administered prior to or immediately after reactivation 
was not found to affect contextual fear reconsolidation.  This has not been 
shown before to the best of our knowledge.  These findings are not in 
agreement with previous systemic research investigating the reconsolidation 
of passive avoidance in chicks (Sherry et al., 2005).  SCH 23390 infused into 
the mPFC was also found to impair the reconsolidation of object recognition 
in non-habituated rats (Maroun and Akirav, 2009).  However intra-mPFC SCH 
23390 infusions did not affect the reconsolidation of object recognition in 
habituated rats (Maroun and Akirav, 2009), in agreement with the present 
findings.   
 
5.4.3 Systemic D1 Receptor Antagonism during Extinction 
Systemic administration of SCH 23390 prior to or immediately after extinction 
was not found to affect extinction acquisition or subsequent extinction 
memory retention twenty four hours and seven days later.  These findings are 
not in agreement with previous systemic research where SCH 23390 was 
found to impair the extinction of CPP (Fricks-Gleason et al., 2012).  Other 
studies have found that intra-PFC SCH 23390 impairs the extinction of 
auditory fear (Hikind and Maroun, 2008), but not inhibitory avoidance 
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(Fiorenza et al., 2012).  Intra-BLA SCH 23390 was not found to affect the 
extinction of auditory fear (Hikind and Maroun, 2008) or inhibitory avoidance, 
whereas intra-hippocampal infusions did (Fiorenza et al., 2012). 
 
It is possible that the dose of SCH 23390 used in the experiments carried out 
in this chapter was not strong enough to produce an effect.  However, the 
same dose was found to impair the acquisition of contextual fear (Chapter 3) 
and also reduced locomotion in the open field (Chapter 3) indicating that this 
is most likely not the case.  It is also possible that SCH 23390 is having 
opposite effects in different brain regions and therefore no net effect is seen 
when the drug is administered systemically.  This could be resolved by future 
studies in which SCH 23390 is administered centrally into different brain 
regions such as the hippocampus and the effect on contextual fear retrieval, 
reconsolidation and extinction determined. 
 
5.4.4 Chapter Five Summary 
It was found that D1R antagonism is not involved in the retrieval, 
reconsolidation and extinction of contextual fear.  This could be because DA is 
not involved or it is possible that the dose of SCH 23390 used in the 
experiments was not high enough to affect the modulation of these 
processes.  It is also possible that D2Rs are important instead.  Previous 
research has implicated D2Rs in the retrieval of FPS (De Oliveira et al., 2006), 
the reconsolidation of CPP (Yan et al., 2013) and the extinction of auditory 
fear (Mueller et al., 2010; Holtzman-Assif, 2010; Ponnusamy et al., 2005).  
Future studies could investigate the role of D2Rs in contextual fear retrieval, 
reconsolidation and extinction. 
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Chapter Six  
Systemic D1 Receptor Antagonism during 
Contextual Fear Memory Destabilization 
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6.1 Introduction 
Memory destabilization occurs when a previously consolidated memory is 
retrieved and becomes unstable.  It has been proposed that prediction error, 
which occurs with a discrepancy between expected and actual events, is 
required to engage the process of destabilization (Ben Mamou et al., 2006).  
Once a memory has been destabilized it must undergo the process of 
reconsolidation in order to be stabilized again.  It was recently demonstrated 
that FPS memory reconsolidation in humans only occurred where a positive or 
negative prediction error was present during the reactivation session 
(Sevenster et al., 2013).  Normally strong memories are less likely to undergo 
reconsolidation.  However the presence of a temporal prediction error 
resulted in destabilization and subsequent impairment of reconsolidation 
even for strong memories (Diaz-Mataix et al., 2013).  The VTA was also shown 
to be important for Pavlovian over-expectation learning following a negative 
prediction error (Takahashi et al., 2009). 
 
The first study to investigate the destabilization process showed that NMDARs 
are important in the process (Ben Mamou et al., 2006).  They developed a 
method in which it was possible to show that the process of destabilization 
had been engaged by using the drug anisomycin.  Anisomycin is a protein 
synthesis inhibitor which has been shown to impair PR-LTM when 
administered immediately following a reactivation session (Nader et al., 
2000).  They therefore argued that if the NMDAR antagonist ifenprodil 
administered before the reactivation session was able to prevent the memory 
impairing effect of administration of anisomycin immediately after 
reactivation, then the destabilization must have been blocked by ifenprodil, 
indicating the requirement for NMDARs in the process (Ben Mamou et al., 
2006).  Using this method but replacing anisomycin with MK-801 it was 
recently shown that VTA activity is involved in the destabilization of appetitive 
goal-tracking memory (Reichelt et al., 2013).  Due to this building evidence 
demonstrating an involvement of prediction error in the destabilization 
process and evidence showing DA is required for prediction error (Schultz, 
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2013), we hypothesised that D1Rs could be important in the destabilization of 
contextual fear memories. 
 
Chapter Six Aims 
The aim of the study undertaken in this chapter was to investigate the effect 
of systemic SCH 23390 administration before and MK-801 immediately after a 
reactivation session, to test if impairing D1R activity would protect the 
memory from subsequent disruption by MK-801 and therefore indicate a role 
for D1Rs in contextual fear memory destabilization.  For this to be relevant it 
must also be shown that MK-801 administered immediately after reactivation 
impaired reconsolidation. 
 
6.2 Methods 
The methods used in this chapter have been outlined in chapter two.  Briefly, 
rats underwent CFC and were injected systemically twenty four hours later, 
with the SCH 23390/MK-801 group (n=9) receiving SCH 23390 thirty minutes 
before and MK-801 immediately after a reactivation session in which they 
were returned to the conditioning chamber for two minutes.  The saline/MK-
801 group (n=8) received saline before and MK-801 after the reactivation 
session and the saline/saline group (n=10) received saline both before and 
after.  The rats had their PR-LTM tested twenty four hours and seven days 
later by again returning them to the chamber for two minutes. A two-way 
mixed ANOVA was used to analyse the freezing levels, with drug group (SCH 
23390/MK-801, saline/MK-801 or saline/saline) as the between-subject factor 
and memory testing session (REACT, PR-LTM1 or PR-LTM7) as the within-
subject factor.  All data are presented as the mean + SEM. 
 
6.3 Results 
There were no differences between any of the groups during retrieval or PR-
LTM (see Fig6.1).  Analysis using a two-way ANOVA revealed no main effect of 
drug (F(1,24)=0.316, P>0.05) and no drug x time interaction (F(6,72)=0.302, 
P>0.05). 
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6.4 Discussion 
It was found that SCH 23390 prior to reactivation and MK-801 immediately 
after had no effect on PR-LTM twenty four hours and seven days later.  
However, because administering saline before and MK-801 immediately after 
reactivation also had no effect, it is not possible to draw any conclusions on 
the role of D1R antagonism in contextual fear destabilization.  The study 
depended on the Saline/MK-801 group having impaired PR-LTM but this was 
not found.  Previous work has shown that systemic MK-801 administered 
after reactivation impaired contextual fear reconsolidation in mice (Charlier 
and Tirelli, 2011).  It has also previously been shown that systemic MK-801 
administered after reactivation impaired appetitive goal tracking 
reconsolidation in rats (Reichelt et al., 2013).  These studies are not in 
agreement with our findings.  However, in another study systemic MK-801 
prior to reactivation of appetitive memory did not affect reconsolidation, in 
agreement with our findings (Lee and Everitt, 2008). 
 
Fig 6.1 The effect of D1R antagonism on contextual fear memory destabilization.  
There was no difference in freezing behaviour between the SCH 23390/MK-801, 
saline/saline and saline/MK 801 groups 24hrs (PR-LTM1) or 7 days (PR-LTM7) 
later.  Conditioning (COND), reactivation (REACT). 
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The lack of effect of MK-801 on contextual fear could be due to the 
reactivation session being too long in duration, leading to extinction rather 
than reconsolidation being engaged, or too short in duration, leading to 
destabilization only being partially induced (Bustos et al., 2009).  It could also 
be that the 0.1mg/kg dose of MK-801 used was not sufficient to effect the 
reconsolidation of contextual fear.  However, in our initial validation study 
(Chapter 2) we found that a 0.1mg/kg dose of MK-801 administered before a 
two minute reactivation did block reconsolidation, which would indicate this 
is most likely not the case.  However, future studies could explore further the 
parameters under which MK-801 given after reactivation might disrupt 
reconsolidation.  A weaker conditioning procedure could be used, the length 
of the reactivation session could be altered, and/or a higher dose of MK-801 
could be administered.  These procedural changes might potentially result in 
blockage of reconsolidation by MK-801 administration immediately after 
reactivation.  Alternatively, future studies could replace MK-801 with a drug 
that impairs contextual fear reconsolidation when administered after 
reactivation to determine whether or not D1Rs are involved in contextual fear 
destabilization.  Possible drug options are the GluN2A preferring NMDAR 
antagonist NVP-D ? ? ? ? ƚŚĞ ŶŽƌĂĚƌĞŶĞƌŐŝĐ ɴ-blocker propranolol or 
midazolam which enhances the effects of GABA at the GABAA receptor 
(Milton et al., 2013; Debiec and LeDoux, 2004; Bustos et al., 2009). 
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Chapter Seven 
General Discussion 
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7.1 Summary 
The role of D1Rs in contextual fear learning and memory was investigated.  
The experiments outlined in chapters three and four found that systemic and 
intra-DH administration of SCH 23390 impaired contextual fear memory 
acquisition whereas intra-BLA SCH 23390 did not.  The effect of intra-dHC and 
intra-BLA D1R antagonism during CFC acquisition has not been investigated 
before, therefore these findings advance the current literature. 
 
The experiments outlined in chapter five found that systemic administration 
of SCH 23390 was not involved in the reconsolidation, retrieval or extinction 
of contextual fear memory.  The effect of systemic D1R antagonism during 
CFC reconsolidation and extinction has not been investigated before and 
advances the understanding of the role of DA in these processes. 
 
The experiments outlined in chapters two and six found that systemic 
administration of MK-801 impaired contextual fear reconsolidation when 
administered prior to, but not immediately after, memory reactivation.  This, 
to the best of our knowledge, has not previously been demonstrated in rats 
and therefore extends the literature on the role of NMDARs in 
reconsolidation. 
 
The experiment outlined in chapter six, looking at whether D1Rs are involved 
in contextual fear memory destabilization, was inconclusive.  Future studies 
that could resolve these have therefore been outlined below, along with a 
discussion of the all the findings presented in this thesis. 
 
7.2 MK-801 Effects on Acquisition and Reconsolidation 
The finding that systemic MK-801 administration prior to CFC impairs 
subsequent memory retention is in agreement with previous systemic 
research (Gould et al., 2002).  The finding that systemic MK-801 
administration prior to CFC reactivation impairs reconsolidation has not, to 
the best of our knowledge, been tested before.  This finding is in agreement 
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with previous research for auditory fear (Lee et al., 2006), appetitive memory 
(Lee and Everitt, 2008) and associative drug-seeking memory (Milton et al., 
2008).  There are, however, a number of alternative explanations for the 
above findings which are worth discussing.  Firstly, it could be that reduction 
in freezing behaviour in the MK-801 injected rats during the reactivation 
sessions are a result of non-specific side effects on locomotion.  Previous 
studies have found that MK-801 increases locomotion in the open field and 
Morris water maze at a dose of 0.1mg/kg (Wegener et al., 2011).  Secondly, it 
is possible that the effects of MK-801 on memory retention twenty four hours 
after conditioning or reactivation could be due to state-dependency, which 
has previously been shown to occur for passive avoidance memory using MK-
801 (Flint et al., 2013).  A future study could test this by administering MK-801 
prior to LTM or PR-LTM, testing to see if memory is still impaired by MK-801 
administration prior to conditioning or reactivation, respectively.   
 
Thirdly, a bigger difference between the freezing behaviour of MK-801 and 
saline groups at twenty four hours, compared with seven days after 
conditioning and reactivation, was found in both experiments and is a trend 
seen throughout the experiments presented in this thesis.  This could be 
because extinction occurred due to the rats being exposed to the chamber 
without footshock, resulting in the rats forming a new competing non-fearful 
memory of the chamber.  It could also be because the saline injected rats 
forgot their conditioning experience due to the passing of time.  To test 
whether the rats had forgotten due to the passing of time, an experiment 
could be carried out in which the rats only have their memory tested seven 
days after conditioning (i.e. instead of both 24 hr and 7 d after conditioning).  
If the rats had a similar level of freezing to the rats in our experiment, then 
this would indicate that the rats forget the conditioning experience after a 
week.  To test whether the rats had undergone extinction, one group of rats 
could be fear conditioned and then returned to the chamber for two minute 
sessions without footshock, on two occasions within a week (similar to the 
reconsolidation experiment), and another group could undergo one return 
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session (similar to the consolidation experiment).  If the rats had similar levels 
of freezing to the rats in our experiment, then this would indicate that 
extinction had occurred. 
 
The finding that systemic MK-801 administration immediately after CFC 
reactivation does not impair reconsolidation in rats has not previously been 
tested and is in agreement with work carried out on appetitive memory (Lee 
and Everitt, 2008).  However, other research has found that MK-801 
immediately after CFC reactivation did impair reconsolidation in mice (Charlier 
and Tirelli, 2011) and appetitive goal-tracking memory in rats (Reichelt et al., 
2013).  It is possible that these differences could be because of the 
experimental parameters used.  It could be that reconsolidation is not being 
engaged in our experiment because the footshock protocol used during 
conditioning was too strong.  Strong memories have been shown to be less 
likely to undergo reconsolidation then weaker ones (Suzuki et al., 2004).  
However, we found that MK-801 administered prior to reactivation impaired 
reconsolidation under the current footshock protocol (Chapter 2).  It could be 
that the two minute reactivation session used in our experiments was not 
engaging the reconsolidation process.  It has previously been shown that if the 
memory reactivation session is too short then contextual fear reconsolidation 
does not take place (Bustos et al., 2009).  However, we found that MK-801 
impaired reconsolidation using a two minute reactivation session when it was 
given before reactivation (Chapter 2).  In conclusion, NMDARs are important 
for the initial acquisition of CFC and reconsolidation of CFC when MK-801 is 
administered systemically prior to, but not immediately after, reactivation. 
 
7.3 Systemic and Central SCH 23390 Effects on Acquisition 
Systemic D1R antagonism was found to modulate contextual fear memory 
acquisition.  Administration of SCH 23390 prior to CFC, led to reduced freezing 
behaviour during subsequent retention tests twenty four hours later.  This 
finding is in agreement with previous research (Inoue et al., 2000, Calzavara et 
al., 2009) and is most likely not due to side effects of SCH 23390 on 
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locomotion or pain sensitivity.  SCH 23390 was not found to effect behaviour 
in the open field when administered twenty four hours prior to testing.  SCH 
23390 was also not found to affect the pain sensitivity threshold of the rats 
compared with saline injected controls.  It is possible that D1R activation 
during contextual fear acquisition could be involved in the synthesis of PRPs.  
These proteins, such as kinase Mɺ  ?EĂǀĂŬŬŽĚĞ Ğƚ Ăů ? ?  ? ? ? ? ? ? ŚĂǀĞbeen 
proposed to be important for the conversion of E-LTP to L-LTP as describe by 
the synaptic tagging and capture hypothesis (Frey and Morris, 1997).  A bigger 
difference between the controls and drug group at twenty four hours 
compared with seven days was observed.  This is similar to what was found 
when MK-801 was administered prior to conditioning (Chapter 2).  This could 
be due to the saline injected controls simply forgetting with the passing of 
time or it could be due to extinction as a result of the rats being exposed to 
the chamber without footshocks.  Future experiments that could address this 
have been outlined above. 
 
Infusion of SCH 23390 into dHC prior to CFC was found to impair freezing 
behaviour during LTM retention.  This indicates that DA modulation in the 
dHC is important during the acquisition of contextual fear.  This is in 
agreement with previous research investigating spatial and episodic-like 
memory  ?K ?ĂƌƌŽůůĞƚĂů ? ? ? ? ? ? ?WĞǌǌĞĂŶĚĂƐƚ ? ? ? ? ? ?Bethus et al., 2010). It is 
possible that D1R activation in the dHC during contextual fear acquisition 
ĐŽƵůĚ ůĞĂĚƚŽƚŚĞƐǇŶƚŚĞƐŝƐŽĨWZWƐ ?ƐƵĐŚĂƐW<Dɺ ?ǁŚŝĐŚĂƌĞ ŝŶǀŽůǀĞĚ ŝŶƚŚĞ
conversion of E-LTP to L-LTP as describe by the synaptic tagging and capture 
hypothesis (Frey and Morris, 1997).  Similar to the findings for systemic SCH 
23390 prior to CFC there was a bigger difference between the control and 
drug groups at twenty four hours compared with seven days when SCH 23390 
was administered centrally.  Future experiments that could address this have 
been outlined above. 
 
Infusion of SCH 23390 directly into the BLA prior to CFC was not found to 
impair acquisition, thus indicating that DA modulation in this brain region is 
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not involved in CFC.  This conflicts with previous research undertaken on 
auditory fear (Guarraci et al., 1999) and CFC (Biedenkapp and Rudy, 2009).  
There are mixed findings for the involvement of BLA DA modulation in the 
acquisition of FPS.  One study found that FPS was impaired (Greba and 
Kokkinidis, 2000) whereas another study found that it was not, in agreement 
with our findings for contextual fear (De Oliveira et al., 2011).  The lack of 
effect of intra-BLA SCH 23390 to modulate contextual fear acquisition could 
also be because other brain regions such as the BNST and IL are compensating 
(Fanselow, 2010).  These brain regions receive DA innervations and express 
D1Rs (Swanson, 1982; Gustafson and Greengard, 1990; Lu et al., 1997) and 
are involved in contextual fear acquisition (Poulos et al., 2010; Zelikowsky et 
al., 2013). 
 
In conclusion, SCH 23390 was found to impair contextual fear acquisition 
when administered systemically and centrally into the dHC but not when 
administered into the BLA.  Understanding the role of contextual fear 
acquisition potentially provides insight into the mechanisms involved in the 
development of anxiety disorders such as PTSD.  For example it could be that 
individual differences in D1R signalling in the dHC could determine why some 
people are more susceptible to the development of PTSD compared with 
others. 
 
7.4 Systemic SCH 23390 Effects on Consolidation, Retrieval, Reconsolidation 
and Extinction 
Systemic D1R antagonism was not found to modulate contextual fear 
consolidation or retrieval.  Systemic administration of SCH 23390 immediately 
after CFC had no effect on freezing behaviour during retention tests twenty 
four hours or seven days later.   Retrieval of contextual fear memory was not 
found to be affected by SCH 23390 administered prior to reactivation.  These 
results are in agreement with previous literature (Inoue et al., 2000).  It was 
also found that SCH 23390 administered either prior to, or immediately after, 
a short two minute reactivation session or longer twenty minute extinction 
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session, did not impair freezing behaviour during the reactivation session or 
during subsequent retention tests.  This indicates that D1Rs are not involved 
in contextual fear memory reconsolidation or extinction, which has not 
previously been shown. 
 
It could be that D2Rs rather than D1Rs are important for these contextual fear 
memory stages.  Previous studies using D2Rs agonists and antagonists have 
indicated that D2R are important in other types of memory paradigms, some 
of which have been outlined below.  Intra-BLA infusion of the D2R antagonist 
sulpiride was found to impair the consolidation of inhibitory avoidance 
(Lalumiere et al., 2004).  Other research has shown the involvement of D2Rs 
in FPS retrieval.  Systemic administration of the D2R agonist quinpirole 
impaired FPS retrieval (De Oliveira et al., 2006).  Intra-VTA infusions of 
quinpirole were also found to impair FPS (Borowski and Kokkinidis 1996; De 
Oliveira et al., 2009).  It has been suggested that quinpirole could be affecting 
pre-synaptic auto receptors resulting in decreased DA levels at VTA DA 
neuronal terminal fields (De Oliveira et al., 2009).  One such terminal field is 
the BLA of the amygdala.  Intra-VTA quinpirole was found to decrease DA 
levels in the BLA (De Oliveira et al., 2011).  Intra-BLA infusion of the D2R 
antagonist sulpiride impaired FPS (De Oliveira et al., 2011).  D2Rs have also 
been implicated in the reconsolidation of CPP to cocaine.  Systemic 
administration of PG01037, a selective antagonist of the D3 receptor, was 
found to impair reconsolidation of CPP when administered following memory 
reactivation (Yan et al., 2013).  Systemic or intra-nucleus accumbens 
administration of haloperidol was found to impair auditory fear extinction 
(Holtzman-Assif et al., 2010).  Systemic or intra-infralimbic administration of 
the D2/3 receptor antagonist raclopride impaired auditory fear extinction 
(Mueller et al., 2010).  Another study found that auditory fear extinction in 
mice was enhanced by sulpiride (D2R antagonist) and partially impaired by 
quinpirole (D2R agonist) (Ponnusamy et al., 2005). 
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In conclusion D1Rs were not found to be involved in the consolidation, 
retrieval, reconsolidation or extinction of contextual fear.  Understanding the 
involvement of D1Rs in reconsolidation and extinction is particularly 
important, given the potential of these memory stages in the treatment of 
anxiety disorders.  The work in this thesis shows that D1Rs do not modulate 
these contextual fear processes, thus providing useful information for future 
hypothesis generation. 
 
7.5 Systemic SCH 23390 Effects on Destabilization 
The experiments carried out to determine whether D1R antagonism is 
involved in contextual fear destabilization were inconclusive due to the 
finding that MK-801 did not impair reconsolidation when administered 
immediately after contextual fear reactivation.  In this study MK-801 was 
ďĞŝŶŐ ƵƐĞĚ ĂƐ Ă  ‘ƚŽŽů ? ŝŶ ŽƌĚĞƌ ƚŽ ƚĞĂƐĞ ĂƉĂƌƚ ƚŚĞ ƌŽůĞ ŽĨ  ?ZƐ ŝŶ
destabilization.  Conclusions therefore cannot be drawn regarding the lack of 
effect observed when SCH 23390 was administered prior to and MK-801 
immediately after contextual fear reactivation.  Future studies could replace 
MK- ? ? ?ǁŝƚŚĂŶĂůƚĞƌŶĂƚŝǀĞ ‘ƚŽŽů ?ĚƌƵŐƚŚĂƚĚŽĞƐŝŵƉĂŝƌĐŽŶƚĞǆƚƵĂůĨĞ ƌǁŚĞŶ
administered immediately after reactivation.  Potential options have been 
discussed below.   
 
One possibility would be a protein synthesis inhibitor such as anisomycin; 
however, systemic application of this drug has been reported to cause 
sickness in rats and is therefore probably best avoided.  It has been 
demonstrated that GluN2A containing NMDARs are engaged in the 
reconsolidation process, whereas GluN2B containing NMDARs are involved in 
destabilization (Milton et al., 2013).  Therefore rather than using MK-801, 
which is a non-selective NMDAR antagonist binding to both subunits, it might 
be sensible to use a GluN2A preferring NMDAR antagonist such as NVP-
AAM077.  This drug has previously been shown to impair the reconsolidation 
of auditory fear when administered into the BLA prior to reactivation (Milton 
et al., 2013) and other studies have used this drug systemically in rats and 
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mice (Chaperon et al., 2003).  Alternative options are the noradrenergic ɴ-
blocker propranolol or the short-acting benzodiazepine midazolam, which 
enhances the activity of GABA at the GABAA receptor.  Systemic and intra-
amygdala administration of propranolol has previously been shown to impair 
the reconsolidation of auditory fear when administered after reactivation in 
rats (Debiec and LeDoux, 2004).  Likewise, systemic administration of 
midazolam immediately after contextual fear reactivation blocked 
reconsolidation in rats (Bustos et al., 2009).  
 
7.6 Conclusion 
In conclusion, the main findings of this thesis are that systemic and intra-dHC 
D1R antagonism impairs the acquisition of contextual fear, whereas 
administration into the BLA did not.  Systemic D1R antagonism, on the other 
hand, was not found to impair the reconsolidation or extinction of contextual 
fear.  These findings are novel and advance the current literature on the role 
of D1Rs during contextual fear learning and memory.  This research aids in 
understanding the underlying causes of anxiety disorders such as PTSD and 
could shed light on why some people may be more susceptible to the 
development of such disorders depending on the modulation of fear learning 
by D1Rs.  This could potentially be useful in the development of preventative 
therapies.  Given that D1Rs were not found to have a role in contextual fear 
reconsolidation and extinction, which could be targeted for treatment, it 
would advisable that future research pursues alternative hypotheses, for 
example, investigating the role of D2Rs in contextual fear reconsolidation and 
extinction. 
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